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Abstract 
 
Enzymes involved in phospholipid biosynthesis  have been suggested as 
possible drug targets to treat Candida infections because several key enzymes, such as 
phosphatidylserine synthase, differ from those of  the human host.We have found that 
phosphatidylserine  synthase of C. albicans is required for virulence in a mouse model 
of systemic Candida infection.In addition,  the C. albicans phosphatidylserine synthase 
mutant (cho1∆/∆) has no detectable phosphatidylserine and loss of phosphatidylserine 
causes alterations in the fungal cell wall. The cho1∆/∆  mutants’ cell wall defects include 
altered calcofluor white staining, resistance to the cell wall perturbing drug Caspofungin, 
and an altered physical appearance by transmission electron microscopy..We are using 
lipidomic analysis and transcriptomics of  phosphatidylserine and 
phosphatidylethanolamine biosynthesis mutants to understand the role that 
phosphatidylserine and phosphatidylethanolamine play in controlling the cell wall in C. 
albicans.The elucidation of  downstream effects of disruption of  pathways involved in 
biosynthesis of phospholipids in C. albicans may validate these phospholipid 
biosynthesis enzymes as plausible anti-fungal drug targets. The role of  
phosphatidylserine and phosphatidylethanolamine in the maintenance of the fungal cell 
wall will  also be of interest in determining how phospholipids impact signaling pathways 
and affect cell wall  composition and architecture.  
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Abstract 
 
Candida albicans remains a major fungal pathogen of humans. The role of  phosphatidylserine 
and phosphatidylethanolamine in the maintenance of the fungal cell wall will  be of interest in 
determining how phospholipids impact signaling pathways and affect cell wall  composition and 
architecture. It is in this light that the examination of basic metabolic processes such as cell wall 
generation and lipid biosynthesis may be useful in finding new therapeutic agents to treat 
Candida infections and understand the host pathogen relationship.   
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Introduction 
Candida albicans is a leading cause of fungal infections in humans and fourth most common 
cause of nosocomial infections in the United States (Edmond et al., 1999). The 
immunocompromised, such as organ transplant and cancer patients are at particularly high risk 
of developing life threatening Candida infections. The mortality rate of these systemic fungal 
infections can reach as high as 40% (Pittet & Wenzel, 1995).  The ability to successfully treat 
this fungal pathogen relies on the continued elucidation of drug targets as drug resistance 
remains a serious threat (Chiller et al., 2012). It is in this light that the examination of basic 
metabolic processes such as cell wall generation and lipid biosynthesis may be useful in finding 
new therapeutic agents to treat Candida infections.   
Diseases caused by Candida albicans 
Candida albicans normally resides in the gastrointestinal tract of healthy individuals and can 
establish an infection when the host defenses are compromised. Oropharyngeal candidiasis is 
the most common fungal infection in immunocompromised patients. This disease can present 
itself in the form of pseudomembranous candidiasis characterized by presence of white plaques 
or xerostomia in nearly 30% of HIV-infected patients (Calderone 2002; Cauda et al., 2012). 
Esophageal candidiasis occurs in patients undergoing treatments for chronic illnesses and 
frequently occurs in patients with advanced HIV infections. C. albicans accounts for more than 
50% of vulvovaginal candidiasis episodes and 75% of women experience at least one episode 
of this disease in their lifetime (Cauda et al., 2012; Calderone 2002). C. albicans can also cause 
superficial infections of the skin and mucous membranes. Mortality rates associated with 
systemic candidiasis (bloodstream infections) is high and at least 10% of all bloodstream 
infections are caused  by Candida species (Pittet, D & Wenzel, R.P. 1995). 
4 
 
C.albicans infections are a consequence of both the virulence properties of this organism 
enabling it to cause invasive infections and the immune status of the host (Singh et al., 2007). 
C.albicans is a successful commensal of the human host and is not readily eliminated since it 
has evolved to persist on host mucosal surfaces and utilize host resources, causing disease 
when host immune deficiencies occur (Cauda et al., 2012).  Treatment of candidiasis is 
hindered by several factors, including the limited number of antifungals and, the emergence of 
drug resistant isolates (Morschhauser J et al., 2012).  
Virulence properties of Candida albicans  
The virulence of Candida albicans is mediated by a series of factors related to its ability to 
survive and colonize the human host (Gow et al., 2011). The ability to survive in the host is a 
complex issue for C. albicans in that it must not only acquire essential nutrients from the host, 
but must also evade attack and avoid clearance by the host immune system (Brown  A.J. et 
al.,2012). Some virulence attributes of C.albicans include production of adhesins (which 
promote host recognition and colonization) secretion of proteases and phospholipases (which 
are digestive enzymes that aid in nutrient acquisition and invasion), and phenotypic switching 
associated with invasiveness of the organism (Calderone, 2002).   
Many of the studies on virulence properties of C.albicans have been aided by gene deletion 
studies that result in the avirulence of the organism in mucosal and systemic animal models of 
candidiasis. These studies  provide direct evidence that specific proteins are important in host 
pathogenesis. A thorough understanding of how these virulence factors contribute to disease 
progression, and pathogenesis is crucial so newer drugs can be designed to inhibit these 
factors and thus prevent colonization or persistence of the organism in the host. 
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Adhesins 
One central problem the fungus must encounter in the host is how to adhere to the host when it 
comes into contact with host tissues and mucosal surfaces.  Adherence to host tissues is 
important for disease progression, and Candida albicans is able to adhere to host surfaces via 
production of adhesins (Udea M et al.,2012). These are surface-bound polysaccharides or 
glycoproteins that bind to specific ligands on the host cell surface. Adhesins were mainly 
identified by studies in which the encoding gene was deleted, and the mutant was evaluated for 
its adherence to host cell monolayers in vitro. A number of adhesins have been identified in the 
organism including, but not limited to – complement receptors, fibrinogen-binding protein, 
integrins, lectins and proteins that bind to host proteins such a N-cadherins (Hube et al., 2011).  
The importance of adhesins in C. albicans pathogenesis is highlighted by the contribution of 
adhesins to binding of plastics and biofilm formation (Filler  et al., 2011). Systemic infections are 
usually established by contamination of indwelling catheters where (in the case of C.albicans), 
yeast cells adhere to the catheter and form a thin film which later develops into a thick layer that 
consists predominantly of hyphal cells. Biofilms are inherently resistant to the penetration of 
drugs and thus confer resistance to their inhabitants, and moreover the biofilm provides a 
means for the constant flow of yeast cells from the film into the bloodstream, thus further 
contributing to disease (Williams C et al., 2012). 
Phenotypic Switching 
C.albicans can exist in three different morphological forms – yeast cells, pseudohyphal cells and 
true hyphae. Phenotypic switching refers to the spontaneous interchange between these three 
different morphological states. Initially, it was believed that virulence of this organism was 
dependent on the hyphal form which can penetrate and invade host tissues better than the 
yeast form (Sherwood et al., 1992). However, the yeast cells are better at dissemination and all 
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three morphological forms have been identified in tissues infected with C.albicans (Odds, F. 
1988), and these transitions are thought to promote and reflect the different stages of disease 
progression (Odds, F. 1994). Morphological transitions are triggered in response to growth 
conditions. Hyphal growth is promoted at temperatures above 35⁰C, pH 7, nutrient limitations, 
especially carbon and nitrogen starvation, presence of serum, non-fermentable carbon sources, 
and low oxygen concentrations (Odds, F. 1988). These conditions are presumed to affect the 
signals that regulate cell morphological transitions. Identification of growth-form specific genes 
can provide valuable insights into regulation of morphogenesis and the signaling pathways 
involved.  
Signaling pathways 
Signaling pathways that regulate morphogenetic transitions are thought to contribute to the 
virulence of Candida albicans by controlling different stages of disease establishment and 
progression (Brown, A.J. & Gow, N.A., 1999). In the host, C.albicans can survive in all three 
morphological forms, using environmental cues to dictate which form is more favorable in the 
particular host niche. Identification of the regulatory circuits that facilitate these transitions is 
essential to obtain a detailed understanding of morphogenesis. Many signaling pathways have 
been identified in the fungus, such as the Efg1 pathway (Lengeler et al., 2000), the MAP kinase 
pathway and a pH signaling pathway(Davis et al. 2010). Inactivation of signaling components 
have shown to attenuate virulence in animal models presumably by interfering with expression 
of virulence factors and thus influencing disease progression. 
Many components of the signaling pathway have been identified using Saccharomyces 
cerevisiae as a model fungus, since there is a high degree of sequence conservation with the 
signaling cascades between these distantly related species (Gustin et al., 1998; Banuett, F. 
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1998)). Moreover, the ease of conducting genetic screens in S.cerevisiae has made this 
organism more suitable for dissecting molecular mechanisms specific to signaling.  
Proteases 
Secreted aspartyl proteases (Sap) are secreted proteins that can proteolytically digest 
exogenous host proteins for the simple purpose of acquiring nutrients (Fusek et al., 1994). The 
digestion of host proteins aids in host tissue colonization by digesting host cell membranes, thus 
facilitating host surface adhesion and penetration into tissues. In addition, secretion of 
proteases can also help evade host defenses by damaging cells and molecules of the host 
immune system. The Sap family consists of 10 genes with distinct roles in C.albicans virulence. 
Sap antigens have been detected in the sera of patients with candidiasis indicating an important 
role for Saps during infection (Ruchel, R. 1992; Ruchel et al., 1991). Sap genes are differentially 
expressed in vitro, for example, some SAPs are expressed only in hyphal cells (SAP 4-
6)(Schaller et al., 1998),  some were found both on yeast and hyphal cells. Sap1- Sap3 
contributes to tissue damage (Schaller et al., 1998), Sap 1, 2 and 8 are more prevalent in 
vaginal infections (De bernadis et al., 1995). Some studies have suggested that early during 
systemic infection, SAP4-6 are important for invasion, and once the infection is established, 
SAP1-3 plays an important role (Staib et al.,2000). More compelling evidence for the role of 
Saps during infection comes from studies that demonstrate that C.albicans mutants lacking SAP 
genes are attenuated for virulence (Schaller et al, 1999). Moreover inhibition of proteinase 
activity using inhibitors prevented initial colonization of mucosal surfaces (Fallon et al., 1997). 
Thus, Saps contribute to the overall virulence of C.albicans by hydrolyzing host proteins, 
proteins of the immune system thus promoting colonization, persistence and dissemination of 
infection.  
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Phospholipases 
Phospholipases are enzymes that hydrolyze ester linkages in glycerophospholipids that have 
been implicated in host penetration, and interaction with signal transduction pathways. 
C.albicans has two phospholipases, encoded by PLB1 and PLB2 (Hube, B 1998; Sugiyama et 
al., 1999). These enzymes are categorized as virulence factors since PLB antigens have been 
detected in the sera of patients suffering from candidiasis and they are expressed. Mutants 
lacking phospholipases are significantly attenuated in virulence using animal models for 
systemic infections ( Leidich et al., 1998; Ghannoum, M.A. 2000).  
Lipases 
Lipases are the least characterized of all the secreted hydrolases in C.albicans. Lipases are 
encoded by a family of 10 genes, LIP1-LIP10 (Hube et al., 2000). Expression of these genes is 
usually induced in media containing lipids such as Tween 40 (Fu et al., 1997), but can be 
induced in a lipid independent manner too, suggesting lipases may fulfill roles other than 
acquisition of nutrients in C.albicans. Some lipases were found to be expressed during infection 
in mice further providing evidence that lipases may contribute to the survival and virulence of 
C.albicans in the host (Goldman et al., 2011). 
Drug Targets in Candida albicans 
Elucidating the complex interaction of Candida albicans with the host during infections and 
identifying key genes or enzymes that can assist the fungus in the colonization, persistence and 
invasion of tissues can lead to the development of new therapeutic strategies, through targeting 
these genes/ enzymes, thus extending the limited repertoire of antifungal drugs currently 
available. In this section, some of the currently exploited drug targets will be described with a 
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brief overview of potential enzymatic or biosynthetic pathways that can provide attractive targets 
for the development of antifungals.  
Cell Wall 
The cell wall is critical to the interaction of Candida albicans with the host, since it the outermost 
protective structure for the organism. The C.albicans cell wall is a complex, dynamic structure 
that undergoes significant changes in composition during growth. The different morphological 
forms of the organism differ in the composition of cell wall components and are also associated 
with differential regulation of virulence factors and proteins. The cell wall contributes not only to 
the cell morphology, but also protects the cell against physical, osmotic and oxidative stress 
and, it promotes cell-cell interactions, adherence to host surfaces, and modulates the immune 
response (Ruiz-Herrera et al., 2006). 
The cell wall (Fig:1-1) consists of 80-90% carbohydrate in the form of glucan (which are linear 
and branched polymers of glucose); β1,4 N-acetylglucosamine (chitin) and mannose polymers. 
Chitin and glucans contribute to the rigidity and morphology of the cell wall (Ruiz-Herrera et al., 
2006).  
Chitin is synthesized on the cytoplasmic side of the cell membrane, and then gets extruded to 
the cell surface where it crystallizes through extensive hydrogen bonding. Chitin synthases 
catalyze the polymerization of N-acteylglucosamine (Bulawa, C. E et al., 1993). Chitinase 
contributes to the maintenance and plasticity of the yeast cell wall (Cabib  E et al, 1987) and 
disrupting the chitin synthase gene (CTS1) in S. cerevisiae, results in clumping of the cells and 
failure to separate following cell division (Kuranda and Robbins 1991). Thus chitin synthase are 
potential drug targets owing to their essential role in cell wall maintenance.  
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Glucans are arranged as β-(1,3)-linked residues with β-(1,6)- side chains. The enzyme that 
catalyzes the polymerization of glucans is glucan synthase, which links glucan synthesis to the 
cell cycle (Kang and Cabib 1986).  
Mannoproteins comprise important constituents of the cell wall that determine the surface 
properties of the cell, facilitating adhesion and interaction of C.albicans with the host (Chaffin et 
al., 1998). These are proteins that are covalently attached to the mannose polymers that 
account for about 40% of the total cell wall polysaccharide.  Mannoproteins are immunogenic, 
with each branch of the polymer corresponding to a specific epitope. The cell wall also consists 
of glycosylphosphatidylinositol (GPI) anchored mannoproteins that are covalently linked to β-1,6 
glucan via a covalent bond between the GPI remnant and β-1,6 glucan (Klis et al., 2001). Some 
mannoporteins can be connected via disulfide bridges to other proteins in the cell wall 
(Boisrame et al., 2011; Casanova et al., 1989) or can be non-covalently attached to the cell wall 
via hydrogen bonds or hydrophobic interactions (Valentin et al., 1984).  
The cell wall consists of the following layers: The inner layer- adjacent to the plasma membrane 
is composed of chitin and glucan polysaccharides. This is followed by a three dimensional 
matrix of β-1,3 gulcans , to which cell wall proteins are linked via GPI anchors. Mannoproteins 
are found adjacent to the membrane and in the outermost layer and can be covalently linked to 
glucan chains. β-1,6 glucans act as an interconnector for most of the cell wall components. 
Other proteins called ‘proteins with internal repeats’ (PIR coded proteins) are covalently linked 
to the β-1,3-glucan scaffold. 
GPI anchored proteins account for about 88% of the covalently linked cell wall proteins in 
C.albicans (Kaptyen et al., 2000). GPI anchored proteins play an important role in cell wall 
synthesis and in modifying cross-linked polymers and thus play an integral role in governing the 
physiology and pathogenicity of C.albicans (Richard and Plaine, 2006). Proteins that are linked 
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to β-1,6 glucan are incorporated into the wall by a transglycosidation reaction between the 
glucan moiety of GPI and β-1,6 glucan (Kaptyen et al., 1995; 1997). GPI can either be present 
on the cell surface by itself or it can be transported to the cell surface if it is covalently attached 
to a protein via the secretory pathway. Several genes required for GPI biosynthesis have been 
identified in Saccharomyces cerevisiae. Mutants lacking some of these biosynthetic genes have 
a fragile cell wall (Benachour et al., 1999), aberrant cell morphologies (Leidich et al., 1994) or 
have defects in GPI anchoring (Gaynor et al., 1999). GPI mutants also exhibit an altered 
composition of their cell wall (Vossen et al., 1997) and increased sensitivity to cell-wall 
perturbing agents (Benghezal et al., 1995; Vossen et al., 1995). Thus disruption of GPI 
biosynthesis can affect GPI-dependent transport of enzymes involved in cell wall assembly, and 
other cell wall proteins. It can also abolish GPI-dependent cross-linking of glycoproteins to the 
cell wall (Ram et al., 1994; Richard et al., 2002) thereby affecting cell wall organization (Fonzi 
1999; Ram et al., 1998). 
Since mammalian cells lack a cell wall,  enzymes responsible for its structural organization or 
for the biosynthesis of cell wall components provide a convenient target for antifungal drugs. 
Few drugs have been developed that target the cell wall, these include: Nikkomycin Z and the 
Echinocandin class of drugs.  
Nikkomycin Z inhibits chitin synthase activity and thus interferes with the chitin content in the 
cell wall. Echinocandins such as caspofungin and micafungin inhibit glucan synthase thereby 
affecting the assembly of β-glucan polymers in the cell wall. Both these classes of drugs display 
fungicidal activity against C.albicans and are effective in animal models(Calderone, 2002). 
Differences in GPI biosynthesis between mammalian and yeast cells (Grimme et al., 2001; 
Smith et al., 1997) can also be exploited to design drugs that inhibit fungal-specific GPI 
biosynthetic enzymes. Some proteins that are tethered to the wall via GPI anchors are important 
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for adhesion to host cells and thus impact the pathogenesis and virulence of C.albicans. Thus, 
any defects in the biosynthesis of GPI anchors can have detrimental effects of the pathogenesis 
of C.albicans (Richard, M.L. and Plaine, A. 2006; Martinez-Lopez 2004; Richard et al 2002). 
GPI anchors also play a contributing role in the morphogenesis of C.albicans, and resistance to 
macrophages and/or oxidative stress (Richard et al., 2002). GPI proteins have also been 
implicated in pivotal processes such as adhesion, biosynthesis and regeneration of the cell wall 
and some have enzymatic functions (Klis et al., 2009; Richard, M.L. and Plaine, A 2007). 
Several GPI proteins have also shown to affect the virulence of C.albicans using a murine 
model of systemic candidiasis (Gelis et al., 2012; De Boer et al., 2010; Martinez-Lopez et al., 
2004; Laforet et al., 2011). For example, the GPI-anchored protein Hwp1 is important for host 
cell attachment (Hoyer, L 2001; Staab et al., 1999). Thus considering the essential role for GPI-
anchored proteins in cell wall reconstruction (Fonzi, W.A. 1999; Grimme et al., 2004), yeast-
hyphal transitions, and adhesion (Castano et al., 2006; Staab et al., 1999) or virulence 
properties of C.albicans (Martinez-Lopez et al., 2004; Pardini et al., 2006, Staab et al., 1999), a 
better understanding of the functions of these proteins and how they influence other signaling 
and biosynthetic pathways and interactions with the host is needed. This could extend the 
number of potential targets for therapeutic treatment of C.albicans.   
Phospholipid Biosynthesis 
Phospholipids fulfill a number of vital roles in fungi. For example,  in S. cerevisiae, they are 
important for  cell biology and have roles in signaling and regulatory functions (Strahl and 
Thorner 2007), membrane trafficking (Vicinanza et al., 2008), and, anchoring membrane 
proteins (Roth et al., 2006; Pittet and Conzelmann 2007) as well as contributing to the 
membrane structure. Thus, it would be of interest to elucidate the role of phospholipids in the 
survival of C.albicans in the host and in its pathogenesis. The major phospholipids in yeast 
include phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylcholine (PC) and 
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phosphatidylethanolamine (PE) (Rattray et al., 1975; Paltauf et al., 1992; Guan and Wenk 
2006).   
In yeast, phospholipid biosynthesis  (Fig:1-2) is initiated from phosphatidic acid (PA), which is 
partitioned to cytidyldiphosphate-diacylglycerol (CDP-DAG) or DAG by either CDP-DAG 
synthase (Carter and Kennedy 1966) or PA phosphatase (Han et al., 2006) respectively. CDP-
DAG and DAG are then used to synthesize PE and PC by two alternative pathways (Fig:1-2): 
the CDP-DAG pathway and the Kennedy pathway. CDP-DAG is converted to PS by PS 
synthase (encoded by the Cho1p enzyme) in the CDP-DAG pathway. This process takes place 
in the endoplasmic reticulum (Atkinson et al., 1980; Letts et al., 1983; Kiyono et al., 1987; Bae-
Lee and Carman 1984). The PS decarboxylases, the inner mitochondrial membrane-localized 
Psd1 and the Golgi-localized Psd2, convert PS to PE (Clancey et al., 1993; Trotter et al., 1995; 
Voelker 2003). PE is then converted to PC by three sequential methylation reactions in the ER 
catalyzed by PE methyltransferase (encoded by CHO2) and phospholipid methyltransferase 
(OPI3 encoded) (Kodaki and Yamashita 1987; Summers et al., 1988; McGraw and Henry 1989). 
Mutants that are defective in either of these pathways have choline/ethanolamine auxotrophies 
(Atkinson et al., 1980; Trotter and Voelker 1995; McGraw and Henry 1989). 
The Kennedy pathway relies on the exogenous transport of ethanolamine and choline by a 
transporter encoded by HNM1 (Nikawa et al., 1986). Cytoplasmic located ethanolamine kinase 
(Eki1) and choline kinase (Cki1) phosphorylate these with ATP to form ethanolamine-P and 
choline-P (Kim et al., 1999; Hosaka et al., 1989). These intermediates are activated by 
cytidylyltransferases to form CDP-ethanolamine or CDP-choline (Min-Seok et al., 1996; 
Tsukagoshi et al., 1987). Phosphotransferases (Hjelmstad and Bell 1988,1990,1991) then 
condense CDP-ethanolamine and CDP-choline with DAG to from to PE and PC.  
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The synthesis of phospholipids in fungi is similar to that in mammalian cells, the only difference 
being in the synthesis of PS. In mammals, PS is synthesized from PE or PC and serine, and in 
fungi it is synthesized from CDP-DAG. This difference can be exploited if phospholipid 
biosynthesis is to be explored as a viable antifungal target. Given the ubiquitous presence of 
phospholipids in the cell, it is not surprising that defects in phospholipids biosynthesis can have 
adverse effects on the growth and proliferation of C.albicans. In S.cerevisiae, PE has been 
shown to play an important role in stabilizing mitochondrial protein complexes (Birner et al., 
2003; Osman et al., 2009). This results in the mutant being non-viable with defects in protein 
and lipid scaffolding complexes (Osman et al., 2009). This in turn has dire effects on the 
functionality and integrity of the mitochondrial inner membrane (van Gestel et al., 2010).  
Phospholipids in virulence: The C.albicans cho1∆/∆ mutant is avirulent in a mouse model of 
systemic candidiasis (Chen et al., 2010). Loss of de novo PE (through disruption of PSD1 and 
PSD2) also attenuates the virulence of C.albicans. These mutants exhibit cell wall defects as 
demonstrated by an increased sensitivity to caspofungin and resistance to caffeine (Chen et al., 
2010). Osmostabilizers such as CaCl2, sorbitol and NaCl rescue the growth defect of the 
cho1∆/∆ and the psd1∆/∆psd2∆/∆ mutants on YPD medium suggesting that loss of PE and PS 
may affect the cell wall (Chen et al. 2010). These findings are further supported by the 
observation of a thick, irregular cell wall by transmission electron microscopy in the cho1∆/∆ 
strain (Chen et al., 2010). Furthermore, defects in PE biosynthesis also impacted the function of 
mitochondria, and this is not surprising since mitochondria are enriched in PE as it is the main 
site of de novo PE biosynthesis. Mitochondrial defects in the PS and PE deficient mutants have 
been demonstrated by an increase in resistance to paraquat (Chen et al., 2010). Paraquat binds 
to complex I in the electron transport chain leading to the generation of superoxide radicals and 
subsequent oxidative damage in cells with an intact mitochondrial membrane. Thus, resistance 
to paraquat is indicative of a defect in the respiratory chain (Cocheme et al., 2008; Blaszczynski 
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et al., 1985) more specifically, a defect in oxidative phosphorylation in C.albicans (Cheng et al., 
2007). Mitochondrial respiration defects are further highlighted by the fact that these mutants 
take up  trypan blue and eosin Y dye more readily than the wild-type strain (Chen et al., 2010; 
Nagai, S 1963). 
Given these findings, it is clear that phospholipids play vital roles in the cell biology of 
C.albicans, but significant gaps lie in our understanding the contribution of phospholipid 
metabolic pathways in membrane biogenesis, signaling and cell cycle transitions. A genome-
wide approach is thus required to gain a global understanding of the different regulatory 
networks and cell processes affected by the loss of PS and de novo PE.  
Phospholipid structures and  polymorphisms: Phospholipid species have been classified as non-
lipid bilayer and lipid bilayer forming due to the cross-sectional area and shape of their 
respective headgroups and acyl side chains (Frolov et al. 2011; Cullis et al. 1986). Lipid bilayer 
forming species, such as PS and PC, are ideally suited to maintain a rigid membrane structure, 
whereas, PE forms a conical shape with a small headgroup and large hydrophobic tail and is 
thereby conducive to increasing membrane fluidity and curvature (Figure 1-3) (Cullis et al. 2002, 
Haque  et al.,2001). A mixture of bilayer and non-bilayer forming phospholipids enables 
association of the membrane into a semi-permeable barrier and allows appropriate distribution 
for the function of integral membrane proteins (Cullis et al 1986, 2002). The dynamic nature of 
the lipid bilayer is evidenced by the effect of changes in tail acyl chain lengths and saturation 
upon cell stresses such as temperature, divalent cation concentration, and membrane disrupting 
detergents (Tumolo et al., 2011). Generally, the higher the saturation number and shorter the 
hydrocarbon length within the acyl chains, the more disordered and less rigid the membrane 
becomes and membrane fluidity is, therefore, increased (Cullis et al. 1986; Lindbolm et al,. 
2004). Diversity in lipid species and function in the membrane is complicated by the presence of 
over 100 different lipid species in a eukaryotic membrane (Gerrit van Meer et al., 2011). The 
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dynamics of lipid fluidity involve the lateral displacement of lipid acyl tails and interactions of the 
headgroups between phospholipids and are dependent upon the phospholipid headgroup, 
saturation number, chain length, hydration state, protein interactions, cationic environment and 
interaction with other lipids such as cholesterol or ergosterol (Rajendran et al 2005; Tumolo et 
al., 2011).   
These dynamic interactions are key to a variety of cellular processes including 
exocytosis and endocytosis which are thought to be at least partially mediated by the presence 
of cone shaped PE molecules (Farge et al., 1999). PS, the least abundant of the phospholipids, 
can be negatively charged due to the presence of an electronegative oxygen atom on its serine 
residue which affects its molecular properties such as its ability to interact with other lipid 
headgroups (Cullis et al. 1986; Marsh et al. 2012) at the surface of the membrane and this in 
turn may affect lateral diffusion of side chain packing within the membrane. At pH below 4.0, PS 
becomes protonated and loses its electrorepulsive properties that may result in aberrant charge 
distribution at the membrane surface and it is hypothesized that this facilitates improper lipid 
spacing and can lead to a disordered membrane consequently disrupting binding of proteins at 
the surface of the membrane (Cullis et al., 2002; Marsh et al 2012).  PS has also been 
described as a co-factor for signaling pathways in fungi such as for protein kinase C (PKC) 
(Kamada et al., 1996) which controls cell wall integrity, as well as in calcium mediated signaling 
via calcinuerin, which controls internal calcium levels (de Lucena et al., 2012). The diversity of 
lipid species, their precise functioning, and how they mediate membrane- structure function  is 
an area of increasing interest that requires close evaluation as much remains to be known  
about the  properties that phosphatidylserine (PS), phosphatidylethanolamine(PE) ,and 
phosphatidylcholine(PC) contribute to lipid interactions and how these interactions ultimately 
affect the cell.    
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Iron Sensing and Uptake 
Candida albicans can colonize and grow in a variety of host environments (Calderone and 
Fonzi, 2001).  Deep-seated tissues and organs, such as the kidneys, and mucosal surfaces like 
the oral and vaginal cavities, present unique environmental niches in terms of the nutrients 
available for uptake by microbial colonizers. Iron is an important co-factor for essential cellular 
processes and is present in very low amounts in the bloodstream (~10-24M free iron) and deep 
tissues. The need to scavenge iron from the host has led to the evolution of distinct iron sensing 
and acquisition pathways in C. albicans. In addition, iron acquisition and utilization is tightly 
regulated as the organism constantly shuttles between iron -replete and –limited environments 
in the host, since high amounts of it can be toxic and low amounts of iron can shut down 
respiration and other cellular processes. In fact, in a variety of both prokaryotic and eukaryotic 
pathogens the ability to acquire and store iron has been shown to be an important virulence 
factor.  
The more robust regulation of iron in C. albicans compared to that of  S. cerevisiae is 
hypothesized to be a direct result of the environments that C. albicans must encounter upon 
infection of the host (Chen et al., 2011). Iron uptake systems have been well characterized in 
S.cerevisiae and many orthologues of the iron-import system exist in C.albicans (Eck et al., 
1999; Ramanan and Wang, 2000; Weissman et al., 2002). Three iron-import systems have 
been identified in C.albicans.  In the bloodstream, C.albicans can directly acquire iron from 
blood cells by secreting hemolysins (Manns et al., 1994; Luo et al., 2001). Rbt51/Pga10 is 
strongly induced in iron-depleted conditions and plays a role in heme-iron utilization (Weissman 
et al., 2002). Rbt5 is another GPI-anchored haem receptor (Weissman and Kornitzer, 2004) that 
tethers haem at the membrane, followed by uptake or internalization via endocytosis (Weissman 
et al., 2008). Iron can also be bound to siderophores and taken up via siderophore transporters 
such as Sit1 (Ardon et al., 2001; Hu et al., 2002).  Finally, free iron can be taken up by iron 
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permeases such as Ftr1 (Knight et al., 2002) following the sequential reduction of Fe3+ by cell 
surface-bound ferric reductases (Hammacott et al., 2000; Knight et al., 2002). The GPI-
anchored protein Als3 can also mediate the extraction of iron from host ferritin through a similar 
reductive system (Almeida et al.,2008).  
Iron sensing and response is mediated by Sfu1 and Sef1/2 in C. albicans, in contrast to 
S.cerevisiae where ScSef1 acts directly upon ScAft2 to up-regulate iron uptake genes (Chen et 
al., 2011).   Under iron-limited conditions, iron acquisition genes are activated through 
repression of Sfu1. The transcriptional repressor, Hap43 increases iron availability under these 
conditions by repressing genes that code for acotinase and cytochrome c both of which are 
involved in iron and or haeme utilization (Baek et al., 2008; Chen et al., 2011; Hsu et al., 2011; 
Singh et al., 2011).  Sef1 is considered the central iron regulator, as it activates HAP43 and 
expression and thus indirectly controls SFU1 expression. Sef1 also activates several target 
genes that are regulated by Hap43 and Sfu1 such as HAP1 (Chen et al., 2011) and  these 
genes are involved in iron response or heme biosynthesis (Chen et al., 2011).  
Interestingly, it has been shown that SEF1 is overexpressed in human plasma and is essential 
for bloodstream infections in a mouse model.  In contrast, SFU1 is up-regulated in the gut, and 
a sfu1∆/∆ mutant is defective for colonization of the gut (Chen et al., 2011). This differential 
regulation of these co-regulated iron-response genes in different host niches highlights how 
C.albicans has evolved a tightly regulated iron regulatory circuit to promote its survival in the 
host.  Amongst the genes regulated by Sef1 are several virulence related genes (Chen et la., 
2011); including cell wall proteins, transporters and transcription factors.  
Analysis of the roles of Sfu1 and Sef1 in C.albicans iron regulatory system has revealed that 
Sfu1 promotes commensalism and Sef1 promotes pathogenesis in the mammalian host (Chen 
et al., 2011). While Sfu1 promotes competitiveness in the gastrointestinal tract and resistance to 
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iron toxicity, Sef1 plays a unique role in C.albicans that is not conserved in other fungal species, 
i.e. it controls several virulence related genes. This ability to maintain expression of genes 
required for the survival of C.albicans in the host while continuously repressing toxicity factors 
further underscores the adaptation that this organism has undergone to promote its existence 
as both a commensal and pathogen in the iron-limited/ -replete host microniches.   Thus any 
disruption of iron homeostasis in Candida albicans may alter the way it senses, responds to and 
interacts with the host.   
Project Overview 
In this dissertation, we demonstrate how loss of phosphatidylserine (PS) and de novo 
phosphatidylethanolamine (PE) in Candida albicans results in significant changes in the cell wall 
that can be attributed to the differential regulation of cell wall protein genes, mainly those 
encoding GPI-anchored proteins, and to dysfunctional mitochondria. Iron homeostasis is also 
affected in mutants that lackde novo PE but the defects are more severe in the cho1∆/∆ strain 
which lacks also lacks PS, as demonstrated by the up-regulation of iron regulators that function 
to transcriptionally repress iron-acquisition genes in conditions of low iron availability. 
Consequently, the mutants fail to survive in iron-limited conditions and this may also in part 
explain the virulence defects in a mouse model of systemic candidiasis associated with the 
cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. Furthermore, profiling the phosphlipidome of these 
mutants has helped in the identification of key lipids that are altered upon disruption of 
phospholipid biosynthesis in C.albicans. This is the first study that links phosphatidylserine (PS) 
synthesis to cell wall biogenesis, mitochondrial dysfunction, and iron homeostasis in C.albicans.  
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APPENDIX AI : FIGURES 
 
 
 
 
Figure  1-1: The structure of the fungal cell wall with the different  polysaccharide and 
protein components depicted. (Image adopted from science.kennesw.edu/fungcellwall) 
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Figure 1-2: The phospholipid biosynthetic pathways in fungi (Saccharomyces 
cerevisiae). Two alternative pathways, the de novo pathway and the Kennedy pathway exist 
in both humans and yeast, but there are significant differences in the de novo synthesis of PS 
between yeast and humans. For a detailed explanation of the biosynthesis, refer to the text. 
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Figure 1-3: Lipid shape polymorphisms influence membrane structure and 
fluidity. Lipids in t e eukaryotic membrane bilayer a e mixture of exagonal an
bilayer  phase lipids.  The relative amounts of each lipid shape can change the 
biophysical  properties of the membra e and lead to disruption of or localization of 
membrane proteins and improper lipid  acyl tail packing. The shape of the lipid  is 
determined by the cross-sectional  area of the headgroup(Ao) versus the  cross 
sectional area of the hydrophobic  tail(Ah). Ao>Ah= inverted cone shape, Ao=Ah= 
cylindrical shape, Ao<Ah= cone shaped. PS= phosphatidylserine, 
PC=phosphatidylcholine, PE = Phosphatidylethanolamine, PG=phosphatidylglycerol, 
PI=phosphatidylinositol, CL= cardiolipin. Ionic stress and low pH can influence these 
properties in PS and CL as indicated (+Ca
2+
 and at pH<4).(Cullis et al., 2001; de Kruijff 
B, 1997). 
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CHAPTER TWO 
Candida albicans cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants exhibit 
defects in cell wall protein expression and iron utilization 
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Abstract 
We show that a loss of de novo PS and PE biosynthesis has pleiotropic effects on the Candida 
albicans cell, including cell wall defects, defects in growth under iron limited conditions, 
sensitivity to low pH, sensitivity to the membrane-targeting drug fluconazole and differential 
expression of hypoxic, cell wall, and mitochondrial related genes. We also show that changes in 
the phospholipidome indicate that  PS 16:0/18:2 is the main lipid species trafficked through the 
de  novo pathway in Candida albicans and that there is a subsequent increase in long acyl side 
chain 18:n18n PE species , presumably, from increased Kennedy pathway PE and PC 
synthesis. The differential effects observed between the cho1∆/∆ and psd1∆/∆psd2∆/∆ strain 
implicate PS as having a direct role in the observed phenotypes. Therefore, we suggest a novel 
role for PS in Candida albicans, whereby, PS  itself is required for cell wall maintenance and 
loss of PS leads to both an altered cell wall and dysfunctional mitochondria. 
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Introduction 
The roles of phospholipids and their functions inside eukaryotic cells have been well 
characterized, however, there remain significant gaps in our understanding of how 
phospholipids affect key biological processes such as their role in the overall structure and 
function of organellar membranes, their contribution to protein-enriched lipid rafts and their 
affect on cellular metabolism (Osman et al. 2011, Dagley et al. 2011, Bishop et al. 2011). 
Recent advances include elucidating key protein complexes that mediate a few of these 
interactions, such as the discovery of the ERMES (endoplasmic reticulum-mitochondria 
encounter structure) (Michel A.H. & Kornmann B, 2012), which aides in tethering the 
mitochondria to the endoplasmic reticulum (ER) to facilitate transfer of phospholipids between 
these organelles. Studies of ERMES have raised questions about the structure and function of 
phospholipids in eukaryotic cell biology and hints that this class of lipids is underexplored (Voss 
et al., 2012; Osman et al., 2011). For example, the roles that different phospholipids and 
particular phospholipid species (i.e. lipids that share the same head group, but differ in fatty acid 
tail length or saturation) have on organelle structure and metabolism are only beginning to be 
understood (Osman et al. 2011, Joshi et al. 2012). 
There exist two major pathways for phospholipid biosynthesis in fungi: they are the de novo 
pathway and the Kennedy pathway (Kent et al., 1995). Together these two pathways synthesize 
all of the cellular phosphatidylserine (PS), phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC) (Chen et al., 2010). The de novo pathway begins with the synthesis of 
PS from cytidyldiphosphate-diacylglycerol (CDP-DAG) and serine by Cho1p. A pool of PS is 
then decarboxylated to PE by the PS decarboxylases Psd1p or Psd2p to produce PE in the 
mitochondria or Golgi/endosome, respectively. A pool of PE is then methylated by Opi3 and 
Cho2p to make phosphatidylcholine (Kent et al., 1995) (Fig;1-2 p20 ). In contrast to de novo 
synthesis, the Kennedy pathway involves utilization of diacylglycerol (DAG) and exogenous 
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sources of ethanolamine or choline to  synthesize PE or PC, respectively. In the Kennedy 
pathway PE can be directly synthesized from ethanolamine by Eki1p, Ect1p, Ept1p or PC can 
be synthesized from choline via Cki1p, Cct1p, and Cpt1p (Bergo et al., 2002 Kent et al. 
1995)(See figure 1-2). Although the enzymes of the Kennedy pathway are conserved in 
mammals, some of the enzymes of the de novo pathway, such as Cho1p and Psd2p, do not 
have human homologs, and may be valuable antifungal drug targets. In mammalian cells, PS is 
synthesized from PE by Pss2p or directly from PC by Pss1p (Arikketh et al., 2008; Bergo et al., 
2002).  
A number of aspects remain unclear about how phospholipid levels and biosynthesis affect the 
mitochondria and how they impact other cellular structures, such as the cell wall. Phospholipid 
homeostasis has been linked to key cellular processes such as respiration, drug transport, and 
metabolism and the effects of disruption of phospholipid homeostasis on these processes 
warrant further study. The relationship of phospholipids to the cell wall may be through their 
indirect or direct effects on activation of  cell wall integrity and signaling pathways such as the 
Rim101 pathway, HOG-1 pathway, and/or the calcenuerin pathway. In C. albicans,  cell wall 
streses such as ionic stress can activate the calcenuerin pathway which can alter transcription 
by the transcription factor CRZ1 (Li et al, 2011). In addition, activation of Rim101 can lead to 
changes in morpohology and cell wall structure (Mitchelll et al. 2000). Interestingly,  the HOG1 
pathway has been shown to be activated under conditions of mitochondrial dysfunction and 
osmotic stress (Alonso-Monge et al. 2008).  
The mitochondria are key in cellular metabolism including oxidative phosphorylation and the 
Krebs cycle (Onishi et al., 1967; Fitton et al., 1994; Cortassa & Aon., 1994; Averet et al., 
1998;Celton et al., 2012). The mitochondrion has also been suggested as the major organelle 
whereby PS and PE are trafficked and synthesized to be transported to the plasma membrane 
(Osman et al., 2011). The mitochondrial outer and inner membranes function as barriers to 
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establish a proton motive force for the synthesis of adenosine triphosphate (ATP) as well as to 
provide a favorable environment for the activity of proteins involved in the transport of electrons 
to the terminal oxygen electron acceptor in the mitochondrial-localized electron transport chain 
(Davies et al., 2012). Both membranes are essential in establishing the membrane potential that 
enables aerobic respiration via the Krebs cycle (Mitchell 1966; Knorre et al., 2012). Due to the 
presence of proteins associated with the electron transport chain, the mitochondrial inner 
membrane is also the most protein rich membrane of any biological membrane thus studied 
(Davies et al., 2012, Osman et al., 2011). Mitochondria are enriched in the lipids cardiolipin and 
PE and normal mitochondrial function is lost when cardiolipin or PE is removed (Joshi et al., 
2012; Gohil et al., 2005; Zhong et al., 2004).  In S.cerevisiae, the Psd1p enzyme is localized in 
the mitochondrial inner membrane, and functions to decarboxylate PS to PE, thereby increasing 
de novo synthesized PE within the mitochondrial inner membrane (Clancy et al., 1993). 
However, the contribution of PS in the mitochondria, other than as a substrate for PE synthesis, 
is not well understood.   
In this chapter, we investigate the effects of disruption of the biosynthesis of PS and de novo PE 
on the fungal cell and provide evidence that PS itself has an effect on the mitochondria in 
addition to defects associated with downstream de novo PE synthesis.  Furthermore, PS loss 
leads to cell wall defects in Candida albicans.  We suggest that the defects in mitochondrial 
function are due to PS loss and cause specific effects on the cell wall. Finally, we demonstrate 
evidence that the loss of PS leads to differential phenotypes in Saccharomyces cerevisiae 
indicating that the phenotypic role of PS in cell wall maintenance is different in these two fungi.   
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Materials and Methods 
Strains and Culture conditions 
All strains used in this study are listed in Table 2-1. Unless otherwise mentioned, the strains 
were grown in (1%) yeast-extract (2%) peptone (2%) dextrose, (YPD) medium (Styles, 2002) at 
30ºC with shaking. 
Phospholipid profiling  
Cells were grown overnight and then inoculated at .4 O.D. / ml in 25 ml of (1%) yeast extract 
(2%)peptone (2%) dextrose (YPD) and grown for 6 hours at 30°C with shaking. The cells were 
then pelleted at 13,000xG for 1 min and washed with 1ml H20. Next, the cells were suspended 
in 1 ml of 100 % methanol.  5 mg of glass beads were added and the sample was bead-beated 
five times using a mini-Bead beater-1 Biospec beater on ice with 30 second incubation on ice in 
between bead beating. Next, 3 ml of   chloroform was added to the cell suspension and the 
solution was mixed by vortexing for 30 seconds. Cells were then transferred to a separatory 
funnel and washed with 900 µl of 0.9% NaCl solution. The bottom organic layer (1 ml) was then 
collected using a separatory funnel and dried under N2 gas for 1 hour. Prior to organic extraction 
and separation, internal standards of 10 µg of PE 28:0, PC 28:0 and PS 30:0 were added for 
quantification. The lipid pellets were then analyzed by electrospray ionization tandem mass 
spectroscopy (ESI-MS/MS) and the relative amounts of each class of phospholipids were 
quantified relative to the standard.  
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RNA sequencing 
Overnight cultures were added to 25 ml of YPD at .4 O.D/ml and allowed to grow with shaking 
at 30°C for  5 hours. 10 O.D.(A600)equivalents per strain were collected by centrifugation. Total  
RNA was extracted using the phenol method (Dhomedy et al., 1991).  Extracted RNA was 
treated with DNAse following the manufactures protocol (Ambion® (TurboDnase)).  It was then 
assayed for purity by gel electrophoresis. DNase treated total RNA was then cleaned with an 
RNeasy column (Qiagen) according to the manufacturer’s instructions.  mRNA libraries were 
constructed and sequenced at the Vanderbilt Genome Technology Core following Illumina® 
specifications on an Illumina HiSeq 2000. 50bp read sets from each of the four samples were 
independently mapped to the Candida albicans SC5314 reference transcriptome using BLAST. 
Over 20 million reads were mapped for each sample (cho1∆/∆:  34,537,503; psd1∆/∆: 
21,041,937; psd1∆/∆psd2∆/∆: 21,271,203; and cho1∆/∆::CHO1: 25,147,891). In all samples, 95-
96% of mapped reads uniquely mapped to a single transcript. The nucleotide content of 
mapped reads represented an average 128x coverage of the C. albicans SC5314 reference 
transcriptome (cho1∆/∆:  193x; psd1∆/∆: 117x; psd1∆/∆psd2∆/∆ :119x; and cho1∆/∆::CHO1: 
140x).Reads were trimmed from 101 bp to 50 bp by removing the first 11 bp and last 40 bp of 
each read to maximize overall read quality. Gene expression levels were quantified as 
previously described (Gibbons et al. 2012) by mapping reads against the Candid albicans 
SC5314  Assembly 19 reference transcriptome using the SeqMap software, version 1.08 (Jiang 
and Wong 2008 – doi:10.1093/bioinformatics/btn429) allowing 2 mismatches per read. For each 
gene, gene expression levels were quantified in terms of reads per kilobase per million mapped 
reads (RPKM) (Mortazavi et al. 2008) using the rSeq software, version 0.0.5 (Jiang and Wong 
2009 –doi:10.1093/bioinformatics/btp113). False discovery Rate (FDR) was used to determine 
statistical differences between the mutants and the wild type strain. A p-value was set as 1E-10 
as statistically significant (Conesa et al., 2011, Mortazavi et al., 2008).The data was then 
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normalized to five housekeeping genes ACT1, PMA1, RIP, RPP2B and LSC2 (Nelis et al., 
2006). RNA sequencing results were verified by immunofluorescent staining for ALS and HWP1 
genes as described below. 
Sensitivity to cell wall and membrane perturbing drugs 
For the spot dilution tests, overnight cultures of C.albicans strains were washed twice in 1 ml 
phosphate buffered saline (PBS), and resuspended at 1 O.D./ml in 1 ml of  H20. The cells were 
then serially five-fold diluted and spotted onto minimal media (Yeast Nitrogen Base(YNB) + 2 % 
glucose+ histidine +luecine+1mM ethanolamine)  containing either calcoflour white (20µg/ml) or 
congo red (10µg/ml) or Fluconazole (2µg/ml). All plates were imaged after incubation at 37ºC for 
48h.  
Fluorescence Microscopy 
The C.albicans strains were grown overnight in YPD at 37°C for 24 hours and then collected by 
centrifugation at 13,000x g for 1 min, and washed thrice in phosphate buffered saline (PBS),  
Next, the cells were diluted to .4 OD/ml in 25 ml of  YPD and  grown for  5 hours  at 30°C. Cells 
were collected washed with 1 ml H20 and  then stained with monoclonal antibodies against 
Als1p, Als3p and Hwp1p obtained from Lois Hoyer (University of Illinois, Urbana-Champagna).  
Samples were further stained with a goat anti-mouse secondary antibody conjugated to Cy3. 
Microscopic images were then taken under bright field or TRITC filter to observe fluorescent 
staining. 
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Growth in low pH conditions 
For growth in low pH media, cells were grown overnight in YPD then inoculated at .1 O.D./ml 
into 5 ml of minimal media (Yeast Nitrogen Base(YNB)+glucose+uracil+luecine+histidine+1 mM 
Ethanolamine) plus  phosphate citrate buffer to pH 4.0 and pH 2.7 and allowed to grow for 48 
hours at 37°C with shaking. The pH was measured before and after the assay using a pH meter 
to assure correct pH. 
Iron-limitation assay  
The cells were inoculated from overnight culture into minimal media with addition of 1 mM of the  
Iron chelator  bathophenanthroline disulfonate  (BPS), or in minimal media  containing 1 mM 
BPS plus  the addition of 100 µM or 300 µM Iron (II) Sulfate. The cells were inoculated into 5 ml 
of minimal media and allowed to grow at 37C for 48hours with shaking.   Growth was then 
measured by optical density at 600 nm. For solid media, cells were inoculated in spot dilutions 
from  a starting concentration of 1  O.D./ml   minimal media (Yeast Nitrogen Base + 2% 
glucose+uracil+luecine+histidine+1 mM Ethanolamine +3 % agar) plates with or without 1mM 
BPS, or 1mMBPS + 100 µm Iron (II) Sulfate. Images were taken after 48 hours of growth at 
37°C.  
Chitin Staining 
Strains were grown overnight in YPD at 37°C with shaking. 1ml at 5 O.D./ml of cells were 
collected and washed with 1 ml of water.  Cells were then stained by addition of 1 ml of 1mg/ml 
calcofluor white and rocked at room temperature for 5 min. The cells were centrifuged and 
washed three additional times and then resuspended in 500 uls water and 5 ul was spotted onto 
a slide for microscopy. The cells were visualized at 200X magnification under bright field and 
fluorescence (UV-DAPI filter) microscope. Results are expressed as percentage of cells that 
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exhibited increased fluorescence out of the total cells counted. The statistics are based on the 
average of three different fields of view. Approximately ~400 cells were counted for each strain. 
Transmission Electron Microscopy 
Cells growing at log phase in 25 ml of YPD were harvested and fixed for electron microscopy 
using a modification of a protocol by Wright (Wright, 2000). 1ml of 10 O.D/ ml of cells were 
collected and resuspended in a fixative consisting of 3% glutaraldehyde and 3% 
paraformaldehyde in 0.1 M phosphate buffer. Cells were centrifuged, then re-suspended in 
fixative and incubated overnight at 4°C. Cells were then washed in 0.1 M phosphate buffer for 
10 mins. Cells were washed in 1% KMnO4 and re-suspended in fresh KMnO4 for an additional 
90 min. Cells were then en-bloc stained in 1% aqueous uranyl acetate for 60 min and then 
dehydrated in a graded ethanol series at 15 min intervals. This was repeated twice. Cells were 
treated with Spurr resin/ethanol over a 24 h period. Spurr resin was replenished and samples 
were heated in a 68°C oven for 24 h. Thin sections were cut with a Reichert OMU3 
ultramicrotome, mounted on copper grids, stained with lead citrate, and examined with a 
HitachiH800 transmission electron microscope operating at 75 KeV. 
Statistical Analysis 
Prism 4.0 software (Graph Pad) was used to determine the significance of differences in growth 
under low pH and iron-limitation conditions. Statistically significant differences were determined 
using the two-tailed unpaired t test. Statistical significance was set at a P value of <0.05. 
Results 
Lipid profiling of phospholipid biosynthesis mutants 
In order to better understand the specific changes associated with disruption of PS and/or de 
novo PE biosynthesis, global lipid profiles of cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants were 
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compared to wild-type. For the lipidomic analysis, C. albicans strains were grown in YPD 
medium for 6 hours at 30°C with shaking and total lipids were extracted as described in the 
materials and methods. Extracted lipids were subjected to Electrospray Ionization Tandem 
Mass spectrometry (ESI-MS/MS). The total lipids were quantified and normalized to internal 
standards PE (14:0/14:0), PC 14:0/14:0 and PS (14:0/14:0) (These lipid standard species are 
not found in Candida albicans).   
PS species in wild-type were all of the 16:n/18:n variety (16 and 18 indicate the number 
of carbons in the sn-1 and sn-2 fatty acid tails, respectively, and “:n” indicates the number of 
unsaturated bonds in that particular tail).  The most abundant species of PS species in the wild-
type were 16:0/18:2 or 16:1/18:2 (Table 2-2); all of these species were completely absent in the 
cho1∆/∆ mutant, as expected.  In contrast, there is a build-up of PS in the psd1∆/∆ psd2∆/∆ 
mutant (Table 2-2).   
In contrast to PS, PE in wild-type is represented by species that include 16:n/18:n (34%), 
18:n/18:n (41%), and 18:n/20:n (25%) (Table 2-2). The most abundant wild-type 16:n/18:n PE 
species is 16:0/18:2, which makes up 20% of total PE.  In the cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
mutants, the substantial drop in PE that was noted previously by TLC, appears to be almost 
exclusively due to a decrease in 16:n/18:n PE, with the most substantial decrease occurring in 
16:0/18:2 PE.  Conversely, the other species of PE do not decrease, and instead become a 
larger percentage of the total PE.  These other species are likely generated by the Kennedy 
pathway from exogenous ethanolamine in YPD medium.   
PC is also represented by 16:n/18:n (59%), 18:n/18:n (36%), and 18:n/20:n (5%), with a 
small percentage of 14:n/16:n in the wild-type (Table 2-2).  In cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
there is a substantial loss of the 16:n/18:n species, but a strong increase in 18:n/18:n species, 
that may be due to compensation from the Kennedy pathway.   
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Thus, in C. albicans, the majority of species contributed to PS, PE, and PC by the de 
novo pathway appear to be 16:n/18:n, and the Kennedy pathway contributes species with 
longer fatty acid tails.    
Transcriptional profiling of PS- and de novo PE- deficient Candida albicans mutants by 
RNA sequencing 
The lipidomics data suggested that loss of the de novo pathway specifically blocks synthesis of 
16:n/18:2 PS, PE, and PC.  The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants both have a similar 
drop in 16:n/18:2 PE and PC, but only the cho1∆/∆ mutant has a complete loss of PS as well.  
Both mutants have mitochondrial and cell wall defects and in both cases, the defects seem to 
be greatest in the cho1∆/∆ mutant. In order to determine what effects the losses of these 
species of PE and/or PS have on the mitochondria, cell wall or other organelles, transcriptional 
profiles of the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants were compared to wild-type using RNA 
sequencing (RNA seq). Genes in either strain that showed ≥3-fold up or down regulation 
compared to wild-type, after normalization, were selected for further analysis.  
There are 114 genes that are transcriptionally up-regulated by ≥3-fold in the cho1∆/∆ 
mutant compared to the WT (SC5314), and 129 genes are up-regulated by ≥3-fold in the 
psd1∆/∆psd2∆/∆ double mutant v/s the WT strain (Appendix Tables A-3 and A-5).  Of the 114 
genes up-regulated in the cho1∆/∆ mutant, 47 (41%) were also up-regulated by ≥3-fold in the 
psd1∆/∆ psd2∆/∆ mutant compared to wild-type. The total number of genes up-regulated in 
each mutant were sorted according to gene ontology (GO) term corresponding to subcellular 
localization (component) using the GO SLIM Mapper function in the Candida Genome Database 
(CGD).  This analysis revealed that in both mutants, 16-24% of the genes that were up-
regulated compared to wild-type related to the mitochondria (Fig 2-1).    
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As both of these mutants have cell wall defects, we more carefully examined cell wall 
genes that were up-regulated in the mutants compared to wild-type (Tables 2-3 to 2-5).  
Interestingly, both mutants up-regulated a number of cell wall genes that are involved in hyphal 
growth, even though they are being grown in YPD at 30˚C, a condition that is normally not 
conducive to forming hyphae.  These genes included ALS1-3, PGA6, and PGA10 (Table 2-5).   
Some other cell wall genes that are usually associated with hyphal formation like HWP1 and 
RBR1 were up-regulated very highly in the cho1∆/∆ mutant (Table 2-3), but were not up-
regulated in the psd1∆/∆ psd2∆/∆ strain.   
In order to further explore the expression changes in the cell wall genes, we focused first 
on the ALS genes, which represent a highly conserved family of glycosylphosphatidylinositol 
(GPI)-anchored cell wall adhesin genes.  This was explored using a set of monoclonal 
antibodies specific to the Als1, Als3, and Als4 proteins and Hwp1p (Coleman et al., 2012; 
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Figure 2-1: Gene ontology (GO) comparison of all genes UP regulated in the cho1∆/∆ and 
psd1∆/∆psd2∆/∆ mutants. Genes were input into the Candida Genome Database (CGD) SLIM 
mapping tool and mapped for their cellular components. Gene  ontology is expressed as both 
component and process and the percentages are displayed comparing the cho1∆/∆ strain and 
the psd1∆/∆psd2∆/∆ strain .  
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Coleman et al., 2009), which is another GPI-anchored cell wall protein that is not highly 
conserved with ALS1-4.     
Fluorescence microscopy of wild-type, cho1∆/∆, and psd∆/∆ psd2∆/∆ cultures grown in 
YPD at 30˚C for 5 hours (under identical  conditions as the RNAseq experiment) revealed that in 
wild-type, psd1∆/∆ psd2∆/∆ and cho1∆/∆ strains the Als1p and Als4p were expressed (Fig 2-2, 
data not shown), but Als1p was slightly higher in cho1∆/∆ and psd1∆/∆ psd2∆/∆ than wild-type.  
In contrast, Als3p was not expressed very strongly in any strain except cho1∆/∆, and this was 
primarily associated with a higher number of hyphal-like cells found in the culture (Fig 2-2).   
These data, especially regarding Als3p, do not agree with the RNAseq data which 
indicates that ALS3 is up-regulated in both cho1∆/∆ and psd1∆/∆ (Table 2-5). However, this 
may be because ALS1 was more highly expressed and ALS1 and ALS3 are practically identical 
over much of their sequence (data not shown).  Thus, the BLAST searches matching the RNA 
sequencing library to the database may have generated artifacts due to this close homology. 
In order to clear this up, another hyphal cell gene, HWP1 was tested, since it shows 
much higher expression in cho1∆/∆ than in the psd1∆/∆ psd2∆/∆ strain (Table 2-3), but has little 
homology with the ALS gene family.  It was found that Hwp1p was highly expressed in cho1∆/∆ 
hyphal cells, but not in the other strains, including psd1∆/∆ psd2∆/∆ (Fig 2-2).  The wild-type and 
psd1∆/∆ psd2∆/∆ cultures grew mainly as yeast cells. Thus, the cho1∆/∆ mutant appears to 
have more hyphae in YPD at 30˚C.  
In addition to the up-regulation of cell wall genes that are involved in hyphal formation, 
the cho1∆/∆ mutant up-regulated several genes involved in cell wall repair including PGA31, 
PGA13, IFF11, and ECM331.  ECM331 was up-regulated in psd1∆/∆ psd2∆/∆ as well, although 
it was more highly expressed in the cho1∆/∆ mutant.  Both mutants exhibit cell wall defects, 
although the defects are greater in the cho1∆/∆ mutant.  These include an altered cell wall  
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Figure 2-2: Immunostaining of C.albicans strains to determine expression of Als1, Als3 
and Hwp1. Candida cells were grown in YPD medium at 30 °C, washed in saline, counted and 
transferred into pre-warmed RPMI medium at a cell density of 5×106 cells ml−1. Fixed cells were 
immunosatined with anti-Als1 or –Als3 and –Hwp1. Cells were observed by fluorescence 
microscopy. The cho1∆/∆ mutants showed increased expression of Als3 and Hwp1 proteins 
(middle and last panels) and both the cho1∆/∆ mutant and psd1∆/∆psd2∆/∆ mutant showed 
increased expression of Als1 (first panel). (Sarah Davis contributed to this figure). 
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structure, based on transmission electron microscopy (TEM) and increased staining for chitin 
(Chen, et al 2010). 
It was hypothesized that the alterations in the wall in these mutants would result in 
increased sensitivity to cell wall stress-inducing agents. This was previously tested and found 
not to be the case using YPD media. However, when it was re-examined on minimal media, it 
was discovered that the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants display increased sensitivity to 
both calcofluor white and congo red compared to the wild-type strain (Fig: 2-3). The cho1∆/∆ 
mutant shows greater cell wall defects which is consistent with its other cell wall defects (Chen 
et al., 2010). 
Down-regulated genes in cho1∆/∆ and psd1∆/∆ psd2∆/∆ are enriched for iron uptake  
In addition to the genes up-regulated by the loss of PS and de novo PE, there were genes that 
were down regulated compared to wild-type as well.  There were 29 genes that were down-
regulated in the cho1∆/∆ mutant compared to wild-type by ≥3-fold (Appendix Table A-4).  There 
were 103 down-regulated genes (≥3-fold) in the psd1∆/∆ psd2∆/∆ mutant compared to wild-type 
(Appendix Table A-6).  The genes are summarized based on their categorizations according to 
cellular component GO terms (Fig: 2-4).   
 Among the genes down-regulated in cho1∆/∆ compared to wild-type, there were five 
(~17%) that had to do with iron uptake or utilization including CFL2, FRE10, FTR1, 
orf19.6873.1, and CHA1 (Table 2-6). Iron related genes make up only 2.4% of the genes in the 
whole genome, so the down-regulated genes in cho1∆/∆ are substantially enriched for iron 
uptake genes.   Of these 5 genes, 2 are down-regulated in psd1∆/∆ psd2∆/∆ compared to wild-
type as well, CFL2 and FRE10 (Table2-6).   
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Figure 2-3 :Sensitivity to the cell wall perturbing drugs Calcofluor White 
and Congo Red. The C .albicans cho1∆/∆, psd1∆/∆, and psd1∆/∆psd2∆/∆ 
mutants are sensitive to the cell wall perturbing drugs Calcofluor White and 
Congo Red but the cho1∆/∆ mutant’s sensitivity is greater as its growth was  
highly diminished in the presence of either Calcofluor White or Congo Red 
(Panel B and C). Serial dilutions of 5 µl of 1  O.D./ml  of  overnight cultured 
cells were spot inoculated on solid  minimal media (Yeast Nitrogen Base 
+dextrose, +uracil+histidine+1 mM Ethanolamine) either with (A) no drug (B) 
20 µg/ml Calcofluor white, a chitin synthesis inhibitor or (C) 40 µg/ml Congo 
Red, a β-1-3 glucan synthesis inhibitor. The plates were incubated  at 37°C 
and images were  taken at 24 hours.  
A B C 
No Drug Calcofluor  White  Congo Red 
WT 
cho1∆/∆ 
psd1∆/∆ 
psd1∆/∆/ 
psd2∆/∆ 
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Figure 2-4: Gene ontology (GO) comparison of all genes DOWN regulated in the cho1∆/∆ 
and psd1∆/∆psd2∆/∆ mutants. Genes were input into the Candida Genome Database (CGD) 
SLIM mapping tool and mapped for there cellular component. Gene  ontology is expressed as 
both component and the percentages are displayed comparing the cho1∆/∆ mutant (white) and 
the psd1∆/∆psd2∆/∆ mutant (black).  
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The down-regulation of iron utilization genes suggested that the cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
mutants might have defects in the ability to grow in iron limiting conditions.  Therefore, overnight 
growth of the strains was compared in minimal media containing or lacking the iron chelator 
bathophenanthroline disulfonate  (BPS), and minimal media + BPS with iron sulfate added back 
(100 µM or 300µM).  This experiment revealed that growth of the cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
mutants was significantly attenuated compared to wild-type in media where iron was limiting 
(100 µM or 300 µM, Fig: 2-5; data not shown).  Thus, iron limitation does inhibit the growth of 
both the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants.  
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Figure 2-5: Growth response to iron limitation in liquid media. Overnight cultures were 
diluted to 0.1 OD/ml in 5 ml of  minimal media (Yeast Nitrogen Base + dextrose + histidine + 
leucine + 1mM ethanolamine)  (A) with no chelator  or (C) + 1mM of the iron chelator, BPS or 
(B)  with 1mM of the iron chelator BPS and 100 µM Iron(II) sulfate. Toxicity to iron was assayed 
in minimal media with  the addition of 100 µM of Iron (II) Sulfate to the medium (Panel D).  Cells 
were grown with shaking at 37°C and optical density was measured after 48 hours.  (* indicates  
a p-value < .05 ** indicates  a p-valuue < .001)  
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The cho1∆/∆ mutant showed greater attenuation compared to psd1∆/∆ psd2∆/∆, and this might 
be because it had more iron utilization genes down-regulated (Table 2-7).  A comparison of the 
50 genes that are more down-regulated in the cho1∆/∆ mutant than the psd1∆/∆ psd2∆/∆ 
mutant by ≥2 fold, revealed that  20% of them are involved in iron utilization (Table 2-7, 
Appendix Table A-4).  This would help explain why cho1∆/∆ is more sensitive to iron depletion. 
These results are limited to liquid aerated culture and were not observed in the same media on 
agar plates (Fig: 2-6).  On plates containing BPS with iron added back, the growth between the 
strains was similar (Fig: 2-6). 
In contrast to down-regulating genes involved in iron uptake and utilization, both the cho1∆/∆ 
and psd1∆/∆psd2∆/∆ strains up-regulated genes known to be involved in response to hypoxia 
(low oxygen) (Table 2-9). A number of these genes are known to be induced under hypoxic 
conditions (Synnott et al., 2010) in Candida albicans. We observed a more robust (higher fold) 
up-regulation of some of these genes in the cho1∆/∆ strain compared to the psd1∆/∆psd2∆/∆ 
strain. This data suggests that while both strains exhibit a transcriptional response similar to a 
response to hypoxia, the cho1∆/∆ mutant response is indicative of a greater hypoxic response 
compared to the psd1∆/∆psd2∆/∆ strain. 
In addition, genes involved in oxidative stress response are up-regulated in the cho1∆/∆ 
mutant compared to the psd1∆/∆ psd2∆/∆ strain (Table 2-8).  These genes include the 
alternative oxidase (AOX2), which may help shunt electrons away from the classical electron 
transport chain to avoid oxidative damage.  In addition, genes that neutralize reactive oxygen 
and nitrogen species were also up-regulated like SOD5 and YHB1.  Several alcohol 
dehydrogenases including IFE2 and ADH5 were up-regulated which may help to metabolize 
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increased alcohol production if fermentation is increased to compensate for decreased 
respiration (data not shown). 
Reactive oxygen species (ROS) have been shown to be generated in the mitochondrial 
inner membrane under hypoxic conditions (Murphy et al., 2009; Cap et al. 2012). Consistent 
with the cho1∆/∆ mutants’ observed mitochondrial defects (Chen et al., 2010), ROS may be 
produced in the mitochondria under hypoxic conditions in the PS lacking cho1∆/∆ strain 
resulting in more defective mitochondria than the de novo PE lacking psd1∆/∆psd2∆/∆ strain. 
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Figure 2-6: Growth on solid minimal media under iron limited conditions.  The cho1∆/∆, 
and psd1∆/∆psd2∆/∆, and cho1∆/∆:CHO1 strains exhibit no differences in growth under iron  
limited conditions on solid minimal media compared to the WT (SC5314) strain (Panel C).  
Serial dilutions of  5 µl of  1  O.D./ml  of  overnight cultured cells were spot inoculated on solid 
media (Yeast Nitrogen Base + 1mM ethanolamine + uracil + histidine + Leucine + glucose) on 
minimal media plates  (A) without chelator or iron or (B) + 1 mM  of the iron chelator, 
Bathophenanthrolinedisulfonic acid (BPS) or (C)  + 1mM BPS + 100 µM Iron (II) Sulfate. The 
plates were incubated at 37°C and images were  taken at 48 hours. 
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Saccharomyces cerevisiae cho1∆ mutant has less severe cell wall defects compared to 
the Candida albicans cho1∆/∆ mutant 
S. cerevisiae has served as a template for studying phospholipid biosynthetic pathways in C. 
albicans (Kent et al 1995).To compare the cell wall phenotypes between the C. albicans 
cho1∆/∆ mutant and S. cerevisiae cho1∆ mutant, the susceptibility of the S. cerevisiae cho1∆ 
mutant to cell wall perturbing drugs was tested.  It was observed that like the C. albicans 
cho1∆/∆ mutant, the S. cerevisiae cho1∆ mutant is sensitive to congo red (Fig: 2-7), however, 
unlike the pathogen, it is not sensitive to calcofluor white.    
The cho1∆/∆ mutant in C. albicans has higher chitin content in the cell wall. The loss of 
PS in S. cerevisiae does lead to increased chitin content as evidenced by calcofluor white 
(CFW) staining (Fig: 2-8). However, the increase in chitin is about two- fold in the S.cerevisiae 
cho1∆ mutant, whereas in C. albicans the cho1∆/∆ mutant has a ten-fold higher chitin content 
compared to the wild-type strain (Chen et al., 2010).  Therefore, the effect of loss of PS on the 
cell wall is less severe in S. cerevisiae compared to C. albicans.  
Phenotypic differences in response to a loss of PS between C. albicans and S. cerevisiae are 
further highlighted by the fact that the ultrastructure of the cell wall differs between the two 
mutant strains of different species. Transmission electron microscopy (TEM) was performed to 
examine the ultra-structure of the cell wall and quantify its thickness. As we previously reported, 
the C.albicans cho1∆/∆ mutant displays a thick, irregular cell wall compared to the wild-type 
strain (Chen et al, 2010). However, unlike in C. albicans, the S. cerevisiae cho1∆ mutant does 
not display a disordered or thick cell wall. The cell wall appears to be identical to the wild type 
strain in both thickness and observable structure (Fig: 2-9). 
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Figure 2-7: Sensitivity  of the Saccharyomyces cerevisiae cho1∆ mutant to the cell wall 
perturbing drugs Calcofluor White and Congo Red. Serial dilutions of 5 µl of  1  O.D./ml  of  
overnight cultured cells were spot-inoculated on minimal media containing (A) no Drug or (B) 20 
µg/ml Calcofluor White, a chitin synthesis inhibitor or  (C) 40 µg/ml Congo Red, a β-1-3 glucan 
synthesis inhibitor. Images were taken after 48 hours of growth at 30°C. The cho1∆ mutant is 
hypersensitive to  the cell wall perturbing agent Congo Red compared to WT (Panel C) but is 
not hypersensitive to Calcofluor white (Panel B). The plates were incubated at 30°C and images 
were  taken at 24 hours.  
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Figure 2-8: Chitin content  of the Saccharomyces cerevisiae cho1∆ strain.  The 
Saccharomyces cerevisiae cho1∆ mutant has a higher chitin content compared to the wild type 
strain. However, unlike the ten-fold increase in chitin observed in C. albicans (Chen et al., 
2010), the increase is only two-fold in S. cerevisiae. Cells were grown overnight in  2% Yeast 
extract 2% Peptone 2% Dextrose (YPD) at 30°C and 1ml of 1 O.D./ml  of cells were stained with 
calcofluor white (1mg/ml) for 5 mins, washed with 1 ml H20, and visualized under a light 
microscope equipped with a fluorescent DAPI filter. Percentage fluorescence at low exposure is 
expressed as a percentage of total cells. ~400 cells were examined per strain. (** p value < 
0.001)  
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Figure 2-9: Transmission Electron Microscopy of the Saccharomyces cerevisiae cho1∆ 
strain. TEM images reveal that the cho1∆ strain (Panel B) shows no observable differences in 
cell wall ultrastructure compared to the WT strain (Panel A). Arrows indicate the outer surface of 
the cell call.  Note that the cell wall thickness and order is not changed, unlike that observed in 
the Candida albicans  cho1∆/∆ strain (Chen et al., 2010). Overnight cultures were growing at log 
phase were harvested using a modification of a protocol by Wright (2000).  Cells were 
resuspended in a fixative consisting of 3% glutaraldehyde and 3% paraformaldehyde in 0.1 M 
phosphate buffer, washed in 1% KMnO4 and  then  en-bloc stained in 1% aqueous uranyl 
acetate for1 hour. Cells were infiltrated with gradually increasing ratios of Spurr resin/ethanol 
over a 24 h period. The final 4 h of incubation were in 100% Spurr resin. Image is representative 
of  the ~150 cells examined by transmission electron microscopy. Scale Bar= 1 µm (panel A) 
and 0.8 µm (Panel B).  
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Discussion 
C. albicans is an important fungal pathogen and accounts for a majority of the cases of invasive 
candidiasis. Phospholipid biosynthesis enzymes, in particular the PS synthase Cho1p, have 
recently been shown to be required for virulence in a mouse model of systemic candidiasis 
(Chen et al., 2010). The mechanism underlying the avirulence of the cho1∆/∆ mutant remains 
unknown. However, we have found that this mutant, along with the psd1∆/∆ psd2∆/∆ mutant, 
has a defective cell wall as demonstrated by increased chitin content and disordered 
ultrastructure using transmission electron microscopy (Chen et al., 2010). An enormous amount 
of scientific effort has been spent in understanding the fungal cell wall as a plausible and 
effective antifungal drug target and to elucidate the biogenesis of this durable and complex 
structure (Blankenship et al, 2010, Plaine et al., 2008; Mora-Montes et al., 2012). In fact, the cell 
wall has often been referred to an organelle because of its dynamic structure as well as its 
essential role in survival (Chaffin et al., 1998; Nobel et al., 2000; Bussey et al., 2004). In C. 
albicans, the cell wall plays a crucial role in maintaining cell structure and regulates 
morphogenesis (Gelis et al., 2012; Cabib et al., 1997; Martinez-Lopez et al., 2004; Kelly et al., 
2004). It is crucial to environmental sensing and dictates interactions with the host by facilitating 
adhesion, evading immune recognition (McKenzie et al., 2010; Lewis et al., 2012; Mora-Montes 
et al., 2012), and activating signaling cascades allowing the fungus to respond to its 
environment (Birkaya et al., 2009; Blankenship et a., 2010; LaFayette et al., 2010; Rauceo et 
al., 2008). Therefore, a better understanding of how phospholipids  influence the cell wall and its 
maintenance is necessary for a more  complete  view  of how phospholipids mediate cellular 
processes in Candida albicans. 
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The cho1∆/∆ mutant has stronger effects on cell wall genes than the psd1∆/∆ psd2∆/∆ 
mutant 
Despite their strong effect on the cell wall, there is currently a lack of information on why losses 
of certain phospholipids, in particular PS and de novo PE, affect the cell wall in C. albicans.  To 
better understand the roles of PS and PE biosynthesis in maintaining the integrity of the cell 
wall, we examined whether specific lipid species were affected and what transcriptional changes 
occur upon loss of these species of PS and/or PE. RNA sequencing was used to measure 
changes in transcripts associated with blocking PS and de novo PE synthesis (cho1∆/∆) or de 
novo PE synthesis alone ( psd1∆/∆ psd2∆/∆). Three fold up- and down-regulated genes were 
then annotated by Gene Ontology (GO) using GO Slim Mapper tool on the Candida Genome 
Database (CGD) website http://www.candidagenome.org/ based on gene component (Figure 2-
1). Both mutants were compared to the wild type strain, and we found that the cho1∆/∆ mutant 
up-regulated a greater percentage of genes related to cell wall maintenance than the psd1∆/∆ 
psd2∆/∆  mutant (Figure 2-1).  
While several cell wall proteins (GlycosylPhosphatidyinositol (GPI)-anchored) were up-regulated 
in both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants (Tables 2-3 and 2-4), the up-regulation of 
ALS1 in both was confirmed using monoclonal antibodies, but Als3p was up-regulated only in 
the cho1∆/∆ mutant (Fig:2-2).  This may have been due to the fact that many ALS genes are 
very similar in sequence.  In fact, BLAST searches using ALS1 reveal large regions with very 
strong homology to ALS3, ALS2, ALS5, ALS 4, and ALS9,( in that order), where ALS3 and 
ALS2 are the strongest. Since RNAseq works by BLASTing the results of the sequenced library 
against the database, and ALS1 is strongly expressed in psd1∆/∆ psd2∆/∆, this may have 
caused an artifact that suggested increased expression of ALS3, as it is the closest ALS gene in 
homology.  
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In contrast, expression of the HWP1 gene was reflected very accurately by the RNAseq 
data (Table 2-3), as the cho1∆/∆ mutant clearly overexpressed it, but the psd1∆/∆ psd2∆/∆ had 
wild-type levels, based on immunofluorescence (Fig 2-2). This is supported by the fact that 
HWP1 has little homology to the ALS genes. 
Immunofluorescence staining revealed that the cho1∆/∆ mutant, despite having 
problems filamenting at 37˚C in response to some of the canonical stimuli such as neutral pH or 
nitrogen starvation (Chen et al, 2010), has a population of hyperfilamentous cells at 30˚C (Fig 2-
2).  This is clearly a consequence of the loss of PS since the psd1∆/∆ psd2∆/∆ mutant, with a 
similar loss of de novo PE, does not share this phenotype. The pathways affected by the loss of 
PS that lead to his phenotype, however, remain to be discovered. 
There are a number of cell wall genes (GPI-anchor) up-regulated in the cho1∆/∆ mutant, 
but not in the psd1∆/∆ psd2∆/∆ strain (Tables 2-3 and 2-4), and several are involved in cell wall 
repair including IFF11, PGA13, and PGA31 (Richard et al.,2007). GPI-anchored proteins 
regulate cell wall integrity and cell-cell interactions in C.albicans (Richard et al., 2007; Plaine et 
al., 2008). Two recently published studies reported that phospholipid levels play an important 
role in cell wall biogenesis and that mitochondrial defects may lead to cell wall defects in C. 
albicans (Qu et al., 2012, Dagley et al., 2010). Down-regulation of cell wall genes may help 
explain why the cho1∆/∆ mutant is more sensitive to cell wall insults like calcofluor white and 
Congo red than the psd1∆/∆ psd2∆/∆ mutant (Fig: 2-3), and has a more disordered cell wall and 
greater levels of chitin (Chen et al., 2010).  
 
Disruption of phospholipids biosynthesis results in defects in iron utilization 
We examined genes that were down-regulated in the mutants compared to the wild-type, we 
found that there was enrichment for genes that are involved in iron uptake or utilization (Tables 
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2-6 and 2-7). This result led to the hypothesis that our phospholipid biosynthesis mutants would 
be defective for growth in iron-limiting conditions.  Therefore, we assayed growth of the mutants 
under iron-limiting conditions by addition of the iron chelator, bathophenanthroline 
disulfonate (BPS), to deplete the media of iron, and amendment of the media with a low 
concentration (100 µM or 300 µM) of iron sulfate.  Both mutants exhibit defective growth in 
response to iron limitation compared to the wild type strain (Fig: 2-5).  However, the cho1∆/∆ 
mutant showed a more severe defect in response to to iron limitation than the psd1∆/∆psd2∆/∆ 
strain, as addition of 100 µM iron did not rescue growth of cho1∆/∆ to the extent it did for the 
psd1∆/∆psd2∆/∆ mutant (Fig: 2-5). Surprisingly, the phenotypic difference in iron response was 
limited to liquid culture, as we saw no observable difference on solid media (Fig: 2-6). 
The cho1∆/∆ mutant actually exhibits a greater decrease in iron responsive genes than 
the psd1∆/∆ psd2∆/∆ strain (Table 2-7), which probably explains the greater growth defect in 
iron limiting media for the cho1∆/∆ mutant than the psd1∆/∆ psd2∆/∆ mutant. In addition, the 
psd1∆/∆psd2∆/∆ strain exhibited better growth under iron limited conditions compared to the 
cho1∆/∆ strain. In correlation to this, we observed that the psd1∆/∆psd2∆/∆ mutant up-regulates 
a subset of genes involved in iron uptake response that were not up-regulated in the cho1∆/∆ 
strain (Table 2-10). These genes include SEF1, SEF2, and HAP2, CCC2 and orf19.2863.1. 
SEF1 is a transcriptional activator of iron-uptake genes that include SEF2, CCC2, and the iron-
utilization gene HAP2 (Chen et al., 2011). This may be an attempt to abrogate effects of iron 
limitation due to a loss of PS. The host bloodstream is an iron-limited environment, and it may 
be that the poor growth in iron-limiting conditions prevents the mutants from being able to grow 
in these conditions.  
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The cho1∆/∆ and psd1∆/∆psd2∆/∆ strains exhibit a hypoxic response 
We examined genes known to be differentially regulated under hypoxic conditions in Candida 
albicans. We found that both the cho1∆/∆ and psd1∆/∆psd2∆/∆ showed an up-regulation of 
genes associated with a hypoxic response compared to the wild type strain (Table 2-9). 
Specifically, both the cho1∆/∆ and psd1∆/∆psd2∆/∆  strains up-regulated ECM331, a GPI 
anchored protein gene induced under low oxygen conditions, however the cho1∆/∆ strain up-
regulates this gene nine-fold whereas the psd1∆/∆psd2∆/∆ strain only induces a five-fold up-
regulation. In addition, WH11, a phenotypic switching gene, strongly induced under hypoxia is 
also more highly up-regulated in the cho1∆/∆ (6-fold) versus the psd1∆/∆psd2∆/∆ strain (2-fold). 
In addition, we did find that both ERG11 and ERG3, both involved in the biosynthesis of 
ergosterol, were up-regulated in both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. It is also known 
that these genes are induced under hypoxic conditions (Synnott et al., 2010). Taken together, 
this data suggests that both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains exhibit a hypoxic 
response but that the cho1∆/∆ strains response is stronger and is indicative of a more hypoxic 
environment or a response that mimics this hypoxic state. 
 In contrast to the results above with ERG11 and ERG3 upregulation, it was observed that the 
sensitivity of both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strain to the antifungal drug fluconazole 
were increased (Fig: 2-10). Fluconazole inhibits the function of ERG11 (lanesterol -14-
demethylase), and therefore blocks ergosterol biosynthesis. The sensitivity to fluconazole in the 
cho1∆/∆ and psd1∆/∆psd2∆/∆ strains in spite of their upregulation of ERG11 may be due to an 
overall defect in ergosterol biosynthesis, which can lead to increased sensitivity to fluconazole 
(Flowers et al. 2012).   
 
 
56 
 
WT 
cho1∆/∆ 
psd1∆/∆ 
psd1∆/∆/ 
psd2∆/∆ 
A B 
 
 
 
 
 
 
 
 
 
Figure 2-10: Sensitivity  to the antifungal drug Fluconazole.The cho1∆/∆, psd1∆/∆, and 
psd1∆/∆psd2∆/∆ strains are  hypersensitive to the antifungal drug fluconazole, which targets 
lanosterol-4-demethylase, an enzyme  involved in the biosynthesis of the fungal sterol; 
ergosterol. Serial dilutions of 5 µl of  1 O.D./ml  of  overnight cultured cells were spot inoculated 
on solid media containing either (A) no Drug or (B) 5 µg/ml drug of Fluconazole. Images were 
taken after 48 hours of growth at 37°C.  
 
 
 
 
 
 
 
57 
 
Role of specific lipids in affecting the cell wall, iron-limitation, and other phenotypes 
Lipidomics analysis revealed that in addition to the loss of PS, specific species of PE, 16:n/18:n 
species were depleted.  This is consistent with the fact that these species are most likely 
derived from PS, which itself is composed of 16:n/18:n species.  We suspect that the defects 
seen in the psd1∆/∆ psd2∆/∆ mutant are due to specific loss of this species of PE, and not just 
general decreases in PE, as the Kennedy pathway can make more PE to compensate for loss 
of the de novo pathway, but its species are generally larger (18:n/18:n and 18:n/20:n). However, 
this remains to be tested experimentally.   
 Since PS is converted to PE in the mitochondria and endosome/Golgi by Psd1p and 
Psd2p, respectively, the observed phenotypes may be partly due to mitochondrial defects 
because of specific loss of 16:n/18:n PE or even endosomal sorting defects.  Defects in 
mitochondrial function affect the cell wall in C. albicans (Dagley et al., 2011), and endosomal 
defects affect signaling pathways that regulate the cell wall, like the Rim101p pathway. Again, 
this remains to be explored.   
 Finally, the cho1∆/∆ mutant has added defects, as it is missing de novo PE (16:n/18:n) 
and PS.  PS has been shown to be enriched in the endosomal and plasma membranes, and 
could affect a number of signaling proteins that affect the cell wall  such as the Rim101p 
pathway, which depends on the endosomal components for proper processing (Davis et al, 
2010). Pkc1p has not been implicated and our lab has demonstrated that it is likely not 
significantly involved in these events (data not shown: Sarah Davis personal communication) 
Finally, PS is required for calcineurin to associate with membranes (Kennedy et al., 1997), in 
vitro, so this cell wall pathway could be affected as well.  We also noted an increase in 
phosphatidylglycerol (PG) and phosphatidylinositol (PI) upon blocking de novo PE biosynthesis, 
suggesting  a possible shuttling of CDP-DAG into PG and PI biosynthesis to prevent a build-up 
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of CDP-DAG in the cell (Blankenship et al. 2005). We observed differences in sensitivities to low 
pH that may be due to the cell wall defects (Figure 2-11).  
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Figure 2-11: Sensitivity of C.albicans strains to low pH.  Overnight cultures of C.albicans 
were inoculated into 5 ml of  minimal media at the indicated pH (Panel A ) pH 4.0 and (Panel B) 
pH 2.7 . The pH was adjusted by phosphate citrate buffer. The strains were grown   at 37°C with 
shaking and the optical density was measured after 48 hours of growth. 
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Proposed model for the phenotypic effects observed upon a loss of de novo PS and PE 
in Candida albicans 
 We propose that the loss of phosphatidylserine (PS) in the fungal membrane leads to 
pleiotropic effects in C. albicans. These include, a defective cell wall as determined by 
sensitivity to the cell wall perturbing drugs, calcofluor white and congo red (Fig: 2-3) , differential 
expression of cell wall or glycosylphosphatidylinositol (GPI) anchored proteins (Tables 2-3 and 
2-4),  a defective  response to  iron limited conditions (Fig:2-5) and sensitivity to low pH (pH<4) 
(Fig:2-11). We hypothesize that the differences observed between the cho1∆/∆ and 
psd1∆/∆psd2∆/∆ mutants may be due to dysfunctional mitochondria as the cho1∆/∆ strain 
shows a lowered expression of mitochondrial related genes as well as an up-regulation of genes 
involved in the neutralization of reactive oxygen species (ROS) generated within the 
mitochondria compared to the psd1∆/∆psd2∆/∆ strain. These differences may be caused by 
changes in membrane fluidity due to a disruption of de novo aminophospholipid biosynthesis in 
the cho1∆/∆ mutant or by a direct chaperone activity of PS, but the exact mechanism remains to 
be explored. We examined the phospholipidome of the mutants to determine what species of 
lipids were changed upon disrupting the de novo synthesis pathway. We discovered that the 
major lipid species absent in the cho1∆/∆ mutant was PS  16:n/18:2 (Table 2-2) and noted a 
subsequent decrease in similiar species of downstream de novo synthesized PE and PC. We 
also observed an increase in longer acyl chained 18:n/18:n  PE  species suggesting that the 
Kennedy pathway up-regulates synthesis of this PE species upon disruption of the de novo 
pathway. It is possible that loss of the anionic PS and a shift toward longer acyl chained 
Kennedy pathway derived PE and PC may result in a more rigid membrane structure and this 
could lead to improper protein localization inside the mitochondrial membrane, however, more 
experiments are necessary to directly test this hypothesis. We show that the cho1∆/∆ strain has 
much more severe cell wall and mitochondria defects  compared to the psd1∆/∆psd2∆/∆ and 
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wild type strains. Our data suggest that mitochondrial dysfunction and generation of reactive 
oxygen species, in part, may account for the observed phenotypes in the cho1∆/∆ strain and we 
demonstrate  a novel role for PS in mitochondrial function. Firstly, transcriptional data is 
consistent with a hypoxic stress response in both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains 
(Table 2-9). Also, in support of this idea, the PS deficient cho1∆/∆ strain up-regulates genes 
involved in neutralization of reactive oxygen species (ROS) (Table 2-8). ROS are generated 
within defective mitochondria and can lead to cell damage and/or death (Murphy et al., 2009). 
We observed an up-regulation of genes involved in breaking down the reactive oxygen species 
such as nitric oxide (NO) and hydrogen peroxide (H202) in the cho1∆/∆ mutant but did not see 
these genes up-regulated in the psd1∆/∆psd2∆/∆ strain. Previously published data 
demonstrated the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains have defects in mitochondrial function  
but the full implications and differences between the strains remained unknown (Chen et al., 
2010). Our transcriptional data indicates that cho1∆/∆ has much more severe mitochondrial 
defects than psd1∆/∆psd2∆/∆ which implicates PS in a previously unknown role in mitochondrial 
function. It is known that nitric oxide is generated when iron bound by a porphyrin (heme) fails to 
receive electrons from cytochrome c (Nicholls et al., 1998; Yi et al., 2012), and instead reacts to 
produce damaging nitric oxide in the mitochondrial inner membrane. It will be of interest to 
investigate if PS itself, through its anionic headgroup mediates this interaction either directly or 
indirectly, and how a loss of PS could affect electron transport and generation of ROS. We also 
demonstrate that, in support of this model, the cho1∆/∆ strain represses iron-uptake genes and 
unlike the psd1∆/∆psd2∆/∆ mutant does not up-regulate genes involved in iron uptake such as 
the canonical iron response regulator SEF1.  This may be due to a shift toward glycolysis and a 
shut-down of aerobic respiration that mitigates production of oxygen radicals in the mitochondria 
in an effort to protect itself from generating damaging intracellular free radicals.  The effect of 
this damage on cell signaling such as activation of ion or osmotic stress pathways like Hog1 and 
Rim101 remains to be explored. We did not see any transcriptional changes in Rim101 or Hog1, 
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but that does not  necessarily mean that these pathways are not being activated as 
transcriptional activation is only a small part of mediating activation of  signaling pathways as 
proteolytic cleavage and phosophorylation are more common ways to initiate a quick response 
to cell damage. It is possible that a combination of the cellular energy and metabolic state, the 
generation of reactive oxygen species, and defects in signaling pathways, all related to PS 
and/or PE deficiencies, lead to defects in cell wall protein gene expression and thereby lead to 
defects in the structure of the wall.  
Losses of PS and PE have different consequences for S. cerevisiae and C. albicans 
Phospholipid biosynthesis pathways are practically identical between S. cerevisiae and C. 
albicans (Chen et al., 2010). However, we wanted to determine if the phenotypes that result 
from altered aminophospholipids between the S. cerevisiae cho1∆ mutant and that of C. 
albicans  cho1∆/∆ are conserved. It was demonstrated that the S. cerevisiae cho1∆ mutant does 
not have a disordered and thick cell wall (Fig: 2-9). The chitin content, while increased, was only 
two-fold (Fig:2-8) compared to a ten-fold increase in the C. albicans cho1∆/∆ mutant (Chen et 
al., 2010).  Therefore, there exist differences in the phenotypic response to loss of PS between 
S. cerevisiae and C. albicans. It may be that the ability of S. cerevisiae to tolerate mitochondrial 
dysfunction compared to C. albicans (which unlike S. cerevisiae cannot survive a loss of the 
mitochondrial genome) may contribute to these cell wall phenotypes as cell wall and 
mitochondrial function have been linked by the cell signaling pathway Hog-1.  This may indicate 
a fundamental difference between these two fungi, whereby in C. albicans cell wall maintenance 
and mitochondrial function may be more strongly linked compared to  S. cerevisiae.  However, 
the mechanism behind this difference remains to be tested.  It may also be related to 
differences in conserved, but distinct, cell wall signaling pathways that exist in both microbes, 
such as calcineurin and/or Rim101p. 
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Conclusions 
We show that a loss of de novo PS and PE biosynthesis has pleiotropic effects on the Candida 
albicans cell, including cell wall defects, defects in growth under iron limited conditions, 
sensitivity to low pH, sensitivity to the membrane-targeting drug fluconazole and differential 
expression of hypoxic, cell wall, and mitochondrial related genes. We also show that changes in 
the phospholipidome indicate that  PS 16:0/18:2 is the main lipid species trafficked through the 
de  novo pathway in Candida albicans and that there is a subsequent increase in long acyl side 
chain 18:n18n PE species , presumably, from increased Kennedy pathway PE and PC 
synthesis. The differential effects observed between the cho1∆/∆ and psd1∆/∆psd2∆/∆ strain 
implicate PS as having a direct role in the observed phenotypes. Therefore, we suggest a novel 
role for PS in Candida albicans, whereby, PS  itself is required for cell wall maintenance and 
loss of PS leads to both an altered cell wall and dysfunctional mitochondria. This is evidenced 
by the increased defects observed upon loss of PS compared to the defects observed upon a 
loss of PE alone. We also demonstrate that C. albicans and S. cerevisiae have different PS-
deficient cell wall phenotypes and this highlights a major difference between the response of 
these fungi to changes in phospholipid composition. Therefore S. cerevisiae cannot be used as 
a model to fully extrapolate phospholipid-related phenotypes or responses in C. albicans. It will 
be of interest to further explore how these interactions are mediated and, in particular, to 
elucidate a direct mechanism for  PS in cell wall maintenance and mitochondrial function.   
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APPENDIX B: TABLES  
Table 2-1: Candida albicans (Ca) and S. cerevisiae (Sc) strains used in this study 
Strain Genotype Reference 
SC5314    Ca. wild-type Gillum et al. 1984 
YLC 337  Ca.cho1∆/∆ Y.Chen et al. 2010 
YLC 344  Ca.cho1∆/∆::CHO1-SAT1 Y.Chen et al. 2010 
YLC 345  Ca.cho1∆/∆::CHO1-SAT1 Y.Chen et al. 2010 
YLC 280  Ca.psd1∆/∆ Y.Chen et al. 2010 
YLC 294  Ca.psd1∆/∆::PSD1-SAT1 Y.Chen et al. 2010 
YLC 375  Ca.psd1∆/∆psd2∆/∆ Y.Chen et al. 2010 
TRY 153 Sc.ura3∆,his3∆ This study 
TRY 155 Sc.ura3∆,his3∆,cho1::KanMX6 This study 
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Table 2-2: Differences in phospholipids species of the cho1∆/∆ and psd1∆/∆psd2∆/∆  
strains compared to the wild type strain. Values are relative amounts(ug) of each 
phospholipid species that were normalized to PE (phosphatidylethanolamine), PS 
(phosphatidylserine), and PC (phosphatidylcholine) standards in their own classes.The 
standarsd used were PE 28:0, PS30:0,and PC 28:0.  
 
   Strains 
Species m/z Lipid WT psd1∆/∆psd2∆/∆ cho1∆/∆ 
PE       
710.4 16:1/18:3 8 6 6  
712.4 16:1/18:2 35 8 14  
714.4 16:0/18:2 134 18 22  
716.4 16:0/18:1     37 5 13  
736.4 18:2/18:3 64 51 59  
738.4 18:2/18:2 75 57 79  
740.4 18:2/18:1 70 63 89  
742.4 18:0/18:2 29 79 31  
744.5 18:0/18:1 17 18 36  
746.5 18:0/18:0 15 17 5  
762.5 18:2/20:4 17 11 14  
764.5 18:1/20:4 41 38 51  
766.4 18:0/20:4 47 57 57  
768.4 18:1/20:2 23 41 33  
770.4 18:0/20:2 16 14 9  
772.4 18:0/20:1 15 14 13  
 Total 
amount 
                                           643 496 529  
PS   WT psd1∆/∆psd2∆/∆ cho1∆/∆ 
760.7 16:0/18:1 5 12 n.d.  
756.7 16:1/18:2 51 127 n.d.  
758.7 16:0/18:2 23 46 n.d. 
 
 
Total 
amount 
 79 185 0  
      
PC   WT psd1∆/∆psd2∆/∆ cho1∆/∆ 
730.4 16:0/16:2 10 10 9  
732.5 16:0/16:1 12 12 10  
734.4 16:0/16:0 18 18 16  
752.4 14:0/20:5 9 9 9  
754.4 16:2/18:2 62 15 12  
756.5 16:1/18:2 107 22 20  
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Table 2-2. n.d.= not detected.  m/z= charge to mass ratio of species.  
Lipid component is described as number of carbon atoms: saturation number/ number of carbon atoms: saturation  
number. 
 
 
 
 
 
 
 
 
 
Table              
 
  m/z 
 
2-2  continued. 
 
 lipid  
 
 
WT 
 
 
psd1∆/∆psd2∆/∆ 
 
 
cho1∆/∆ 
 
  760.5 16:0/18:1 137 34 33  
762.6 16:0/18:0 112 24 21  
778.4 16:2/20:4 78 112 121  
780.4 16:1/20:4 106 147 157  
782.5 18:2/18:2 66 108 132  
784.5 18:1/18:2 49 84 91  
786.5 18:1/18:1 35 44 52  
788.5 18:0/18:1 24 29 26  
808.5 18:1/20:4 6 13 10  
810.5 18:0/20:4 8 24 24  
812.5 18:1/20:2 12 33 13  
814.5 18:0/20:2 14 26 14  
816.5 18:0/20:1 7 10 8  
 Total 
amount 
 1025 811 814  
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Table 2-3: Cell Wall related genes up-regulated in the cho1∆/∆ mutant compared to wild 
type 
Gene Fold up-
regulated 
Function p- value 
PGA31 84 Cell wall protein 1.0E-300 
PGA23 32 GPI-anchored protein transcription is 
negatively regulated by Rim101p      
          
1.0E-300 
RBR1  31 GPI-anchored cell wall protein 
required for filamentous growth at 
acidic pH 
            
4.6E-70 
PGA58 13 Putative GPI-anchored protein                     
 
1.9E-158 
PGA13 6 cell wall regeneration and core 
caspofungin response 
 
1.0E-300 
IFF11 5 Secreted protein required for normal 
cell wall structure and for virulence 
7.1E-46 
AMS1 4  Adhesin-like cell wall protein                          
 
7.0E-180 
HWP1 3 N-linked mannoprotein of cell wall 
and membrane  
1.0E-300 
SAP9 3 Secreted aspartyl protease; roles in 
adhesion             
 
1.0E-300 
orf19.2076 
 
3 N-linked mannoprotein of cell wall 
and membrane  
4.2E-54 
PGA44 3 GPI-anchored protein                                      
 
6.5E-12 
SAP10 2 Secreted aspartyl protease 1.6E-12 
IFF6 2 Putative GPI-anchored adhesin-like 
protein                         
 
2.6E-20 
orf19.12206 2 Cell wall adhesin   
 
5.4E-50 
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Table 2-4: Cell wall-related genes up-regulated in the psd1∆/∆ psd2∆/∆ mutant compared 
to wild type. 
Gene psd1∆/∆ 
psd2∆/∆> WT 
(fold up-
regulated) 
Function p value 
RBT5 4 GPI-anchored cell wall protein involved in 
hemoglobin utilization  
7.08E-55 
PGA54 3 Putative GPI-anchored protein 3.47E-149 
PGA18 3 GPI-anchored protein                                  7.99E-51 
PGA27  3 GPI-anchored 
protein                                      
   3.40E-15 
PGA55 3 GPI-anchored protein; adhesin-like protein; filament 
induced 
7.66E-23 
PLB5  2 GPI-linked phospholipase B                 6.87E-27 
PGA1 2 induced during cell wall regeneration; required for 
normal adhesion                     
1.76E-19 
CHT2 2 GPI-linked chitinase required for normal filamentous 
growth 
1E-300 
HYR4  2 GPI-anchored adhesin-like protein  1E-16 
orf19.2677 2 Putative GPI transamidase component 2.9E-48 
PGA25  2 GPI-anchored adhesin-like protein        4.5E-24 
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Table 2-5: Cell wall genes up-regulated in both cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants 
compared to the wild-type 
 
Gene 
 
cho1∆/∆ 
 
psd1∆/∆psd2∆/∆ 
                               
Function 
p value   
psd1∆/∆psd2∆/
∆ vs wt 
p value 
cho1∆/∆ 
PGA10 9 4 Plasma membrane 
protein of heme-iron 
utilization         
2.4E-17 7.8E-98 
ECM331 9 5 GPI-anchored protein          1.2E-62 1.5E-200           
ALS2 8 4 Cell wall adhesion                    1.1E-65 1.0E-300 
ALS3 5 5 Cell wall adhesin               3.1E-177 1.0E-300 
HYR1 4 3 Hyphal-induced GPI-
anchored cell wall 
protein; macrophage-
induced              
2.6E-30 1.4E-50 
ALS4 4 3 Cell Wall adhesin                   1.3E-77 1.0E-300 
GPI1 4 4 Protein GPI synthesis 1.1E-48 3.5E-48                   
ALS1 3 5 Adhesin 1.0E-300 1.0E-300 
PGA6 3 6 cell wall adhesion                             1.0E-300 1.0E-300 
HYR3 3 2 adhesin-like protein                7.1E-99 1.1E-174 
IFF5 2 2 GPI-anchored protein; 
adhesin-like protein  
9.6E-23 1.35E-35                  
ALS9 2 3 Cell wall adhesin                         7.3E-32 2.7E-34 
PGA45 2 2 GPI-anchored protein                4.5E-194 9.4E-211 
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Table 2-6:  Iron response genes down-regulated ≥ 3 fold in the cho1∆/∆ and 
psd1∆/∆psd2∆/∆ mutants compared to wild-type  
Gene 
name 
WT > cho1∆/∆  
(fold 
downregulated) 
WT>psd1∆/∆psd2∆/∆ 
(fold downregulated) 
Cellular function  P-value  
CFL2 -11.3 -10 Putative 
oxidoreductase, ron 
utilization      
1E-300, 1E-300 
FRE10 -5.0 -4 Ferric reductase 1E-300, 1E-294 
FTR1 -4.3 no change High affinity iron 
permease 
4.2E-171 
CHA1 -3.4 no change Regulated by 
Rim101p and iron 
3.0E-67 
orf19.2067 no change -3                                                                                                 
Putative protein 
with a predicted 
role in 
mitochondrial iron 
metabolism                                       
7.4E-284 
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Table 2-7: Iron response genes down-regulated ≥2fold in the cho1∆/∆ mutant compared 
to psd1∆/∆ psd2∆/∆ mutant 
 
Gene name cho1∆/∆> 
psd1∆/∆ psd2∆/∆  
Cellular function                         p-value 
RBT5 -5 Cell wall-Hemoglobin utilization    2.2E-88 
orf19.4459 -3 Heme binding                                2.2E-90 
HAP3 -3 Iron regulation gene                      8.0E-18 
orf19.6976 -3 Heme carrier protein                     3.1E-49 
CCC2 -2 Iron assimilation                            2.3E-61 
PGA32 -2 Cell wall-regulated by iron             4.8E-16 
FTR1 -2 High affinity iron permease            7.0E-47 
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Table 2-8: The cho1∆/∆ strain up-regulates genes associated with neutralization of 
reactive oxygen species (ROS). 
Gene  Fold up-regulated in 
cho1∆/∆ vs 
psd1∆/∆psd2∆/∆                    
Function P-value  
cho1∆/∆ vs 
psd1∆/∆psd2∆/∆ 
orf19.10993 112 H2O2 stress 1.0E-300 
AOX2 63 Alternative oxidase 1.0E-300 
SOD5 15 superoxidedismutase; 
oxidative stress 
1.0E-300 
YHB1 7 Nitric oxide dioxygenase 1.0E-300 
orf19.711  7 Uncharacterized ORF 
induced by nitric oxide 
1.0E-34 
PCK1 5 Phosphoenolpyruvate 
carboxykinase;H202 
stress 
1.0E-300 
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Table 2-9: Hypoxic genes up-regulated in the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains 
compared to WT. 
 
 
 
 
 
 
 
Gene cho1∆/∆ psd1∆/∆psd2∆/∆ Function p value 
cho1∆/∆ vs 
WT 
 
p-value 
psd1∆/∆psd2∆/∆ 
vs WT 
ECM331 9 5 GPI-anchor protein; 
hypoxia induced 
1.5E-          
200 
1.2E-62 
WH11 6 2 cytoplasmic protein; 
hypoxia induced 
6.0E-146 2.1E-10 
orf19.1691 3 3 uncharacterized 1.0E-300 1.6E-200 
ERG3 3 3 C-5 sterol 
desaturase; 
1.0E-300 3.3E-168 
ERG11 3 3 Lanosterol 14-alpha-
demethylase 
1.0E-300 1.0E-300 
SLD1 3 3 Sphingolipid delta-8 
desaturase 
1.7E-148 5.5E-82 
RBE1 no change 2 Cell wall protein 6.1E-31 3.4E-64 
orf19.6117 2 no change uncharacterized; 
hypoxia induced 
1.3E-97 1.9E-72 
CSH1 3 2 Aldo-keto reductase 
family member 
3.1E-245 2.5E-78 
PNG2 6 3 Putative peptide:N-
glycanase 
1.0E-300 1.8E-160 
GDH3 8 11 NADP-glutamate 
dehydrogenase 
1.0E-300 1.0E-300 
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Table 2-10: Iron uptake genes up-regulated in psd1∆/∆psd2∆/∆ mutant compared to the 
wild type 
Gene psd1∆/∆psd2∆/∆  
(fold up-regulated) 
Function                                       p-value 
orf19.1195 5 Cellular iron ion homeostasis        1.0E-300 
RNR3 5  Ribonucleotide reductase             1.7E-82                 
PGA10  4  Protein of heme-iron utilization      2.4E-17 
ALS2  4 Adhesin                                          1.1E-65 
SFU1 4  Transcriptional regulator of iron    8.0E-149 
SEF2 3  Putative zinc cluster protein          8.0E-95  
FTR2 3  High-affinity iron permease           1.0E-300 
SEF1 3 Regulates iron uptake                     1.5E-64 
orf19.2863.1 3 Cellular iron ion homeostasis          2.1E-74 
FTH2 2  Putative iron transporter                4.5E-52 
HAP2  2 CCAAT-binding factor                     2.0E-21 
MNT4  2  Mannosyltransferase                      2.5E-11 
CCC2 2  Copper-transporting ATPase         2.3E-24 
MNN2 2  Alpha-1,2-mannosyltransferase     5.1E-75 
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CHAPTER THREE 
Conclusions and future directions 
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Abstract 
In this study, we examine specific changes to the phospholipidome that may help explain some 
of the observed phenotypic differences for the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. 
Phospholipid profiling revealed that PS 16:018:2 is the major PS species absent in the cho1∆/∆ 
strain and this is likely the major lipid species trafficked through the de novo pathway in Candida 
albicans. We also noted a shift toward longer acyl chained PE species in the cho1∆/∆ and 
psd1∆/∆psd2∆/∆ strains suggesting that these species are synthesized via the Kennedy 
pathway in C. albicans. Defects in mitochondrial function are a consequence of 
phosphatidylethanolamine (PE) deficiency, and loss of PS causes a loss of de novo synthesized 
PE (Kent et al., 1995; Chen et al., 2010).  However, a comparison between mutants lacking just 
de novo PE (psd1∆/∆ psd2∆/∆) and both PS and de novo PE (cho1∆/∆) reveals that 
mitochondrial and cell wall defects are more severe in the cho1∆/∆ mutant, suggesting a direct 
role for PS in both of these functions. 
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Introduction 
The aim of our study is to elucidate the functions of de novo phospholipid biosynthesis in 
Candida albicans. We found that disruption of de novo phospholipid biosynthesis leads to both a 
defective cell wall and dysfunctional mitochondria. Our data suggests that loss of 
phosphatidylserine (PS) itself specifically affects mitochondrial function and  leads to the down-
regulation of iron uptake genes and up-regulation of hypoxia induced genes as well as  genes 
involved in cell wall repair,  and generation of a transcriptional response to neutralize  
intracellular reactive oxygen species (ROS) in the fungal pathogen Candida albicans.  Defects 
in mitochondrial function are a well-known consequence of phosphatidylethanolamine (PE) 
deficiency, and loss of PS causes a loss of de novo synthesized PE (Kent et al., 1995; Chen et 
al., 2010).  However, a comparison between mutants lacking just de novo PE (psd1∆/∆ 
psd2∆/∆) and both PS and de novo PE (cho1∆/∆) reveals that mitochondrial and cell wall 
defects are more severe in the cho1∆/∆ mutant, suggesting a direct role for PS in both of these 
functions.  
The defects in the cell wall in the cho1∆/∆ mutant may be partially or completely 
attributable to mitochondrial defects as recent studies link cell wall defects to mitochondrial 
dysfunction (Dagley et al. 2011, Qu et al., 2012). The role of PS in mediating mitochondrial 
function has not been well described.  We propose a model wherein PS loss leads to 
dysfunctional mitochondria, which in turn regulates the pathogen’s response to hypoxia and iron 
limitation. In response to a loss of PS, we propose that cho1∆/∆ activates compensatory 
pathways involved in cell wall integrity and neutralization of damaging oxygen species. We also 
report that PS plays divergent roles in Saccharomyces cerevisiae as we do not see similar cell 
wall defects in the S. cerevisiae cho1∆ strain. This demonstrates a fundamental difference in 
phospholipid roles between Candida albicans and Saccharomyces cerevisiae and suggests that 
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this model organism should  be used  only with caution in elucidating the roles of these 
phospholipids in Candida albicans.  
Summary of Results 
In this study, we examine specific changes to the phospholipidome that may help explain some 
of the observed phenotypic differences for the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. 
Phospholipid profiling revealed that PS 16:018:2 is the major PS species absent in the cho1∆/∆ 
strain and this is likely the major lipid species trafficked through the de novo pathway in Candida 
albicans. We also noted a shift toward longer acyl chained PE species in the cho1∆/∆ and 
psd1∆/∆psd2∆/∆ strains suggesting that these species are synthesized via the Kennedy 
pathway in C. albicans.  
Linking cell wall defects and mitochondrial dysfunction in the C. albicans cho1∆/∆ strain 
 A comparison of the transcriptional profiles of the cho1∆/∆ strain to the psd1∆/∆psd2∆/∆ strain 
indicates that the cho1∆/∆ strain has more defective mitochondria as it up-regulates genes 
involved in neutralization of mitochondrial-generated reactive oxygen species (ROS). Recent 
advances in the study of mitochondrial and ER-localized protein complexes provide a direct link 
between mitochondrial dysfunction and cell wall defects in Candida albicans (Qu et al., 2012, 
Alonso-Monge et al., 2009).  For example, the SAM (Sorting and Assembly Machine) complex 
localized within the mitochondria has been shown to be important for maintaining mitochondrial 
function and its deletion (sam37∆/∆) leads to cell wall defects in Candida albicans (Qu et 
al.,2012). In addition, this complex has been hypothesized to be involved in the transfer of 
phospholipids to and from the mitochondria as it shares Mdm10, a key component of the ER-
Mitochondrial Encounter Structure (ERMES) which aides in tethering mitochondria to the ER to 
facilitate phospholipid transfer (Dagley at al., 2011 Osman et al., 2012).  The sam37∆/∆ mutant, 
like the cho1∆/∆ mutant, exhibits increased chitin content and sensitivity to the cell wall 
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perturbing drugs calcofluor white and congo red (Qu et al., 2012). Interestingly, Qu et al. 
demonstrate that the sam37∆/∆ mutant showed a loss of mitochondrial DNA (mtDNA) indicating 
that the mitochondrial genome is partially lost upon disruption of this SAM37 complex. This data 
correlates with the defects in the cell wall observed in the sam37∆/∆ mutant, including the 
observation that, like the cho1∆/∆ strain, sam37∆/∆ has a thickened cell wall by transmission 
electron microscopy, suggesting that a deletion of SAM37 leads to cell wall defects and an 
inability of Candida albicans to maintain the mitochondrial genome by an as yet unidentified 
signaling pathway (Qu et al., 2012). It therefore may be possible that loss of PS affects this 
complex, directly or indirectly and that some of the shared phenotypes may be due to a 
conserved mechanism linking mitochondrial dysfunction to cell wall defects. 
We speculate that the phospholipid environment of the mitochondria, in particular the loss of 
PS, may lead to a loss of either the mitochondrial genome or transcription of many of its genes. 
We also identified nuclear gene products localized to the mitochondria that were down-
regulated in the cho1∆/∆ verses psd1∆/∆psd2∆/∆ strain including MCD1, SEN2, orf19.2090 and 
orf19.4273. MCD1 acts to regulate mitochondrial membrane potential upon oxidative stress in 
S. cerevisiae (Yang et al., 2008) but has not been studied in Candida species, SEN2 is a 
mitochondrial localized endonuclease and  orf19.2090, orf19.4273  are  found in the 
mitochondria but are of unknown functions (Candida genome database). In addition, we have 
identified several  genes such as COX2, COX3A, COX3B, NAD1, NAD3, and NAD6, which are 
all encoded by the mitochondrial genome and directly involved in the electron transport chain, 
that are down-regulated in the cho1∆/∆ mutant compared to the psd1∆/∆ psd2∆/∆ mutant 
suggesting a difference in mitochondrial genome stability. However, these genes need to be 
independently verified by other means such as qPCR as in our study they were not significantly 
different despite their two fold down-regulation.  Taken together, this data suggests an inhibition 
of the electron transport chain, which may result in respiratory deficiency and  the  production of  
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reactive oxygen species (ROS).  In addition, the observed loss of mitochondrial function and the 
hypothesized electron transport dysfunction may explain  the link between cell wall defects as 
these genes are down-regulated in both the cho1∆/∆ and sam37∆/∆  strains (Qu et al.,2012). 
It may be that mitochondrial dysfunction in both the cho1∆/∆ and sam37∆/∆ mutants may lead to 
activation of cellular mechanisms normally expressed in response to changing metabolic and 
oxygen conditions in Candida albicans, which can be induced upon mitochondrial-generated 
ROS (Synnott et al., 2010). It is known that hypoxic conditions can cause changes in expression 
of iron uptake genes and lower sterol levels in the Candida albicans membrane (Dhamgaye et 
al. 2010; Sosinska et al. 2008; Mungai et al., 2011). It may also be that loss of PS causes 
defects in respiration that lead to the observed increase in ROS-related genes which may also 
be tied to  the down-regulation of iron transport genes (the products of which are integral to  the 
electron transport chain via heme interactions with cyotochrome c)  and an increase in hypoxia 
induced genes. It is also possible that the Hog1 signaling pathway may be activated upon loss 
of PS  due to a more fluid membrane as it is known to be activated by changes in membrane 
fluidity (Hickman et al., 2011). Therefore, C. albicans may have evolved a mechanism where 
mitochondrial dysfunction leads to production of ROS which initiates a response that alters cell 
wall structure, regulates iron uptake, neutralizes damaging free radicals, and thus allows the 
fungus to thrive in diverse environmental niches of varying carbon sources and  environmental 
stresses . In addition, it is known that respiratory deficiency in S. cerevisiae leads to increased 
mRNA stability of the cho1∆ transcript which also supports the idea that PS has some function 
in mitochondrial maintenance (Carmen et al., 2007). Our work examines some of these 
connections and presents a model where PS is critical for normal cell wall structure and 
mitochondrial function C. albicans. 
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A proposed role for phosphatidylserine in hypoxic response and iron uptake  
We found that both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains are sensitive to the anti-fungal 
drug fluconazole, although cho1∆/∆ was much more sensitive than psd1∆/∆psd2∆/∆. 
Fluconazole targets the Erg11 (lanosterol-14α-demethylase) enzyme that is involved in the 
biosynthesis of the major fungal sterol, ergosterol. It is known that ERG11 is up-regulated under 
hypoxic conditions (low oxygen, ~1% O2) and, sterols are important markers of hypoxic 
response (as molecular oxygen is required for ergosterol biosynthesis) in several fungi including 
Candida albicans , Saccharomyces cerevisiae,  Schizosaccaharomyces pombe and Aspergillus 
fumigatus (Hughes et al., 2006;  Blatzer et al., 2011;  Synnott et al., 2010; Hickman et al., 2011; 
Blosser et al., 2012). The decreased expression of mitochondria related genes and the 
production of ROS in C. albicans may mimic hypoxia.  In Candida albicans and 
Saccharoymyces cerevisiae, heme biosynthesis is also central in mediating the response to 
hypoxia (Lai et al., 2008; Mcdonagh et al., 2011; Sosinska et al. 2008). In Candida albicans, the 
transcription factor UPC2 directly activates hypoxic response upon lowered sterol levels 
(Synnott et al., 2010). In parallel, the heme binding transcription factor HAP1 acts to reduce 
aerobic respiration and activates expression of hypoxic genes in low oxygen environments 
(Synnott et al.,2010; Sing et al. 2011). In S. cerevisiae, under normoxic conditions HAP1 binds 
directly to heme and activates the transcriptional repressor ROX1, but upon loss of molecular 
oxygen, heme biosynthesis ceases, as oxygen is required for the biosynthesis of heme, and 
HAP1 can no longer bind to heme, thereby causing the loss of the repressor and activation of 
hypoxia induced genes (Synnott et al., 2010).  The ortholog to ROX1 in C. albicans , RFG1, 
does not mediate hypoxic response but rather activates cell wall enzymes required for 
filamentation (Synnott et al., 2010). This may, in part, explain how cho1∆/∆ exhibits changes in 
cell wall structure, increased filamentation (Fig 2-2) (Chen et al. 2010), and the repression of  
iron uptake genes. In C. albicans, an increase in ROS by decreased expression of the 
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alternative oxidase (AOX1) has been shown to induce hypersensitivity to fluconazole (Yan et al., 
2009). Thus, increased ROS due to a loss of PS  may be responsible for the observed 
phenotypes in the cho1∆/∆ mutant.  This is consistent with our proposed model of mitochondrial 
dysfunction leading to these phenotypes as decreased oxygen levels have been linked to 
generation of ROS (Mungai et al., 2011) and a reduction in heme biosynthesis.  
In psd1∆/∆psd2∆/∆ increased ROS may be mitigated by activation of the iron uptake 
transcriptional activator SEF1 and this may explain why growth under iron limited conditions, 
while defective, is not as deficient as that observed in the cho1∆/∆ strain. SEF1 acts to up-
regulate heme biosynthesis genes and iron utilization genes (Chen et al., 2011). This may aide 
in stabilizing the slight defects in the mitochondria observed in the psd1∆/∆psd2∆/∆ strain by 
increasing heme biosynthesis and thereby reducing generation of ROS.  
In addition to less of a defect with regards to iron assimilation genes, the 
psd1∆/∆psd2∆/∆ strain grew better than the cho1∆/∆ strain under iron limited conditions. This 
indicates a role for PS in iron response in Candida albicans. It could be that loss of PS  
inherently alters iron uptake and this causes defects in iron related processes such as heme 
biosynthesis and uptake. Alternatively, the observed  hypoxic-like response causes decreased 
expression of  iron uptake genes as oxygen and iron sensing are tightly linked (Sosinska et al., 
2008, Dhamgaye et al., 2012, Chen et al., 2011). This suggests that cho1∆/∆  may shift away 
from aerobic respiration possibly to mitigate  damaging effects of ROS due to dysfunctional 
mitochondria. The observed up-regulation of AOX2 (Alternative Oxidase 2) in cho1∆/∆ 
compared to the psd1∆/∆psd2 ∆/∆ supports this idea, as AOX2 is an electron acceptor which 
has recently been shown to be involved in the neutralization of reactive oxygen species 
generated from leaky electron transport chains (Cvetkovska et al., 2012).  
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We found that the cho1∆/∆ mutant up-regulated genes involved in hypoxic response and 
neutralization of H2O2 (hydrogen peroxide) and NO (Nitric oxide) compared to the wild type 
strain. These reactive oxygen species can be generated by dysfunctional mitochondrial electron 
transport chains, NO is produced upon failure of cytochrome c to transfer electrons to heme 
during aerobic respiration (Bourens et al., 2012). It is also known that reactive oxygen species 
(ROS) can inhibit mitochondrial function and biogenesis in S. cerevisiae but little is known of 
their effect in C. albicans (Chevtzoff et al., 2010).   
Taken together our data indicate a novel function for phosphatidylserine (PS) in maintaining 
mitochondrial function and cell wall structure.  We propose a model whereby loss of PS leads to 
a hypoxic type response that shuts down iron uptake and heme biosynthesis, and generation of 
reactive oxygen species that activate cell wall integrity stress pathways and leads to differential 
cell wall protein expression. This could be due to changes in membrane fluidity caused by the 
loss of PS but more experiments are necessary to confirm the role of membrane fluidity in these 
processes. It may also be that PS acts directly as a molecular chaperone either through 
interaction with Sam37p or with components of the electron transport chain such as   
cyotochromes. As PE has been shown to act as a molecular chaperone in E. coli, through 
interaction with the membrane protein lactose permease (Xie et al., 2006), a chaperone function  
has not yet  been described for PE or PS in yeast. The pathways most likely to be activated 
upon loss of PS are the Rim101 pathway, shown to be linked to hypoxia and ion stress, or the 
Hog1 pathway which has been linked both to mitochondrial defects and changes in membrane 
fluidity in S. cerevisiae (Hickman et al., 2011; Ikeda et al., 2008).   
The defects observed in psd1∆/∆psd2∆/∆ are not as severe as in the cho1∆/∆ and they can 
possibly be explained by the observed shift in acyl length of the phosphatidylethanolamine (PE) 
species leading to less severe changes in mitochondrial function when compared to cho1∆/∆ 
mutant, as it still has PS present in the membrane. It may also be that greater changes in 
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membrane fluidity due to a loss of phosphatidylserine (PS) cause these differential wall and 
mitochondrial phenotypes in cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. In S. cerevisiae, hypoxic 
response has been directly linked to changes in membrane fluidity via the transcription factors 
MGA2 and SPT23 (Jiang et al., 2001, Kelley et al., 2009) but this remains to be tested in 
Candida species.    
Our study also demonstrates that C. albicans and S. cerevisiae do not conserve cell wall 
phenotypes associated with disruption of de novo phospholipid biosynthesis, suggesting they 
have evolved different mechanisms to respond to stresses associated with disruption of 
phospholipid biosynthesis. In support of this, it has been shown that the hypoxic response and 
iron sensing pathways are not identical between S. cerevisiae and C. albicans. This may be due 
to the fact that C. albicans is not viable upon loss of its mitochondrial genome (a petite negative 
yeast) whereas S. cerevisiae (a petitie positive yeast) is better able to overcome mitochondrial 
genome loss and the problems associated with loss of PS. In S. cerevisiae psd1∆ psd2∆ and 
cho1∆ strains require PE  for growth on non-fermentable carbon sources and  this growth is 
correlated to an increase in  mitochondrial  PE content (Birner et al. 2001). PE depletion also 
causes increased respiratory deficiency suggesting that PE itself may play a more direct role in 
S. cerevisiae mitochondrial dysfunction and cell wall phenotypes.  This is in contrast to C. 
albicans where a loss of PE alone does not explain the observed cell wall and mitochondrial 
defects suggesting that PS has an independent function in this petite negative yeast. 
Future Directions  
To test the hypothesis that the cho1∆/∆ strain produces more reactive oxygen species (ROS) 
compared to the psd1∆/∆psd2∆/∆ and wild type (SC5314) strains, the dye Lucigenen 
(Invitrogen™) that specifically binds to reactive oxygen species and produces a quantifiable 
colorimetric signal  can be used to measure differences in ROS between cho1∆/∆,  
psd1∆/∆psd2∆/∆, and wild type (SC5314) strains. Also, it will be of interest to delete AOX2 in 
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the cho1∆/∆ strain, since it may be involved in preventing electron leakage from the electron 
transport chain and thereby compensate for generation of ROS in the cho1∆/∆ strain.  A 
aox2∆/∆ cho1∆/∆ double mutant could be used to test if this can further increase damage 
caused by ROS generation compared to wild-type, cho1∆/∆, and aox2∆/∆ single mutants. 
Alternatively, the AOX inhibitor, salicylhydroxamic acid (SHAM) can be added to the media to 
test if blocking Aox1p and Aox2p function enhances the mitochondrial and cell wall defects 
observed in the cho1∆/∆ strain.  Specific dyes that bind to nitric oxide, hydrogen peroxide and 
O2 – species, such as MitoSOX red (Mukhopadhyay et al., 2007, Cvetkovska et al., 2012), or 
DAF-FM (which measures NO production) can also be utilized in our mutant strains. These 
experiments will provide a method to directly test our hypothesis that the cho1∆/∆ strain 
produces reactive oxygen species (ROS) due to dysfunctional mitochondria.  
Transcriptional profiling revealed a possible down-regulation of mitochondrial-encoded genes 
such as COX1 and COX2. This can be directly tested by qPCR of DNA. It is speculated that 
down-regulation of mitochondrial genes reflects a partial loss of mitochondrial genome in 
cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants, and this can be assayed by staining the cells with 4',6-
diamidino-2-phenylindole (DAPI) to visualize for punctate spots that are indicative of a loss of 
the mitochondrial genome. Alternatively, mitochondrial morphology changes can be examined 
using Mitotracker® Red (a dye that stains mitochondria) and transmission electron microscopy 
(TEM) for more detailed analysis.  
Since there are many similarities between the sam37∆/∆ and the cho1∆/∆ mutants, it might also 
be relevant to delete the SAM37 complex component, Mdm10, to test if this complex is 
responsible for any of the phenotypes seen in the cho1∆/∆ strain. Since mislocalization of 
Mdm10 causes mitochondrial and cell wall defects (Qu et al., 2012), examining the localization 
of a C-terminally GFP-tagged Mdm10p or Sam37p may be useful to determine if this key protein 
is mislocalized due to loss of PS in the cho1∆/∆ mutant. This can be accomplished by 
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flouresecnt microscopy. Conversely, it will be of interest to also measure the phospholipid 
composition of the mitochondria in both the sam37∆/∆ and cho1∆/∆ strains to directly measure 
differences in phospholipids and how this may directly affect mitochondrial function by coupling 
it with morphological studies and oxygen consumption assays to measure electron transport 
chain activity.  
The cell wall phenotypes will also be tested under low and high oxygen conditions (using an 
anaerobic chamber to control oxygen levels) to assay if hypoxic conditions exacerbate  these 
cell wall defects in the cho1∆/∆ , psd1∆/∆psd2∆/∆ and wild type (SC5314) strains; we expect a 
large decrease in available oxygen would  limit free radical production. Strains grown under 
anoxic conditions and normoxic conditions could be subjected to TEM to determine if the 
cho1∆/∆ mutants’ cell wall defects are present even under limited oxygen conditions. It is 
expected that the further reducing oxygen levels in the environment may mitigate wall defects 
by reducing electron transport activity and thereby reducing reactive oxygen species. If our 
model is valid and the wall defects are due to activation of cell wall repair pathways induced by 
ROS, we would expect to see no differences in sensitivities to cell wall perturbing drugs 
calcofluor white and congo red between the cho1∆/∆, psd1∆/∆ psd2∆/∆ ,and wild type strain 
upon neutralization of ROS in the presence of the scavengers  6-Hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid or terbinafine.  
The role of iron in mediating these processes remains to be tested. For example, does 
exogenous heme addition abrogate the cell wall defects in the mutant and what effect would 
addition of heme have on the cell wall phenotypes, response to hypoxia,  or Als adhesin and 
other cell wall protein expression? It will be of interest to determine the role of SEF1 in these 
processes by knocking out SEF1 in psd1∆/∆psd2∆/∆ and assaying if it has more severely 
altered cell walls like those observed in the cho1∆/∆ strain 
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It would also be of interest to determine if deletion of ERG11 may change the fluidity of 
the membrane and transcriptionally effect hypoxic response gene expression in C. albicans.  
Gene expression can be quantified and measured by RNA sequencing or qRT PCR. A more 
direct approach to measure membrane fluidity in the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains 
would also be extremely valuable as inherent lipid polymorphisms (see chapter 1) most likely 
influence biochemical interactions between proteins and lipids and/or lipid-lipid interactions in 
membranes. This assay may be accomplished by generating protoplasts and using the dye 1,6-
diphenyl-1,3,- hexatriene that intercalates within the membrane and then measuring its change 
in optical absorbance (which is directly dependent on membrane fluidity). As we hypothesized 
that the cho1∆/∆ strain has a less fluid membrane, we predict an increase in fluorescence of this 
dye in cho1∆/∆ mutant compared to the wild type or psd1∆/∆psd2∆/∆ strains.  
In vitro phosphatidylserine (PS)/phosphatidylethanolamine (PE) liposome complexes 
may also be a valuable tool to test the hypothesis that phosphatidylserine (PS) directly interacts 
with components of the electron transport chain. Assays to determine the effects of phospholipid 
structural changes, including acyl chain length and saturation on the interactions of components 
of the electron transport chain such as the interaction of cytochrome c with heme in the 
mitochondrial inner membrane  may indicate a previously unknown role for phosphatidylserine 
(PS)  in facilitating correct orientation and proper protein-protein and/or protein- lipid interactions 
within  these membranes.  
The identity of the specific signaling pathway activated by loss of phosphatidylserine (PS) and 
/or de novo phosphatidylethanolamine (PE) may provide a direct mechanism for how these 
specific phospholipid changes cause defects in the Candida albicans cell wall. The role of the 
signaling pathways - Rim101, the major ion stress response pathway and Hog-1, an osmo-
sensing mitochondrial activated pathway should be investigated(Davis et al., 2011, Alonso 
Monge et al., 2008). Western blotting can help elucidate if these pathways are activated and if 
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they are involved in the cell wall phenotypes in the cho1∆/∆ strain. It would be of interest to test 
the effect of cell wall glycosylphosphatidylionositol (GPI) anchor proteins that are highly 
differentially expressed between the strains on the cell wall phenotypes by deleting genes such 
as PGA31 and ECM331 and assaying the effect  these deletions have on cell wall ultrastructure 
and biochemical make up.  
Conclusions 
Taken together, these experiments should provide a better understanding of the role of PS in 
maintaining the cell wall and mitochondria in C. albicans. The diverse cellular process that are 
influenced by phospholipids are  just being uncovered and the ability to use phospholipid 
biosynthesis as a tool for elucidating drug targets and  chemotherapies against the fungal 
pathogen Candida albicans is a promising area for future research.   
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Abstract 
The cho1 ∆/∆ mutant is effectively cleared five days post-infection and therefore it may serve as 
an ideal live vaccine strain. The cho1∆/∆ strain is however not viable as an anti-candidal 
vaccine strain against systematic candidiasis despite its lack of virulence and ability to initially 
colonize and grow in the mouse host. We also characterize the cell wall glycomic composition of 
the different strains and determine that unmasking of β-1,3-glucans may be responsible for the 
avirulence of the cho1∆/∆ mutant. 
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Introduction 
Vaccines against Candida albicans have been proposed to protect against both systemic and 
vulvovaginal candidiasis (Filler et al., 2010; Antonio C., 2000). We therefore hypothesized that 
since the cho1∆/∆ mutant is able to grow in the host, but is avirulent in a murine model of 
disseminated candidiasis, it may be an ideal candidate for a live vaccine against C. albicans. 
The mutant is however effectively cleared five days post-infection and therefore it may serve as 
an ideal live vaccine strain. Cell surface components or wall proteins have been proposed as 
vaccine candidates (Bundle et al. 2012; Luo et al., 2012; Paulovicova et al. 2012; Filler et al., 
2010). The cell wall changes observed in the cho1∆/∆ mutant as well as the transcriptional 
increase in cell wall gene expression coupled with its hyper-filamentation suggested that the 
cho1∆/∆ strain may present to the host an altered cell wall structure (Chapter 2 and Chen et al., 
2010). We hypothesize that its unique cell wall phenotype via differential expression of Als 
proteins and Hwp1 may lead to enhanced recognition by host immune cells and effective 
clearance from host tissue. Thus this strain could confer resistance to re-infection by a virulent 
wild-type strain of C. albicans and represents a candidate for an experimental live, attenuated 
vaccine against systemic candidiasis and can be used as a tool to further decipher mechanisms 
of protective immunity during candidiasis. This section demonstrates that the cho1∆/∆ mutant is 
not a viable vaccine candidate despite its lack of virulence and ability to initially colonize and 
grow in the mouse host. 
As another analysis, we also analyzed the glycomic composition of these phospholipid 
mutants and delineated if the avirulence of the mutant is due to an auxotrophic growth defect.  
In Chapter 2, we showed that the phospholipid biosynthesis mutants have a defective cell wall.  
However, the biochemical make-up of the cell wall in these mutants has not been analyzed.  
Furthermore, the failure of the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants to cause virulence in the 
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host is not fully understood. We hypothesized that the lack of virulence may be due to an 
auxotrophic growth defect as the mutant may fail to grow by not acquiring essential phospholipid 
precursors, such as ethanolamine and choline, in the host environment. The resulting loss of 
virulence could be due to an inability to grow or due to a more effective clearance and response 
by the host immune system.  
Materials and Methods 
Strains and Growth conditions 
All strains used in this study are listed in Table 2-1. Unless otherwise mentioned, the strains 
were grown in 2% yeast-extract 2 % peptone 2% dextrose (YPD) medium for 24 hrs at 30ºC 
with shaking.  
Growth in the mouse host 
To examine growth in the host, the cells were stained with Alexa fluor 647 label. Cells were 
grown at 37°C overnight in YPD and were washed three times in phosphate buffered saline 
(PBS) and resuspended in PBS at a concentration of 1x109/ml.  Alexa fluor 647 (Molecular 
Probes) was dissolved and stored in DMSO at a concentration of 10 mg/ml. Prior to labeling, 11 
µL of 1 M NaCO3 pH 10 was added to the Candida cells and then 2 µL of Alexa fluor 647 was 
added and mixed briefly by vortexing. Cells were labeled for 1 hour at room temp, then washed 
five times with PBS, counted by hemacytometer, and used for infection ( as described in the 
mice virulence section below). Viability of the cells used for injection was determined by plating 
the suspension on   2% yeast extract 2 % peptone 2% dextrose (YPD) agar plates. 6 h post-
infection, mice kidneys were collected and homogenized in PBS, and suspensions were 
observed by fluorescence microscopy using Alex fluor and GFP specific filters. Images were 
taken with a MagnaFire Olympus digital camera and Olympus BX50 microscope (Olympus 
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America, Melville, NY,USA). Images were superimposed with PictureFrame software 
(Optronics, Goleta,CA).  
β-Glucan exposure and Dectin-1 binding 
The strains were sent to Dr.Robert Wheeler (University of Maine, Dept. of Molecular and 
Biomedical Sciences) to determine the unmasking of β-1,3-glucan and dectin-1 binding. Briefly, 
cells were grown overnight in YPD, washed, collected by centrifugation, resuspended in saline 
and then stained with anti-β-glucan antibody, specific for β1,3-glucan (Biosupplies, Inc., 
Australia), diluted 1:200 in 2%BSA /PBS overnight at 4°C on a rotator and washed three times 
with PBS. Then homogenates were stained for 1 hour at room temp with goat anti-mouse Cy3 
antibody (Jackson Immunoresearch) diluted 1:100 into 2%BSA/PBS with or without Alexa647-
labeled Dectin-CRD (diluted 1:40 in 2%BSA/PBS). After three washes, cells were visualized by 
fluorescence microscopy. Live cells were identified based on GFP fluorescence.  
Extraction of Cell Wall Polysaccharides and Glycosyl Composition Analysis 
Glycosyl composition analysis was performed by combined gas chromatography/mass 
spectrometry (GC/MS) at the Complex Carbohydrate Research Center by Dr.Parastoo Azadi. 
The per-O-trimethylsilyl (TMS) derivatives of the monosaccharide methyl glycosides produced 
from the sample by acidic methanolysis. Between 100 and 400ug of sample was used for the 
analysis. 20ug of inositol was added to the samples. The samples were initially hydrolyzed 
using 4M HCL at 100 degrees for 2 hours. Methyl glycosides were then prepared from the 
samples by methanolysis in 1 M HCl in methanol at 80C (18 hours), followed by re-N-
acetylation with pyridine and acetic anhydride in methanol (for detection of amino sugars).  The 
samples were then per-O-trimethylsilylated by treatment with Tri-Sil (Pierce) at 80C (0.5 hours). 
These procedures were carried out as previously described in Merkle and Poppe (1994). 
GC/MS analysis of the TMS methyl glycosides was performed on an Agilent 6890N GC 
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interfaced to a 5975B MSD, using a Supelco EC-1 fused silica capillary column (30m  0.25 mm 
ID). 
Mouse virulence studies 
For the infection studies, 5- to 6-week old male ICR mice from Harlan Laboratories were used. 
Five mice were housed per cage. C.albicans strains were grown overnight in 2% Yeast 2% 
Peptone 2% Dextrose (YPD) at 37ºC with shaking and were washed three times in phosphate 
buffered saline. Cell numbers were determined by a haemocytometer and adjusted to a final 
concentration of 107 cells/ml in phosphate buffered saline. 100µL of the cell suspension (10^6 
total cells) were injected into the tail veins of mice. Mice were monitored for three weeks for 
signs of infection. Moribund mice were euthanized. Each experiment was done in triplicate with 
five mice in each group. All experimental procedures were carried out in accordance with the 
NIH guidelines for the ethical treatment of animals. CFU numbers were determined from the 
weighed kidneys 3 and 5 days after infection by plating tissue homogenates on YPD agar. For 
the vaccine study, mice were first pre-inoculated with the cho1∆/∆  or control strain using the 
same procedure and monitored for two weeks, after which the mice were challenged with 1x106 
Candida albicans wild-type(SC5314) cells and monitored as described above.  
Statistical Analysis 
Prism 4.0 software (GraphPad) was used to determine the significance of differences for the 
mouse virulence studies. Statistically significant differences were determined using the Kaplan 
Meir survival curve test. Statistical significance was set at a P value of <0.05.  
Results and Discussion 
Lack of virulence of the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains are not due to auxotrophic 
growth defects 
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We tested the hypothesis that the lack of virulence of the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants 
is due to auxotrophic growth defects. In order to test if the strains could grow in vivo we injected 
Alexa fluor stained yeast form C. albicans cells expressing GFP and examined if they were able 
to form hyphae upon infection of the host by microscopy (see methods). We show that in the 
systemic model of infection that all the C.albicans strains are able to grow and form hyphae in 
mice kidneys 6 hours post infection (Fig:A-1). We also found that there are no differences in 
growth in mouse serum for all the strains tested (data not shown). This suggests that these 
strains are capable of obtaining ethanolamine or choline from the host and the avirulence of the 
mutants is not due to nutritional auxotrophies leading to starvation and death in the host. 
Increased β-glucan exposure on cho1∆/∆ mutant may enhance host immune recognition 
β-1-3 glucan “unmasking” is the uncovering of inner cell wall layer, namely β-13-glucan, that is 
normally covered by mannoproteins. Masking of β-glucan avoids immune recognition through 
the Dectin-1 receptor on phagocytes (Brown et al., 2002; Gow et al., 2007; Netea et al., 2008).  
Recognition by Dectin-1 has been shown to activate defense mechanisms for the stimulation of 
pro-inflammatory cytokines (Le et al., 2012, Wheeler et al., 2008). In addition, Candida infection 
have been shown to be mitigated by IL-33 pretreatment; IL-33 mediates neutrophil recruitment 
to Candida infection sites via activation of Dectin-1 on host macrophages (Le et al., 2012). We 
propose that the cell wall defects of the cho1∆/∆ mutant may cause an increase in immune-
mediated clearance by increased immune recognition. This hypothesis is supported by an 
increased exposure of β-1-3 glucan on the fungal cell surface (Fig: A-2A) and increased binding 
of the soluble binding domain of Dectin-1 receptor on macrophages to the less virulent cho1∆/∆ 
and psd1∆/∆psd2∆/∆ mutants (Fig:A-2B). This is also consistent with the finding that the cho1 
∆/∆ mutant has increased sensitivity to caspofungin (Chen et al., 2010), a strong inhibitor of β-1 
3 glucan synthesis. Thus, increased exposure of β-1 -3 glucans may be responsible for 
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increased host recognition and at least partially explain the lack of virulence observed in the 
cho1∆/∆ strain.  
Cell wall carbohydrate analysis reveals no differences in amounts of glucose or mannose 
residues between strains 
We next analyzed the cell wall glycosyl composition by combined gas chromatography/mass 
spectrometry (GC/MS) of the per-O-trimethylsilyl (TMS) derivatives of the monosaccharide 
methyl glycosides collected from each strain by acid methanolysis. We observed no difference 
in wall carbohydrates suggesting that the total amount of β-1-3 glucans in the cell is not 
changed in the cho1∆/∆ or psd1∆/∆psd2∆/∆ mutant (Table A-1).This is similar to the observed 
cell wall polysaccharide structure in the mitochondria-defective sam37∆/∆ strain that 
interestingly has similar phenotypes to cho1∆/∆ (Qu et al., 2012, Chapter 2). We were unable to 
quantify chitin content in these strains but we did note an increase in Nacetyl glucosamine (a 
break down product of chitin) in the cho1∆/∆ strain compared to the wild type. This is consistent 
with our fluorescent calcofluor white staining data that indicates much higher chitin content in 
the cho1∆/∆ strain. 
Pre-inoculation with cho1∆/∆ mutant provides no protective effect against systemic 
candidiasis in mice. 
The avirulence of the cho1∆/∆ mutant and its clearance by the immune system after infection 
enabled us to examine its possible use as a live vaccine to prevent Candida infections. Isolated 
peptides against cell wall components and cell wall proteins have been utilized to show 
protective effects in Candida albicans systemic  mouse infections such as the  β-(Man)3-Fba 
glycopeptide, mannosides, Hyr-1 recombinant vaccines (Cutler et al., 2011; Bar et al., 2012, 
Pietrella et al., 2012; Paulovicova et al., 2012; Luo et al., 2012). Anti-β-glucan antibodies have 
also shown to confer protective properties against vaginal candidiasis (Pietrella et al., 2010; 
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Torosantucci et al., 2009). In addition Filler et al. (2010), have found a vaccine to Als3p to be 
protective in mice, and we found Als3p be highly up-regulated in the cho1∆/∆ strain in YPD (see 
Chapter 2). Since Als3 is highly expressed at the surface of the cho1∆/∆ strain and β-1-3 glucan 
is highly exposed in this mutant, we hypothesized that the cho1∆/∆ strain may be a good 
vaccine strain. To test our hypothesis, we performed in vivo infection assays to determine if 
pretreatment with cho1∆/∆ cells leads to prolonged survival upon subsequent infection with wild 
type Candida albicans cells in a mouse model.  We found that there was no protective effect in 
mice using this method suggesting that cho1∆/∆ is not a viable vaccine candidate for the 
preventive treatment of invasive candidiasis despite its initial colonization of the host kidneys 
and its subsequent clearance from the host (Fig:A-3)(Chen et al., 2010).  
No difference in virulence between the psd2∆/∆ strain and the wild type strain in a mouse 
model of systemic infection. 
The avirulence of the cho1∆/∆ mutant and the severely reduced virulence of the 
psd1∆/∆psd2∆/∆ mutant also led us to assay the virulence of the psd2∆/∆ mutant alone.We had 
initially found that the psd2∆/∆ strain may be hypervirulent in a mouse model of  systemic 
infection as it had a higher fungal burden and more virulent survival curve data.  We therefore 
tested the strain repeatedly to verify if our previous results were valid, and found that  there is 
no difference in virulence between the wild type strain and the psd2∆/∆ strain (Fig: A-4).  
Summary  
The data presented in this section suggests that although the cho1∆/∆ strain is able to grow in 
the host kidney and form hyphae initially upon systemic infection, the cho1∆/∆ strain is not an 
ideal vaccine candidate to prevent systemic infection as it did not provide any protection in our 
mouse model. We also propose that differences in virulence may be due to unmasking of β-1,3 
glucans as we show that the cho1∆/∆ strain has much more unmasking β-1,3 glucan and higher 
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Dectin-1 binding. Therefore, it is likely that alterations in the cell wall and immune recognition 
attenuates the virulence of the mutant and may modulate its response to hypoxia or iron 
limitation in the host. Recently it has been demonstrated that disruption of MAP kinase 
pathways in C.albicans causes enhanced β-glucan exposure, triggering more efficient immune 
responses (Galan-Diez et al., 2010). Thus, enhanced β-glucan exposure and altered cell wall 
organization (reflected in the transcriptional profile) in the cho1∆/∆ mutant may trigger activation 
of signaling pathways. Similar to the cho1∆/∆ mutant, these mutants that are defective in 
phosphorylation are hypersensitive to the cell wall perturbing drugs  congo red and calcofluor 
white (Galan-Diez et al., 2010), suggesting that similar signaling pathways may be affected in 
the cho1∆/∆ mutant leading to unmasking of β-glucan and enhanced immune recognition in 
these strains.  
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Supplementary Figures 
 
 
 
Figure A-1: Growth of the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains in mice kidneys in vivo. 
The cho1∆/∆ and psd1∆/∆psd2∆/∆ showed no defects in hyphal formation and growth 6 hours 
post infection. 1 x 106  Alexa fluor-labeled (RED) yeast cells were injected in the tail vein of 
mice, 6 h post-infection kidneys were harvested homogenized and viewed under a fluorescent 
microscope.  Green fluorescence is indicative of new hyphal growth in vivo. Image is 
representative of 40 cells per strain.Sarah Davis collaborated on this figure and experiment. 
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Figure A-2: Increased β-glucan exposure on the cho1∆/∆ strain.  (A) Cells were grown in 
YPD, washed, diluted and stained with anti-β-glucan antibody and Cy2-labeled secondary 
antibody. Images are representative of three independent experiments. Scale bar is 20µm. This 
experiment was done in colloboration with Robert Wheeler at the University of Maine.  
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Untreated  
cho1∆/∆ pre-treated 
mice 
 
 
 
 
 
 
 
 
Figure A-3: Survival curves of the cho1∆/∆ pre-treated and untreated mice challenged 
with the wild type strain. For the pre-treated group, mice were inoculated with1x106 Candida 
albicans cho1∆/∆ cells by tail vein injection.   For the untreated group, saline was injected as a 
control. After two weeks, mice in both groups were challenged with 1x105 wild-type (SC5314) 
cells. Survival was monitored for four weeks. No difference in survival was observed between 
the two treatment groups. Number of mice used is indicated in parentheses. P value cho1 ∆/∆-
treated v/s untreated mice = 0.059 (no difference).  
 
 
 
 
 
 
 
 
 
 
 
 
102 
 
A 
 
B 
Figure A-4: (A)Survival curve of the psd2∆/∆ strain in a mouse model of systemic 
infection.   Mice were infected with  1x106  Candida albicans cells by tail vein injection and mice  
were monitored for 21 days. Survival curves for the wild type (SC5314), psd2∆/∆ and 
psd2∆/∆:PSD2 were examined. The number of mice used is indicated in parentheses.  P value 
of wild type verses psd2∆/∆ = 0.186 (no statistical difference).(B) Fungal burden in the kidney of 
the psd2∆/∆ strain compared to the wild type (SC5314) strain. 1x106 Candida albicans cells 
were injected by tail vein injection.  After five days post infection, kidneys were harvested, 
homogenized, and the fungal burden was measured by counting CFUs on YPD agar plates.   
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Table A-1: Glycosyl Composition analysis of C.albicans strains by GC/MS. 
Glycosyl 
redidue 
Mol % 
Wild-type 
Mol%  
cho1∆/∆ 
Mol% 
psd1∆/∆ 
Mol% 
psd1∆/∆psd2∆/∆ 
Mol% 
cho1∆/∆::CHO1 
Ribose - - - - - 
Arabinose - - - - - 
Rhamnose - - - - - 
Fucose - - - - - 
Xylose - 2.0 10.6 2.6 - 
Glucuronic acid - - - - - 
Galacturonic 
acid 
- - - - - 
Mannose 48.1 40.6 24.6 43.3 39.0 
Galactose - 0.2 0.5 0.4 - 
Glucose 51.9 53.8 63.5 52.0 60.2 
N-acetyl 
galactosamine 
- - - - - 
N-acetyl 
glucosamine 
- 3.3 0.8 1.7 0.9 
N-acetyl 
mannosamine 
- - - - - 
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Table A-2: Expression of glucan and chitin synthases genes 
 
Gene 
Name  
CGD Function   cho1∆/∆              
psd1∆/∆psd2∆/∆ 
GLS1 Glucan Synthase 1  1.39 1.41  
GLS2 Glucan Synthase 2  2.14 2.83  
CHS1 Chitin Synthase 1  1.35 2.82  
CHS2 Chitin Synthase 2  2.83 2.46  
CHS3 Chitin Synthase 3  1.52 1.83  
CHS4 Chitin Synthase 4  1.23 2.22  
CHS5 Chitin Synthase 5  1.40 1.14  
CHS6 Chitin Synthase 6  1.41 1.35  
CHS7 Chitin Synthase 7  1.44 1.74  
CHS8 Chitin synthase 8  2.00 1.74  
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Table A-3: List of all the genes up-regulated in the cho1∆/∆ mutant compared to the wild-
type strain.  
 
 Gene ID Fold up-
regulated 
 CGD annotated Function                                                     P-value          
 CAL0005124 125 Secreted Protein                      1.00E-300          
 CAL0004244 86.6 Uncharacterized ORF                            1.00E-300          
 CAL0000215 50.1  Inositol-1-phosphate synthase          1.00E-300          
 CAL0001195 33.16 Putative GPI-anchored protein      1.00E-300          
 CAL0000162 31.48 GPI-anchored cell wall protein required 
for filamentous growth at acidic pH 
4.64E-70          
 CAL0004933 30.16 Immunogenic stress-associated protein          1.00E-300          
 CAL0003753 19.11 Putative transcription factor; required for 
wild-type resistance to cell wall 
perturbation                      
1.00E-300          
 CAL0002828 15.10 Uncharacterized ORF                                         1.09E-76          
 CAL0000413 14.78 General amino acid permease            4.54E-166          
 CAL0000986 13.30 Putative GPI-anchored protein                    1.19E-158          
 CAL0001735 10.76 Putative ribonucleoside diphosphate 
reductase            
1.00E-300          
 CAL0001866 10.69 Member of the secreted aspartyl 
proteinase family  
1.59E-225          
 CAL0002992 10.40 Basic amino acid permease  1.00E-300          
 CAL0000567 9.77 Verified ORF; Protein required for 
cohesion, adhesion, and biofilm formation            
1.14E-39          
 CAL0001974 9.63 Urea amidolyase        1.00E-300          
 CAL0000715 9.48 Plasma membrane protein of heme-iron 
utilization upregulated by Rim101p         
7.82E-98          
 CL0000259 9.01 GPI-anchored protein 1.50E-200          
 CAL0004374 8.34 Uncharacterized ORF; Ortholog(s) have 
tubulin binding activity, role in microtubule 
cytoskeleton organization, mitochondrion 
inheritance         
1.00E-300          
 CAL0000188 8.34 Plasma-membrane-localized protein; 
filament induced; Hog1p-, and hypoxia-
induced 
1.00E-300          
 CAL0001283 8.10 ALS family protein  1.00E-300          
 CAL0120975 7.94 Uncharacterized ORF                      1.00E-300          
 CAL0120924 7.39 Putative adhesin-like protein                                      2.99E-05          
 CAL0001538 6.70 Putative peroxisomal copper amine 
oxidase                                    
1.08E-189          
 CAL0000427 6.68 Protein similar to plant pathogenesis-
related proteins; required for virulence in 
mouse systemic and rabbit corneal 
infections        
1.00E-300          
 CAL0004799 6.43 Uncharacterized ORF; Hap43p-repressed 
gene                         
6.26E-56          
 CAF0006989 6.25 Cytoplasmic protein expressed 
specifically in white phase yeast cells   
6.03E-146          
 CAL0002282 6.24 Unchara Putative ceramide hydroxylase; 
predicted enzyme of sphingolipid Tsa1Bp   
1.00E-300          
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 Gene ID Fold up-
regulated 
 CGD annotated Function                                                     P-value          
 CAL0000377 6.15 Uncharacterized ORF; Planktonic growth-
induced gene                                      
5.38E-14          
 CAL0001605 5.98 ALS family cell wall adhesin          1.00E-300          
 CAL0001407 5.91 Putative DNA-binding transcription factor                   1.01E-53          
 CAL0003337 5.75 Putative ARP2/3 complex subunit                          4.63E-42          
 CAL0002165 5.71 GPI-anchored protein       1.00E-300          
 CAL0005195 5.64 Predicted ORF in retrotransposon Tca8             1.45E-113          
 CAL0000023 5.61 Uncharacterized ORF  5.67E-222          
 CAL0006337 5.60 Ammonium permease  1.00E-300          
 CAL0005305 5.55 Uncharacterized ORF                                         1.00E-300          
 CAL0001738 5.36 Uncharacterized ORF  4.52E-39          
 CAF0007042 5.32 Uncharacterized ORF                                         2.29E-15          
 CAL0004418 5.29 Putative protein of unknown function; 
Hap43p-repressed gene 
1.00E-300          
 CAL0000494 5.24 Essential protein involved in cytokinesis                    4.62E-50          
 CAL0000285 5.20 Uncharacterized ORF                                         5.88E-88          
 CAL0004349 5.15 Putative DNA cross-link repair protein  4.11E-124          
 CAL0000177 5.05 Putative aminopeptidase  6.07E-183          
 CAL0004191 4.99 Uncharacterized ORF  1.86E-55          
 CAL0003075 4.94 Uncharacterized ORF                              5.56E-09          
 CAL0003484 4.94 Uncharacterized ORF; Hap43p-induced 
gene                                       
6.46E-75          
 CAL0002632 4.92 G1 cyclin     3.45E-144          
 CAL0003166 4.70 Uncharacterized ORF                         1.00E-300          
 CAL0005585 4.68 Uncharacterized ORF; Biofilm-induced 
gene                                       
9.17E-40          
 CAL0004553 4.63 Essential transcription factor      1.00E-300          
 CAL0006272 4.60 Acyl CoA:sterol acyltransferase                   3.27E-220          
 CAL0000709 4.59 Basic amino acid permease               1.45E-90          
 CAL0003763 4.57 Uncharacterized ORF 1.00E-300          
 CAL0004442 4.55 Uncharacterized ORF        7.80E-46          
 CAL0005876 4.51 Putative peptide:N-glycanase          1.00E-300          
 CAL0000443 4.45 Cell wall acid trehalase                1.41E-176          
 CAL0000739 4.43 Uncharacterized ORF 3.41E-70          
 CAL0003828 4.42 Secreted lipase      1.00E-300          
 CAL0004833 4.40 Uncharacterized ORF                     2.40E-258          
 CAL0000503 4.39 Uncharacterized ORF                       1.68E-11          
 CAL0004522 4.36 Predicted membrane transporter                        2.54E-12          
 CAL0000209 4.32 Putative transcription factor                1.00E-300          
 CAL0002724 4.26 Member of a family encoded by FGR6-
related genes  
2.35E-32          
 CAL0002389 4.25 Uncharacterized ORF        3.99E-45          
 CAL0005923 4.24 Uncharacterized ORF               2.79E-44          
 CAL0001357 4.19 Uncharacterized ORF;role in 
mitochondrial genome maintenance   
2.33E-191          
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 CAL0004258 4.16 Putative GPI-anchor                          7.02E-180          
 CAL0002907 4.12 Putative phosphomethylpyrimidine kinase                  1.92E-53          
 CAL0001619 4.11 Uncharacterized ORF; ATP sulfurlyase of 
sulfate assimilation         
5.84E-80          
 CAL0003020 4.02 Zinc finger transcriptional regulator of 
nitrogen utilization     
2.61E-105          
 CAL0006302 4.00 Mannose-1-phosphate guanyltransferase                   1.13E-132          
 CAL0000359 3.97 Uncharacterized ORF                        1.51E-113          
 CAL0005075 3.97 Hypha-specific G1 cyclin-related protein            1.91E-37          
 CAL0005323 3.96 Secreted lipase 2.14E-28          
 CAL0006398 3.94 Hyphal-induced GPI-anchored cell wall 
protein  
1.36E-50          
 CAL0002156 3.94 Uncharacterized ORF                                3.89E-74          
 CAL0001358 3.93 Putative mitochondrial leucyl-tRNA 
synthetase                                     
1.00E-300          
 CAL0120845 3.90 Uncharacterized ORF                                         0.0013996          
 CAL0002630 3.90 Putative mitochondrial translation 
initiation factor                          
1.00E-300          
 CAL0001625 3.87 Zinc cluster DNA-binding transcription 
factor          
1.69E-30          
 CAL0002161 3.87 Uncharacterized ORF 1.00E-300          
 CAL0002939 3.86 UDP-glucose:ceramide 
glucosyltransferase                   
9.80E-36          
 CAL0002789 3.85 ALS family protein      1.00E-300          
 CAL0005541 3.84 Squalene epoxidase      1.00E-300          
 CAL0002798 3.82 Uncharacterized ORF                                         5.03E-15          
 CAL0006312 3.82 Putative DNA mismatch repair factor          1.57E-92          
 CAL0003055 3.80 Phosphofructokinase alpha subunit                    1.00E-300          
 CAL0002550 3.80 Predicted zinc-finger protein                 1.00E-300          
 CAL0000318 3.74 Uncharacterized ORF; Hap43p-induced 
gene                                       
8.91E-177          
 CAL0001295 3.73 Uncharacterized ORF; Hap43p-repressed 
gene                                       
1.18E-35          
 CAL0004519 3.71 Putative mitochondrial biogenesis protein                              1.00E-300          
 CAL0006341 3.71 Biofilm- and planktonic growth-induced 
gene        
3.14E-72          
 CAL0003546 3.70 Uncharacterized ORF; Ortholog(s) have 
role in mitochondrial genome 
maintenance                                
1.56E-22          
 CAL0001212 3.68 DNA binding protein with Cys2-His2 zinc-
finger            
1.00E-300          
 CAL0002964 3.66 Uncharacterized ORF 2.68E-06          
 CAF0007422 3.65 Uncharacterized ORF; Ortholog(s) have 
role in mitochondrial genome 
maintenance and integral to mitochondrial 
inner membrane localization                           
4.17E-267          
 CAL0001762 3.60 Putative transporter of ATP-binding 
cassette (ABC) superfamily 
1.00E-300          
 CAL0005303 3.60 Uncharacterized ORF       2.97E-71          
 CAL0000374 3.59 Putative protein of GPI synthesis                             3.26E-48          
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 CAL0000998 3.56 Uncharacterized ORF                      1.31E-183          
 CAL0003593 3.55 Uncharacterized ORF                                         8.47E-37          
 CAL0002878 3.54 Member of a family encoded by FGR6-
related genes               
1.57E-62          
 CAL0000151 3.54 Predicted zinc-finger protein            1.22E-16          
 CAL0001515 3.52 Uncharacterized ORF                  1.56E-32          
 CAL0004602 3.52 Uncharacterized ORF; Ortholog(s) have 
cytosol localization                                     
1.15E-39          
 CAL0002404 3.47 Uncharacterized ORF; Protein related to 
arginases                    
1.63E-14          
 CAL0002930 3.44 Uncharacterized OR; induced by hypoxia             4.42E-209          
 CAL0006342 3.44 Verified ORF; Hap43p-repressed gene                            1.20E-216          
 CAL0001440 3.43 ALS family of cell-surface glycoproteins             1.00E-300          
 CAL0005593 3.41 Verified ORF; Putative mitochondrial 
protein with a predicted role in respiratory 
growth; mutants display a strong defect in 
biofilm formation; fluconazole-induced; 
ketoconazole-repressed                     
1.00E-300          
 CAL0000040 3.41 Uncharacterized ORF; Putative acyl-CoA 
oxidase               
2.83E-22          
 CAL0000601 3.38 Uncharacterized ORF                                  1.00E-300          
 CAL0003697 3.35 Uncharacterized ORF; Hap43p-induced 
gene                                       
1.00E-300          
 CAL0003797 3.33 Uncharacterized ORF                        1.13E-192          
 CAL0003896 3.33 Uncharacterized ORF                                         6.32E-130          
 CAL0005961 3.32 Putative glucokinase                          1.00E-300          
 CAL0004071 3.32 Uncharacterized ORF                           4.55E-142          
 CAL0002158 3.32 Uncharacterized ORF 6.76E-14          
 CAL0001776 3.31 Uncharacterized ORF        2.28E-33          
 CAL0000212 3.31 Secreted aspartyl protease  1.00E-300          
 CAL0005531 3.31 Predicted extracellular or membrane-
associated glucoamylase  
9.16E-31          
 CAL0002488 3.31 Uncharacterized ORF;gene induced by 
hypoxia                           
1.79E-44          
 CAL0004528 3.30 Inositol phosphoryl transferase  1.04E-41          
 CAL0006186 3.30 Mannosyltransferase  5.73E-27          
 CAL0004027 3.30 Chitin synthase  1.73E-148          
 CAL0002852 3.29 Uncharacterized ORF  1.86E-19          
 CAL0004944 3.29 Zn2-Cys6 transcriptional regulator of 
ergosterol biosynthetic genes and sterol 
uptake  
1.00E-300          
 CAL0003435 3.28 Plasma membrane-localized protein; 
repressed by nitric oxide; Hap43p-
repressed gene                                
1.13E-11          
 CAL0005027 3.25 Coproporphyrinogen III oxidase  1.00E-300          
 CAL0000800 3.23 Putative GPI-anchored protein                                      9.83E-07          
 CAL0002549 3.23 Uncharacterized ORF  0.000571786          
 CAL0003463 3.22 Putative transcription factor with zinc 
cluster DNA-binding motif                     
2.45E-25          
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 CAL0003217 3.21 Putative stretch-activated Ca2+ channel     2.25E-20          
 CAL0001985 3.21 Putative ceramide hydroxylase                    1.00E-300          
 CAL0003499 3.21 Uncharacterized ORF 6.94E-14          
 CAL0004275 3.20 Uncharacterized ORF  1.75E-06          
 CAL0003180 3.18 Uncharacterized ORF                                         1.00E-300          
 CAL0004436 3.16 Uncharacterized ORF; role in endosome 
transport         
1.00E-300          
 CAL0001911 3.16 Putative adhesin-like protein  3.68E-22          
 CAL0003637 3.15 Uncharacterized ORF                                         1.00E-300          
 CAL0001478 3.15 Uncharacterized ORF; Ortholog(s) have 
role in mitochondrial translation and 
mitochondrion localization                                
2.10E-216          
 CAL0001393 3.13 Trehalose-6-phosphate (Tre6P) 
phosphatase  
1.00E-300          
 CAL0004601 3.12 Uncharacterized ORF  4.22E-09          
 CAL0004745 3.12 Purine-cytosine permease of pyrimidine 
salvage;  
2.62E-179          
 CAL0004169 3.12 Uncharacterized ORF                           1.00E-300          
 CAL0005203 3.11 Putative GPI-anchored protein                                      6.42E-09          
 CAL0003532 3.11 Uncharacterized ORF                                         1.41E-172          
 CAL0000344 3.10 Uncharacterized ORF  3.76E-95          
 CAL0005136 3.09 Putative transcription factor  2.03E-112          
 CAL0005640 3.07 Predicted membrane transporter  1.38E-26          
 CAL0004499 3.07 N-linked mannoprotein of cell wall and 
membrane  
4.19E-54          
 CAL0004417 3.06 Putative peroxisomal 3-ketoacyl CoA 
thiolase  
6.86E-106          
 CAL0001962 3.06 Aldo-keto reductase family member  3.01E-245          
 CAL0002117 3.06 Transcriptional regulator of the CTR1 
copper transporter 
1.28E-81          
 CAL0003915 3.03 Translation factor eRF3  1.00E-300          
 CAL0005752 3.02 Putative nicotinic acid mononucleotide 
adenylyltransferase                             
7.81E-284          
 CAL0005674 3.01 Neutral trehalase  2.74E-173          
 CAL0005400 3.01 Uncharacterized ORF 1.31E-16          
 CAL0004456 3.00 Uncharacterized ORF  1.00E-300          
 CAL0000422 2.99 Cytochrome oxidase assembly protein  1.00E-300          
 CAL0004319 2.96 Putative choline/ethanolamine transporter                     1.00E-300          
 CAL0004678 2.96 Uncharacterized ORF                                         5.97E-232          
 CAL0004368 2.96 Uncharacterized ORF                                         8.43E-27          
 CAL0000899 2.94 Uncharacterized ORF  3.19E-11          
 CAL0001558 2.94 DNA ligase  2.62E-86          
 CAL0000390 2.94 Uncharacterized ORF;  8.20E-131          
 CAL0000808 2.93 Uncharacterized ORF; Protein similar to 
isoleucyl-tRNA synthetase  
1.00E-300          
 CAL0000041 2.93 Uncharacterized ORF; Hap43p-repressed 
gene                                       
2.92E-42          
 CAL0002752 2.93 Uncharacterized ORF  6.25E-285          
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 CAL0004026 2.92 Putative cystathionine gamma-synthase  6.41E-165          
 CAL0004624 2.92 Uncharacterized ORF; Putative actin 
interacting protein;  
4.86E-58          
 CAL0001294 2.91 Uncharacterized ORF  3.68E-17          
 CAL0003069 2.91 Uncharacterized ORF                                         2.02E-11          
 CAL0005571 2.91 Uncharacterized ORF; Protein similar to 
GTPase regulators 
8.13E-177          
 CAL0001564 2.90 Uncharacterized ORF; Hap43p-repressed 
gene                               
1.02E-109          
 CAL0000820 2.90 Putative cytochrome c lysine 
methyltransferase  
1.00E-300          
 CAL0004892 2.90 Uncharacterized ORF; Hap43p-repressed 
gene                                       
3.45E-13          
 CAL0000430 2.89 Putative mitochondrial translation 
elongation factor         
2.76E-260          
 CAL0000779 2.88 Putative GPI-anchored protein                                      6.45E-12          
 CAL0002436 2.88 Putative prolyl-tRNA synthetase                   2.94E-156          
 CAL0003968 2.87 Phosphomannose isomerase  1.25E-15          
 CAL0004017 2.87 Uncharacterized ORF  5.14E-92          
 CAL0001729 2.86 Uncharacterized ORF; Possible stress 
protein  
1.61E-75          
 CAL0004146 2.86 Putative RNA polymerase II subunit B150  6.71E-56          
 CAF0007014 2.85 Uncharacterized ORF  9.28E-85          
 CAL0002758 2.85 Uncharacterized ORF  7.38E-96          
 CAL0003714 2.85 Uncharacterized ORF  4.35E-252          
 CAL0005643 2.84 Putative zinc transporter 1.00E-300          
 CAL0005848 2.82 Uncharacterized ORF 1.30E-262          
 CAL0005127 2.82 Uncharacterized ORF; role in oxidation-
reduction process                        
2.25E-58          
 CAL0003889 2.81 Uncharacterized ORF; Biofilm-induced 
gene                                       
2.86E-42          
 CAL0000588 2.81 Uncharacterized ORF                                         1.71E-09          
 CAL0003612 2.81 Uncharacterized ORF; Hap43p-repressed 
gene                                       
7.81E-15          
 CAL0000782 2.81 Uncharacterized ORF; Putative Pol 
Protein          
1.44E-224          
 CAL0005050 2.80 Putative amino acid permease  2.38E-13          
 CAL0004394 2.80 Uncharacterized ORF; Putative low-
affinity copper transporter                  
8.35E-193          
 CAL0002471 2.79 Uncharacterized ORF; Hap43p-repressed 
gene                                  
1.79E-233          
 CAL0005937 2.79 Uncharacterized ORF          5.76E-09          
 CAF0006940 2.79 Uncharacterized ORF  4.10E-05          
 CAL0006344 2.79 Glucosamine-6-phosphate synthase  1.00E-300          
 CAL0002198 2.79 Uncharacterized ORF; Ortholog(s) have 
fungal-type vacuole membrane, 
mitochondrion localization                                  
1.75E-89          
 CAL0004847 2.77 Protein similar to S. cerevisiae Ybr075wp                           0.000482213          
 CAL0004976 2.76 Uncharacterized ORF                          1.00E-73          
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 CAL0005306 2.76 Uncharacterized ORF  3.12E-58          
 CAL0004351 2.76 Uncharacterized ORF  1.00E-300          
 CAL0003611 2.75 Uncharacterized ORF  1.12E-07          
 CAL0000416 2.75 Uncharacterized ORF; Putative 
transmembrane protein                                     
6.05E-11          
 CAL0001905 2.74 C-5 sterol desaturase  1.00E-300          
 CAL0002781 2.74 Predicted membrane transporter  7.72E-72          
 CAL0001123 2.72 Uncharacterized ORF 4.60E-195          
 CAF0006926 2.72 Uncharacterized ORF                                         9.51E-08          
 CAL0004652 2.72 Putative glutamine-dependent NAD 
synthetase  
7.08E-44          
 CAL0004120 2.72 Uncharacterized ORF; Predicted 
ribosomal protein  
1.45E-08          
 CAL0001720 2.71 Ribosomal protein of the large subunit, 
mitochondrial;  
1.00E-300          
 CAL0005236 2.71 Glycerol 3-phosphatase  1.00E-300          
 CAL0005673 2.70 Uncharacterized ORF; Putative 
carboxypeptidase            
1.43E-18          
 CAL0002049 2.70 Putative mitochondrial carrier protein                            1.10E-117          
 CAL0001970 2.70 Putative glycogen phosphorylase  1.00E-300          
 CAL0000985 2.69 Putative D-xylulose reductase  1.00E-300          
 CAL0005762 2.69 Isocitrate lyase  5.19E-47          
 CAL0001734 2.69 Putative malate permease  9.88E-12          
 CAL0001803 2.69 Putative glucokinase            1.00E-300          
 CAL0001919 2.69 Uncharacterized ORF                                         2.95E-89          
 CAL0004952 2.69 Uncharacterized ORF  2.35E-33          
 CAL0002546 2.68 Uncharacterized ORF; Putative 
transporter                      
6.08E-14          
 CAL0003251 2.68 Uncharacterized ORF                  8.28E-112          
 CAL0000727 2.68 Cysteine transporter                5.35E-150          
 CAL0003477 2.68 Dynein heavy chain  3.08E-14          
 CAL0003007 2.68 Mitochondrial methionyl-tRNA synthetase 
(MetRS  
6.10E-113          
 CAL0002531 2.67 Uncharacterized ORF; Putative adhesin-
like protein                                      
1.28E-170          
 CAL0001380 2.67 Uncharacterized ORF                                         1.71E-30          
 CAL0001310 2.67 Putative zinc-finger transcription factor  2.33E-35          
 CAL0001963 2.67 Uncharacterized ORF; role in 
mitochondrial aspartyl-tRNA 
aminoacylation and mitochondrion 
localization                            
5.43E-201          
 CAL0003709 2.66 Putative transcription factor with zinc 
cluster DNA-binding motif                                 
1.12E-21          
 CAL0004444 2.66 Uncharacterized ORF; role in 
mitochondrial inner boundary membrane 
1.44E-31          
 CAL0003627 2.66 Protein required for normal filamentous 
growth                                   
1.00E-300          
 CAL0004521 2.65 Putative transcription factor with zinc 
cluster DNA-binding motif           
4.88E-22          
 CAL0005579 2.65 Uncharacterized ORF                         1.68E-19          
 CAL0005583 2.66 Uncharacterized ORF                                         8.95E-31          
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 CAL0004434 2.66 Uncharacterized ORF  9.18E-87          
 CAL0004938 2.65 Uncharacterized ORF  5.96E-15          
 CAL0003100 2.64 Uncharacterized ORF  3.14E-245          
 CAL0001160 2.64 Putative phospholipase B                  7.55E-17          
 CAL0005805 2.63 Uncharacterized ORF; Hap43p-repressed 
gene                                       
6.39E-17          
 CAL0005121 2.63 Cirt family transposase  7.84E-62          
 CAL0004496 2.63 Predicted exocyst subunit  0.00768509          
 CAL0003364 2.63 Putative alcohol dehydrogenase  7.94E-07          
 CAL0001987 2.63 Uncharacterized ORF                                  7.74E-244          
 CAL0004048 2.62 Putative transcription factor with zinc 
cluster DNA-binding motif                                 
6.20E-91          
 CAL0000475 2.61 Predicted serine/threonine protein kinase  1.51E-246          
 CAL0002874 2.61 Uncharacterized ORF; Early-stage 
biofilm-induced gene                                      
7.50E-98          
 CAL0002448 2.61 Amino acid permeases  7.77E-152          
 CAL0002772 2.61 Uncharacterized ORF  1.14E-26          
 CAL0005944 2.60 Dubious ORF                                         2.54E-05          
 CAL0005550 2.60 Uncharacterized ORF  3.88E-120          
 CAL0001861 2.60 Uncharacterized ORF                                         1.67E-21          
 CAL0005146 2.60 Uncharacterized ORF                                         1.43E-135          
 CAL0001663 2.60 Uncharacterized ORF; Hap43p-repressed 
gene  
1.22E-150          
 CAL0002008 2.59 Uncharacterized ORF                                         0.000145466          
 CAL0001534 2.59 Uncharacterized ORF; Hap43p-repressed 
gene                                  
6.00E-31          
 CAL0004987 2.59 Uncharacterized ORF; Hap43p-repressed 
gene                                       
3.28E-123          
 CAL0000884 2.58 Uncharacterized ORF     2.44E-11          
 CAL0006085 2.58 Uncharacterized ORF                        3.19E-118          
 CAL0006226 2.58 Uncharacterized ORF  1.60E-71          
 CAL0004509 2.57 Uncharacterized ORF                                         1.23E-75          
 CAL0004476 2.57 Uncharacterized ORF  6.52E-109          
 CAL0001907 2.56 Uncharacterized ORF  3.73E-120          
 CAL0002764 2.56 Putative ion transporter  1.35E-113          
 CAL0005175 2.56 Uncharacterized ORF                       1.49E-116          
 CAL0004219 2.56 Putative 2-deoxyglucose-6-phosphatase  1.87E-197          
 CAL0000304 2.56 Putative GPI-anchored protein  1.13E-174          
 CAL0006161 2.56 Uncharacterized ORF  2.55E-107          
 CAL0006370 2.55 Putative transcription factor with zinc 
cluster DNA-binding motif                                 
2.39E-34          
 CAL0000780 2.55 Uncharacterized ORF  2.59E-261          
 CAL0001309 2.55 Uncharacterized ORF      8.30E-27          
 CAL0001898 2.55 Uncharacterized ORF 6.33E-31          
 CAL0003133 2.55 B-type mitotic cyclin  1.00E-300          
 CAL0001047 2.55 Uncharacterized ORF  2.11E-55          
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 CAL0003604 2.55 Uncharacterized ORF; Hap43p-induced 
gene                                       
1.91E-41          
 CAL0004443 2.55 Secreted protein required for normal cell 
wall structure 
1.00E-300          
 CAL0004447 2.55 Uncharacterized ORF  3.03E-08          
 CAL0005563 2.54 Uncharacterized ORF  2.35E-45          
 CAL0005693 2.54 Uncharacterized ORF  0.000497533          
 CAL0003608 2.54 Uncharacterized ORF  3.41E-215          
 CAL0006262 2.54 Uncharacterized ORF                                         9.63E-121          
 CAL0005544 2.54 Uncharacterized ORF                                         1.68E-45          
 CAL0005574 2.53 Uncharacterized ORF            1.19E-110          
 CAL0000712 2.53 Ammonium permease and regulator of 
nitrogen starvation  
3.77E-30          
 CAL0001981 2.53 Uncharacterized ORF  3.94E-74          
 CAL0004473 2.53 Uncharacterized ORF                                         4.04E-298          
 CAL0005031 2.53 Uncharacterized ORF  7.26E-35          
 CAL0005771 2.52 Uncharacterized ORF  5.31E-45          
 CAL0003522 2.52 Dubious ORF                                         1.33E-111          
 CAL0001415 2.52 Uncharacterized ORF  1.53E-32          
 CAL0004802 2.51 Potential role in beta-1,6 glucan 
biosynthesis  
7.01E-19          
 CAL0002799 2.51 Putative vacuolar transporter of large 
neutral amino acids                           
3.27E-61          
 CAL0001431 2.51 Putative patatin-like phospholipase  1.00E-300          
 CAL0004432 2.51 Uncharacterized ORF  1.00E-300          
 CAL0002507 2.51 Uncharacterized ORF  6.47E-60          
 CAL0001591 2.50  Protein similar to S. cerevisiae Kar9p  6.16E-34          
 CAL0006406 2.50 Uncharacterized ORF  2.61E-12          
 CAL0004429 2.50 N-acetylglucosamine (GlcNAc)-specific 
transporter  
1.37E-190          
 CAL0002996 2.49 Uncharacterized ORF  5.72E-05          
 CAL0004609 2.49 Putative glucanase; induced during cell 
wall regeneration                                  
5.54E-24          
 CAL0000703 2.49 Uncharacterized ORF; Hap43p-repressed 
gene  
2.80E-58          
 CAL0000402 2.49 Putative dynamin-related GTPase  1.52E-296          
 CAL0004733 2.49 Uncharacterized ORF 5.71E-74          
 CAL0005604 2.49 Uncharacterized ORF                    1.87E-44          
 CAL0006261 2.48 Secreted aspartyl proteinase  2.56E-06          
 CAL0003232 2.48 Protein kinase C  4.23E-09          
 CAL0005369 2.48 Transcriptional activator  2.16E-11          
 CAF0006954 2.48 Uncharacterized ORF  1.79E-30          
 CAL0001744 2.48 Heat shock protein         1.00E-300          
 CAL0003154 2.48 Regulator of nitrogen utilization 8.25E-44          
 CAL0006027 2.48 Putative ferric reductase  4.58E-11          
 CAL0000707 2.47 Uncharacterized ORF  1.31E-18          
 CAL0004107 2.47 Uncharacterized ORF                                         1.00E-300          
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 CAL0003873 2.47 Putative adhesin-like protein                                      6.55E-144          
 CAL0003395 2.47 Putative UDP glucose/starch 
glucosyltransferase 
3.80E-45          
 CAL0004704 2.46 Uncharacterized ORF; Hap43p-repressed 
gene                                       
1.60E-07          
 CAL0005204 2.45 Putative GPI-anchored protein  1.35E-35          
 CAL0001161 2.45 Putative glycerol 3-P dehydrogenases)           1.00E-300          
 CAL0002626 2.45 Uncharacterized ORF                                         0.000985931          
 CAF0006965 2.45 Flavin-linked sulfhydryl oxidase activity 
and role in cellular iron ion homeostasis 
6.24E-111          
 CAL0002283 2.45 NAD(P)H oxidoreductase family protein; 
induced by nitric oxide       
3.37E-41          
 CAL0000393 2.45 Ortholog(s) have mitochondrion 
localization                                     
8.65E-38          
 CAL0003208 2.44 Ortholog(s) have thiol oxidase activity          4.77E-124          
 CAL0004615 2.44 Srb9p transcription mediator 1.43E-18          
 CAL0003229 2.44 Uncharacterized ORF; Similar to Rab 
GTPase                                   
3.84E-32          
 CAL0003874 2.44 Uncharacterized ORF 1.51E-23          
 CAL0001980 2.44 Uncharacterized ORF  3.86E-88          
 CAL0003844 2.44 Putative RNA-binding protein  9.35E-124          
 CAL0003011 2.44 Uncharacterized ORF; Ortholog(s) have 
phosphatidylserine decarboxylase 
activity,  
1.24E-108          
 CAL0005953 2.43 Putative class III aminotransferase  7.43E-07          
 CAL0003062 2.43 Plasma membrane-localized protein                 5.53E-84          
 CAL0001158 2.43 Aldo-keto reductase family member 1.57E-36          
 CAL0000894 2.42 Probable protein kinase 6.32E-176          
 CAL0003267 2.42 Uncharacterized ORF                                         2.20E-48          
 CAL0002010 2.42 Putative mitochondrial respiratory protein                    8.89E-50          
 CAL0000008 2.42 Uncharacterized ORF                        1.58E-64          
 CAL0002917 2.41 Uncharacterized ORF                  1.66E-235          
 CAL0000997 2.41 Uncharacterized ORF                                         7.80E-22          
 CAL0005126 2.41 Putative mitochondrial RNA polymerase                            1.00E-300          
 CAL0006340 2.41  Putative transcription factor with a role in 
colony morphology                
1.64E-52          
 CAL0004070 2.40 Putative thiamin-phosphate 
pyrophosphorylase                        
2.74E-29          
 CAL0002453 2.40 Putative phosphatidylinositol kinase                        7.28E-111          
 CAL0002529 2.40 Cell wall adhesin-like protein;repressed 
by Rim101p                     
3.68E-36          
 CAL0005002 2.40 Sef1p-, Sfu1p-, and Hap43p regulated 
gene                                  
1.67E-05          
 CAL0002087 2.40 Uncharacterized ORF           7.42E-10          
 CAL0005933 2.39 structural constituent of ribosome and 
localizes to mitochondrial small ribosomal 
subunit 
1.00E-300          
 CAL0000530 2.39 Putative beta-mannosyltransferase,  5.53E-124          
 CAL0005365 2.39 Putative RNA-binding protein  3.78E-128          
 CAL0004261 2.38 Uncharacterized ORF                                         3.31E-29          
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 CAL0005727 2.38 Regulated by Sef1p-, Sfu1p-, and 
Hap43p                               
2.17E-124          
 CAL0003673 2.38 Putative translation initiation factor  1.61E-49          
 CAL0003274 2.38 Putative Rho1p GTPase activating 
protein   
9.53E-133          
 CAL0005434 2.38 Ortholog(s) have phosphatidylinositol-4-
phosphate phosphatase activity                          
1.48E-157          
 CAL0003363 2.37 Uncharacterized ORF; Putative fungal-
specific transmembrane protein                                     
1.00E-300          
 CAL0005212 2.37 Putative patatin-like phospholipase                     1.45E-19          
 CAL0005009 2.37 Uncharacterized ORF                                         1.19E-33          
 CAL0002807 2.36 Uncharacterized ORF                               8.61E-52          
 CAL0004422 2.36 Uncharacterized ORF                          1.00E-300          
 CAL0003054 2.36 Putative cell wall protein, member of the 
CRH family        
5.91E-52          
 CAL0005800 2.36 Uncharacterized ORF                                         6.64E-06          
 CAL0005015 2.36 Putative serine/threonine/tyrosine (dual-
specificity) kinase  
2.13E-111          
 CAL0000621 2.35 Putative processing peptidase                           7.39E-147          
 CAL0005588 2.35 Uncharacterized ORF                                         3.04E-50          
 CAL0003243 2.35  Imidazoleglycerol-phosphate 
dehydratase   
2.81E-33          
 CAL0004910 2.35 Protein involved in sphingolipid 
biosynthesis 
4.97E-111          
 CAL0002160 2.35  Protein similar to asparagine and 
glutamine permease 
1.00E-300          
 CAL0004555 2.35 Putative transcription factor with zinc 
cluster DNA-binding motif           
1.34E-42          
 CAL0005224 2.34  ERK-family protein kinase        3.82E-89          
 CAL0002154 2.34 Uncharacterized ORF  2.07E-15          
 CAL0120529 2.34 Uncharacterized ORF  0.285184          
 CAL0005343 2.34 involved in ubiquitin-mediated protein 
degradation                   
3.73E-263          
 CAF0007423 2.34 Rho GTPase activator activity                      1.00E-300          
 CAL0005683 2.34 Verified ORF;mutation affects filamentous 
growth                   
1.53E-14          
 CAL0005653 2.34 Protein mannosyltransferase  1.00E-300          
 CAL0004518 2.34 Ortholog(s) have poly(A)-specific 
ribonuclease activity  
3.47E-198          
 CAL0002941 2.33 Uncharacterized ORF                                         5.21E-34          
 CAL0003907 2.33 Uncharacterized ORF;regulated upon 
white-opaque switching              
2.41E-65          
 CAL0006309 2.33 Protein with a Gal4p-like DNA-binding 
domain                                   
3.88E-139          
 CAL0004511 2.33 Putative oxidoreductas                  1.00E-300          
 CAL0003712 2.33 Uncharacterized ORF                                         2.61E-294          
 CAL0002210 2.33 Uncharacterized ORF  1.91E-13          
 CAL0001069 2.33 Putative membrane protein with a 
predicted role in membrane fusion during 
mating  
3.61E-20          
 CAL0001600 2.32 Protein involved in heme uptake                      2.22E-134          
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 CAL0001725 2.32 Putative protein kinase with a role in cell 
wall regulation                         
1.45E-82          
 CAL0004577 2.32 Protein involved in synthesis of the 
thiamine precursor 
hydroxymethylpyrimidine 
1.00E-300          
 CAL0005580 2.31 Role in manganese ion transport and 
mitochondrion localization                             
2.69E-72          
 CAL0001210 2.31 Putative phosphoglycerate mutas 3.16E-222          
 CAL0002602 2.31 Uncharacterized ORF                                         1.00E-300          
 CAL0002765 2.31 Protein with a predicted role in docking 
and fusion of post-Golgi vesicles with the 
plasma membrane             
8.20E-174          
 CAL0000064 2.31 Required for homologous DNA 
recombination  
1.54E-62          
 CAL0005516 2.30 Possible regulatory protein  1.29E-89          
 CAL0000818 2.30 Uncharacterized ORF  1.00E-300          
 CAL0003539 2.30 Dubious ORF                                         1.07E-93          
 CAL0000429 2.30 Uncharacterized ORF                                         2.80E-37          
 CAL0003065 2.30 3-hydroxyacyl-CoA epimerase 3.11E-113          
 CAL0001565 2.30 Putative cytochrome b2 precursor protein  4.50E-37          
 CAL0006330 2.30 Uncharacterized ORF  2.44E-07          
 CAL0005320 2.29 Uncharacterized ORF                                         4.00E-16          
 CAL0006120 2.29 Uncharacterized ORF  1.44E-70          
 CAL0000099 2.29 Protein similar to Yta6p ATPase  3.99E-76          
 CAL0002790 2.29 Uncharacterized ORF  1.16E-269          
 CAL0005497 2.29 Uncharacterized ORF 1.96E-51          
 CAL0002655 2.29 Uncharacterized ORF  0.000290448          
 CAL0005239 2.29 Uncharacterized ORF  2.46E-46          
 CAL0000417 2.29 Uncharacterized ORF; Hap43p-repressed 
gene  
9.40E-69          
 CAL0000807 2.29 Uncharacterized ORF; Putative adhesin-
like protein                                      
1.53E-27          
 CAL0000816 2.29 Putative tRNA-Pro synthetase  2.46E-235          
 CAL0004665 2.28 Uncharacterized ORF       1.00E-300          
 CAL0001498 2.28 Putative glucose transporter of the major 
facilitator superfamily 
1.19E-22          
 CAL0000139 2.28 Uncharacterized ORF  7.93E-42          
 CAL0003557 2.28 Putative enzyme with predicted indole-3-
glycerol-phosphate synthase                         
8.74E-61          
 CAL0002003 2.28 Putative vacuolar transporter of large 
neutral amino acids                  
1.08E-47          
 CAL0001629 2.27 Uncharacterized ORF  1.05E-20          
 CAL0005560 2.27 Protein mannosyltransferase  1.00E-300          
 CAL0006399 2.27 Uncharacterized ORF           2.06E-39          
 CAL0001441 2.27 ALS family cell-surface glycoprotein  2.72E-34          
 CAL0004068 2.27 Uncharacterized ORF; mitochondrion 
localization                                     
4.63E-142          
 CAL0001828 2.26 Heat shock protein              1.00E-300          
 CAF0006969 2.26 Gene induced by hypoxia                               5.23E-55          
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 CAL0006390 2.26 Uncharacterized ORF; Hap43p-induced 
gene                                       
7.66E-59          
 CAL0001098 2.26 Uncharacterized ORF  3.11E-17          
 CAL0000244 2.25 Putative oligopeptide transporter  1.00E-300          
 CAL0003239 2.25 Uncharacterized ORF; Hap43p-induced 
gene; induced upon biofilm formation                                   
5.71E-114          
 CAL0005620 2.25 Uncharacterized ORF  1.76E-06          
 CAL0003766 2.25 Uncharacterized ORF                    3.24E-92          
 CAL0005021 2.25 Putative glucose transporter of the major 
facilitator superfamily;  
7.93E-28          
 CAL0003571 2.25 Putative sphingosine kinase                                 6.49E-19          
 CAL0001179 2.25 Uncharacterized ORF; Hap43p-repressed 
gene  
1.64E-112          
 CAL0001213 2.25 Uncharacterized ORF; Putative 
serine/threonine protein kinase 
4.63E-78          
 CAL0000075 2.25 Similar to S. cerevisiae Afg3p, a subunit 
of the mitochondrial inner membrane m-
AAA protease  
1.00E-300          
 CAL0005852 2.25 Uncharacterized ORF 4.23E-88          
 CAL0001131 2.24 Uncharacterized ORF                                         8.23E-47          
 CAL0005119 2.24 Late-stage biofilm-induced gene                                8.70E-19          
 CAL0002530 2.24 Uncharacterized ORF  7.17E-22          
 CAL0002548 2.24 Uncharacterized ORF; Hap43p-repressed 
gene                                       
9.91E-111          
 CAL0005698 2.24 Uncharacterized ORF  9.99E-29          
 CAL0005471 2.24 Uncharacterized ORF  1.49E-41          
 CAL0004790 2.24 Uncharacterized ORF       1.35E-09          
 CAL0002761 2.24 Uncharacterized ORF            4.01E-156          
 CAL0003737 2.24 Uncharacterized ORF  1.00E-300          
 CAL0001944 2.24 Uncharacterized ORF                                         5.76E-24          
 CAL0006276 2.23 role in mitochondrial translation and 
mitochondrion localization                                
1.00E-300          
 CAL0003151 2.23 Putative oxidized purine base lesion DNA 
N-glycosylase activity 
0.00207077          
 CAL0002954 2.23 Putative GTPase-activating protein                             1.00E-300          
 CAL0005141 2.23 Ortholog(s) have protein kinase regulator 
activity  
6.25E-37          
 CAL0004072 2.23 Uncharacterized ORF  2.24E-07          
 CAF0006932 2.22 Putative copper metallochaperone; 
Hap43p-repressed gene                     
3.27E-44          
 CAL0004575 2.22 Uncharacterized ORF                  1.40E-253          
 CAL0004606 2.22 Predicted membrane transporter  3.65E-30          
 CAL0000789 2.22 Uncharacterized ORF  4.27E-07          
 CAL0004832 2.22 Ortholog(s) have ATP-dependent RNA 
helicase activity                          
8.53E-141          
 CAL0004600 2.22 Uncharacterized ORF; Adenine 
phosphoribosyltransferase; flucytosine 
induced; repressed by nitric oxide; protein 
level decreased in stationary phase yeast 
cultures                         
1.46E-43          
 CAL0004042 2.21 Putative type-1 protein phosphatase 
targeting subunit  
2.98E-57          
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 CAL0006244 2.21 Uncharacterized ORF                                         4.31E-26          
 CAL0003485 2.21 Uncharacterized ORF                                         2.11E-45          
 CAL0005202 2.21 Putative pyruvate decarboxylase     1.00E-300          
 CAL0006036 2.20 Putative dicarboxylic amino acid 
permease  
1.00E-300          
 CAL0002245 2.20 Ribonucleoside-diphosphate reductase  1.00E-300          
 CAL0004789 2.20 Uncharacterized ORF                                         1.04E-18          
 CAL0000249 2.20 Uncharacterized ORF; Predicted zinc-
finger protein                                      
1.99E-07          
 CAL0005453 2.20 Ortholog(s) have metalloendopeptidase 
activity  
1.43E-159          
 CAL0003949 2.20 Uncharacterized ORF 1.56E-161          
 CAL0004457 2.20 Copper- and zinc-containing superoxide 
dismutase        
1.62E-146          
 CAL0004587 2.20 Uncharacterized ORF                                         1.00E-300          
 CAL0002979 2.20 Protein involved in the negative control of 
pseudohyphal growth          
2.05E-139          
 CAL0003016 2.20 Protein with role in resistance to host 
antimicrobial peptides  
1.00E-300          
 CAL0003838 2.19 Putative RSC chromatin remodeling 
complex component  
5.64E-65          
 CAL0003199 2.19 Cytosolic chaperonin Cct ring complex  4.33E-32          
 CAL0005655 2.19 Uncharacterized ORF; Hap43p-induced 
gene                                       
6.02E-13          
 CAL0003178 2.19 Uncharacterized ORF                                         3.17E-17          
 CAL0006182 2.19 Uncharacterized ORF                                         1.96E-58          
 CAL0002565 2.19 Putative biotin synthase  1.03E-14          
 CAL0005976 2.19 Uncharacterized ORF; Protein similar to 
DNA helicase                 
1.03E-36          
 CAL0002649 2.19 Uncharacterized ORF                                         1.52E-22          
 CAL0005517 2.19 Uncharacterized ORF; Hap43p-repressed 
gene 
1.46E-112          
 CAL0001427 2.19 Putative Arf3p GTPase activating protein  6.30E-71          
 CAL0002041 2.18 Secreted aspartyl protease  1.61E-12          
 CAL0002725 2.18 Uncharacterized ORF  3.33E-17          
 CAL0003641 2.18 Uncharacterized ORF  1.00E-300          
 CAL0005854 2.18 Uncharacterized ORF; Hap43p-repressed 
gene                                       
3.99E-210          
 CAL0001120 2.18 Uncharacterized ORF; Hap43p-repressed 
gene  
3.22E-53          
 CAL0002025 2.18 Protein involved in proteolytic activation 
of Rim101p  
4.85E-38          
 CAL0004709 2.18 Protein with predicted role in beta-1,6-
glucan synthesis  
4.43E-63          
 CAL0005745 2.18 Putative PDR-subfamily ABC transporter  4.63E-95          
 CAL0001297 2.18 Uncharacterized ORF                                         0.00081435          
 CAL0001575 2.18 Putative termination and polyadenylation 
protein                            
1.01E-158          
 CAL0001136 2.18 Putative mitochondrial carrier protein  1.00E-300          
 CAL0005112 2.18 Member of a family encoded by FGR6-
related genes  
8.41E-13          
 CAL0003852 2.18 Uncharacterized ORF                                         3.17E-13          
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 CAL0000385 2.18 oxidoreductase activity, role in 
cytochrome c-heme linkage, 
mitochondrial membrane organization 
and extrinsic to mitochondrial inner 
membrane localization                      
6.79E-92          
 CAL0006152 2.17 Verified ORF; Putative RNA helicase                                      9.78E-45          
 CAL0004999 2.17 mRNA binding activity, role in 
mitochondrion organization             
8.60E-12          
 CAL0120801 2.17 Uncharacterized ORF                                         8.90E-114          
 CAL0004816 2.17 Ortholog(s) have DNA-directed DNA 
polymerase activity mitochondrion, 
nuclear chromatin localization                  
3.39E-29          
 CAL0002229 2.16 Uncharacterized ORF                                         2.29E-11          
 CAL0005461 2.16 Uncharacterized ORF  1.00E-300          
 CAL0005737 2.16 Ortholog(s) have ubiquitin-specific 
protease activity                     
9.93E-127          
 CAL0002777 2.16 Putative secreted aspartyl protease  0.000631581          
 CAL0003073 2.16 Uncharacterized ORF; induced by nitric 
oxide  
5.01E-06          
 CAL0002942 2.16 Putative GTPase-activating protein (GAP) 
for Rho-type GTPase Cdc42p  
1.03E-132          
 CAL0004311 2.15 Predicted ribosomal protein  2.58E-35          
 CAL0000861 2.15 Putative GINS complex subunit                        7.61E-10          
 CAL0003131 2.15 Uncharacterized ORF                                         1.14E-142          
 CAL0000137 2.15 Uncharacterized ORF                1.28E-64          
 CAL0000012 2.14 Uncharacterized ORF                  2.54E-05          
 CAL0000489 2.14 Uncharacterized ORF  1.83E-31          
 CAL0003370 2.14 Cell wall protein                              7.77E-39          
 CAL0003919 2.14 Ortholog(s) have role in ubiquinone 
biosynthetic process, aerobic respiration 
and mitochondrial inner membrane                            
6.49E-170          
 CAF0007419 2.14 Putative adhesin-like protein                            5.21E-33          
 CAL0000184 2.14 Protein lacking an ortholog in S. 
cerevisiae; transposon mutation affects 
filamentous growth                             
3.69E-106          
 CAL0001237 2.14 Uncharacterized ORF                                         1.75E-11          
 CAL0005436 2.14 VH1 family MAPK phosphatase  8.33E-39          
 CAL0004905 2.13 Putative GPI-anchored adhesin-like 
protein  
2.55E-20          
 CAL0000235 2.13  Monooxygenase of the cytochrome P450  6.85E-09          
 CAL0000885 2.13 Uncharacterized ORF  2.79E-22          
 CAL0000116 2.13 Uncharacterized ORF  1.00E-300          
 CAL0003638 2.13 Uncharacterized ORF                                         7.40E-116          
 CAL0001553 2.13 Cell wall protein; putative GPI-anchor 9.41E-211          
 CAL0004810 2.13 Uncharacterized ORF  1.49E-217          
 CAL0005353 2.13  Malate synthase; glyoxylate cycle 
enzyme  
3.47E-144          
 CAL0005948 2.12 Uncharacterized ORF                               1.00E-11          
 CAL0120947 2.12 Uncharacterized ORF                                         0.130919          
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 CAL0001758 2.12 Putative methionyl-tRNA transformylase                               1.49E-39          
 CAL0001396 2.12 Predicted acyl-CoA oxidase 9.03E-36          
 CAL0003804 2.12 Uncharacterized ORF 6.11E-11          
 CAL0002434 2.12 Plasma membrane, hyphal cell wall 
protein  
4.89E-236          
 CAL0005443 2.12 Uncharacterized ORF  1.72E-152          
 CAL0001496 2.12 Uncharacterized ORF          1.05E-52          
 CAL0000122 2.12 Uncharacterized ORF  1.48E-128          
 CAL0000180 2.11 Uncharacterized ORF; Putative mRNA 
maturation factor 
8.06E-242          
 CAL0005908 2.11 Uncharacterized ORF; Hap43p-repressed 
gene                                  
2.41E-46          
 CAL0002933 2.11 Transcriptional repressor  2.00E-19          
 CAL0001799 2.11 Putative Rho GTPase activating protein                            1.52E-202          
 CAL0005187 2.11 Heme oxygenase     3.10E-129          
 CAL0006202 2.11 Uncharacterized ORF; Putative MFS 
transporter                     
6.17E-15          
 CAL0004874 2.11 Uncharacterized ORF; Hap43p-repressed 
gene                               
2.14E-24          
 CAL0005238 2.11 Uncharacterized ORF 2.71E-20          
 CAL0000305 2.11  Putative allantoate permease 2.42E-17          
 CAL0003619 2.11 Uncharacterized ORF                                         1.00E-300          
 CAL0005019 2.11 Uncharacterized ORF                                         1.82E-23          
 CAL0003351 2.11 Uncharacterized ORF 1.00E-300          
 CAL0002509 2.11  Alcohol dehydrogenase      7.64E-267          
 CAL0003264 2.10 Putative histone acetyltransferase 
complex subunit 
1.00E-300          
 CAL0003448 2.10 Voltage-gated Ca2+ channel of the 
calcium uptake system;  
9.05E-43          
 CAL0006303 2.10 Uncharacterized ORF 1.64E-21          
 CAL0004451 2.10 Cell wall adhesin required for cell-cell 
adhesion, GPI anchored 
5.41E-50          
 CAL0001139 2.10 Uncharacterized ORF                                         1.11E-28          
 CAL0002621 2.105 Protein similar to S. cerevisiae Bck1p 
MAP kinase kinase kinase of cell integrity 
pathway  
6.08E-40          
 CAL0005999 2.10 Subunit of beta-1,3-glucan synthase  1.00E-300          
 CAL0005832 2.103 Uncharacterized ORF  6.30E-05          
 CAL0003148 2.10 Uncharacterized ORF  3.07E-83          
 CAL0001560 2.10 Uncharacterized ORF                                         8.95E-101          
 CAL0000729 2.10 Uncharacterized ORF                                         5.16E-61          
 CAL0001943 2.10 Uncharacterized ORF                                         4.02E-31          
 CAL0005421 2.10 ALS family protein  1.29E-24          
 CAL0000198 2.09 Uncharacterized ORF; Hexokinase II  1.00E-300          
 CAL0004675 2.09 Uncharacterized ORF  2.44E-26          
 CAL0002088 2.09 Uncharacterized ORF  4.58E-15          
 CAL0004157 2.09 Uncharacterized ORF  1.55E-73          
 CAL0000038 2.09 Uncharacterized ORF  2.01E-72          
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 CAL0005977 2.09 Pyruvate kinase 1.00E-300          
 CAL0000651 2.09 Uncharacterized ORF; Hap43p-repressed  1.02E-170          
 CAL0003413 2.08 Uncharacterized ORF; histone 
demethylase activity  
1.50E-19          
 CAL0002370 2.08 Role in heme a biosynthetic process and 
mitochondrion localization                              
6.82E-199          
 CAL0005685 2.08 C-14 sterol reductase                     6.75E-140          
 CAL0003516 2.08 Uncharacterized ORF                    1.12E-82          
 CAL0000518 2.08 Uncharacterized ORF                         1.36E-261          
 CAL0003880 2.08  Transcription factor involved in alkaline 
pH response 
8.70E-12          
 CAL0003394 2.08 Dubious ORF                                         1.00E-300          
 CAL0003139 2.08 Uncharacterized ORF  4.73E-58          
 CAL0000858 2.07 Uncharacterized ORF  1.11E-05          
 CAL0000614 2.07 Ferric reductase  2.43E-05          
 CAL0001626 2.07 Uncharacterized ORF  5.49E-31          
 CAL0006048 2.07 Uncharacterized ORF  1.90E-64          
 CAL0003728 2.07 Uncharacterized ORF                                         8.55E-87          
 CAL0000438 2.07 Uncharacterized ORF  4.57E-18          
 CAL0005901 2.07 Glucosaminyl-phosphotidylinositol O-
acyltransferase activity 
9.11E-65          
 CAL0005404 2.07 Phosphatidylinositol 3-phosphate 5-
kinase         
1.79E-64          
 CAL0001834 2.07 Uncharacterized ORF  3.43E-91          
 CAL0004653 2.07 Uncharacterized ORF 3.25E-192          
 CAL0002276 2.07 Uncharacterized ORF; Putative glycerol-
3-phosphate acyltransferase; fungal-
specific (no human or murine homolog)                                
1.77E-70          
 CAL0004490 2.07 Uncharacterized ORF; Hap43p-repressed 
gene  
1.01E-149          
 CAL0002184 2.07 Putative glucose-6-phosphate isomerase, 
enzyme of glycolysis;  
1.00E-300          
 CAL0004695 2.07 Uncharacterized ORF 3.71E-52          
 CAL0000445 2.07 Uncharacterized ORF                                         4.65E-49          
 CAL0005341 2.06 Uncharacterized ORF; Hap43p-repressed 
gene                                      
3.07E-110          
 CAL0001865 2.06 Putative mitochondrial large subunit 
ribosomal protein                        
6.62E-93          
 CAL0005273 2.06 Uncharacterized ORF 2.78E-38          
 CAL0001902 2.06 Putative Golgi alpha-1,2-
mannosyltransferase  
7.80E-141          
 CAL0004450 2.06 Uncharacterized ORF  2.18E-38          
 CAL0004425 2.06 Uncharacterized ORF                                         7.10E-51          
 CAL0003326 2.06 Uncharacterized ORF  1.08E-37          
 CAL0003492 2.06 Uncharacterized ORF  4.56E-47          
 CAL0000052 2.06 Uncharacterized ORF  1.86E-211          
 CAL0003572 2.06 Uncharacterized ORF;induced by nitric 
oxide                             
1.64E-15          
 CAL0006266 2.06 Uncharacterized ORF; oxidoreductase 1.82E-39          
 CAL0002993 2.06 Possible oxidoreductase 1.51E-05          
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 CAL0001941 2.05 Uncharacterized ORF; Putative golgi 
GTPase-activating protein                             
1.49E-108          
 CAL0003528 2.05 Uncharacterized ORF                       2.80E-127          
 CAL0006090 2.05 Uncharacterized ORF                         2.07E-18          
 CAL0002950 2.05 Uncharacterized ORF; Ortholog(s) have 
peptidase activity                  
1.00E-300          
 CAL0004580 2.05 Protein with a role in phosphate transport                 1.00E-300          
 CAL0004949 2.05 Protein similar to S. cerevisiae Ecm29p                         2.72E-153          
 CAF0006924 2.05 Uncharacterized ORF                         2.38E-33          
 CAL0005656 2.05 Uncharacterized ORF; Putative 
proteinase  
1.00E-300          
 CAL0001630 2.05 Putative transcription factor with zinc 
finger DNA-binding motif                         
4.07E-34          
 CAL0004808 2.05 protein involved in regulation of SCF 
complex           
9.38E-104          
 CAL0002479 2.05 Uncharacterized ORF  0.00195682          
 CAL0005679 2.05 Uncharacterized ORF; Ortholog of <i>C. 
glabrata CBS138</i> : CAGL0L12628g                                  
5.77E-37          
 CAL0004963 2.04 Uncharacterized ORF                                         3.51E-05          
 CAL0000444 2.04 Uncharacterized ORF  1.00E-300          
 CAL0002334 2.04  Putative RNA binding protein  4.85E-28          
 CAL0006143 2.04  Predicted membrane transporter,  8.71E-25          
 CAL0001524 2.04 Ribonucleotide reductase large subunit;  1.00E-300          
 CAL0005233 2.04 Protein involved in the pH response 
pathway;  
2.73E-34          
 CAL0005308 2.04 Scaffold protein for the mitogen-activated 
protein (MAP) kinase  
1.88E-16          
 CAL0001752 2.04 Uncharacterized ORF                                         1.28E-12          
 CAL0004037 2.04 Protein with putative zinc finger  1.09E-10          
 CAL0006311 2.04 Uncharacterized ORF  6.91E-48          
 CAL0000549 2.04 Uncharacterized ORF  3.21E-223          
 CAL0002936 2.040 Major carnitine acetyl transferase 
localized in peroxisomes and 
mitochondria            
3.79E-151          
 CAL0005024 2.03 Lysine histone methyltransferase; 
methylates K4 of histone H3  
1.06E-42          
 CAL0005328 2.03 Uncharacterized ORF  2.32E-56          
 CAL0005010 2.03 Hyphal growth regulator 1.00E-300          
 CAL0004775 2.03 Adhesin-like protein;Rim101p-repressed             3.27E-142          
 CAL0003640 2.03 Putative high affinity methionine 
permease; upregulated by Rim101p                                
5.61E-242          
 CAL0000583 2.03 Putative 1,4-glucan branching enzyme 2.71E-240          
 CAL0002321 2.03 Uncharacterized ORF                       1.47E-29          
 CAL0000547 2.029 Uncharacterized ORF                                         1.68E-10          
 CAF0006896 2.028 Ribosomal protein S27                                      4.73E-14          
 CAL0003161 2.028 Uncharacterized ORF; Hap43p-induced 
gene 
3.42E-34          
 CAL0000141 2.025 Predicted zinc-finger protein  5.33E-61          
 CAL0005260 2.023  Putative kynurenine 3-monooxygenase  3.36E-206          
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 CAL0005696 2.022 Uncharacterized ORF                           6.75E-137          
 CAL0004102 2.021 Uncharacterized ORF  9.82E-89          
 CAL0004468 2.021 Uncharacterized ORF; Putative 
transcription factor with zinc finger DNA-
binding motif                                 
1.57E-28          
 CAL0002900 2.020 Essential protein involved in endocytosis 
and polarized growth;  
1.00E-300          
 CAL0001871 2.020 Uncharacterized ORF  1.00E-300          
 CAL0004405 2.019 Uncharacterized ORF  6.18E-173          
 CAL0003306 2.018 Putative ribosomal protein;  2.59E-83          
 CAL0000720 2.018 Uncharacterized ORF  1.50E-270          
 CAL0004028 2.017 Sphingolipid delta-8 desaturase  4.87E-184          
 CAL0003072 2.017  Predicted subunit of the exocyst 
complex,  
1.01E-44          
 CAL0003196 2.017 Uncharacterized ORF  8.16E-177          
 CAL0003800 2.016 Carboxypeptidase Y  4.03E-110          
 CAL0002787 2.015 Uncharacterized ORF  1.71E-53          
 CAL0003545 2.015 Uncharacterized ORF  2.43E-87          
 CAL0001802 2.014 Uncharacterized ORF  6.95E-24          
 CAL0003613 2.014 Uncharacterized ORF                                         1.03E-25          
 CAL0002988 2.014 Uncharacterized ORF                         4.25E-63          
 CAL0002002 2.011 Glycosidase of cell surface  1.00E-300          
 CAL0002890 2.010 Uncharacterized ORF                                         4.98E-24          
 CAL0002238 2.010 Uncharacterized ORF                                         5.74E-08          
 CAL0000516 2.009 Putative glutamate synthase  1.00E-300          
 CAF0006928 2.009 Uncharacterized ORF                         3.06E-12          
 CAL0005962 2.009 Uncharacterized ORF; hypoxia induced                             1.29E-97          
 CAL0003703 2.008 Uncharacterized ORF; role in 
mitochondrial translational termination 
and mitochondrion localization                           
0.0019543          
 CAL0120967 2.008 Uncharacterized ORF                                         0.000246561          
 CAL0003185 2.006 Master regulator (activator) of a-type 
mating  
1.45E-42          
 CAL0000015 2.005 Uncharacterized ORF  7.82E-115          
 CAL0004900 2.004 Uncharacterized ORF  3.35E-09          
 CAL0000796 2.004 Uncharacterized ORF t  1.72E-65          
 CAL0000004 2.004 Uncharacterized ORF                                         1.66E-80          
 CAL0003029 2.000 Protein similar to S. cerevisiae Cdc20p  1.09E-52          
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CAL0003238 2.01 Putative dihydrolipoamide acetyltransferase 7.16E-70 
CAL0003246 2.02 Ortholog(s) have role in protein import into mitochondrial outer 
membrane,phospholipid transport, mitochondrial outer membrane 
translocase complex assembly                       
1.25E-36 
CAL0004170 2.02 GPI-anchored cell wall transglycosylase 6.84E-50 
CAL0001598 2.02 Uncharacterized ORF                                         5.01E-142 
CAL0005139 2.02 Uncharacterized ORF; Hap43p-repressed gene 1.00E-300 
CAL0001250 2.05 Uncharacterized ORF 1.34E-110 
CAL0000435 2.08 Putative 30 kda heat shock protein      1.16E-69 
    
CAL0000520 2.08  Protein with homology to peroxisomal membrane proteins; Sef1p-, 
Sfu1p-, and Hap43p-regulated gene                             
2.47E-18 
CAL0001881 2.08 Putative heme-binding stress-related protein                 4.04E-190 
CAL0005617 2.09 Uncharacterized ORF                                         1.00E-300 
CAL0004738 2.11 Uncharacterized ORF; regulated by Sef1p-, Sfu1p-, and Hap43p                                1.27E-63 
CAL0005454 2.12 Putative mitochondrial inner membrane transporter                          2.20E-92 
CAL0000815 2.14 Uncharacterized ORF              2.36E-46 
CAL0003028 2.17 Uncharacterized ORF                                         0.0472951 
CAL0003510 2.17 Putative 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity 0.000408543 
CAL0001041 2.17 Uncharacterized ORF                                         4.30E-185 
CAL0004846 2.18 Uncharacterized ORF; Hap43p-induced gene                               7.94E-147 
CAL0005956 2.18 Dubious ORF                                         2.72E-36 
CAL0004997 2.19 Uncharacterized ORF         4.67E-247 
CAL0000267 2.23 Putative nucleolar protein                      1.37E-61 
CAL0002986 2.23 Ferric reductase  1.96E-11 
CAL0004548 2.24 Uncharacterized ORF                                         1.00E-300 
CAL0004552 2.25  Alternative oxidase  3.08E-22 
CAL0002995 2.25 Transcriptional repressor  6.36E-288 
CAF0006908 2.26 Hap43p-repressed gene; hypoxia downregulated 1.50E-57 
CAL0000921 2.26 Putative RNase MRP and nuclear RNase P component                           5.43E-83 
CAL0004612 2.28 Uncharacterized ORF                                         0.0411878 
CAL0004328 2.28 Uncharacterized ORF; Protein not essential for viability                                    2.06E-55 
CAL0005065 2.28 Putative nucleolar protein with role in ribosomal assembly                       6.46E-49 
CAL0003742 2.29 a ubiquitin hydrolase 1.97E-07 
CAL0002023 2.31 Ortholog(s) have telomerase inhibitor activity  4.97E-130 
CAL0001782 2.32 Putative inducible acid phosphatase  1.00E-300 
CAL0001718 2.34 Secreted protein  6.49E-176 
CAL0002504 2.38 Uncharacterized ORF                                         4.78E-108 
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CAL0003860 2.38 Uncharacterized ORF  2.32E-27 
CAL0001507 2.46 Putative transcription factor with bZIP DNA-binding motif  3.74E-196 
CAL0001053 2.47 Putative nucleolar protein                   6.97E-130 
CAL0005460 2.48 Putative ATP-dependent DEAD-box RNA helicase                   4.05E-67 
CAL0003683 2.50 Ortholog(s) have phosphatidylinositol-3-phosphate binding, 
phosphatidylinositol-5-phosphate binding activity                                  
3.75E-14 
CAL0000014 2.52 Uncharacterized ORF; Hap43p-induced gene                 1.06E-62 
CAL0000479 2.56 Uncharacterized ORF; Ortholog(s) have rRNA binding activity 8.11E-67 
CAL0006057 2.57 Putative constituent of 66S pre-ribosomal particles 1.08E-144 
CAL0004872 2.58 Uncharacterized ORF                      1.08E-144 
CAL0000754 2.65 Putative zinc finger transcription factor        2.91E-29 
CAL0002350 2.68 Response regulator of a two-component system involved in stress     7.32E-220 
CAL0001258 2.69 Uncharacterized ORF; Hap43p-induced gene                                       3.48E-27 
CAL0002743 2.74 Similar to catabolic serine/threonine dehydratases;               2.69E-268 
CAL0003582 2.78 Putative RNA polymerase III transcription initiation factor complex 
subunit                    
1.84E-38 
CAL0002189 2.89 Uncharacterized ORF     9.61E-20 
CAL0001847 2.92 Protein of unknown function; Plc1p-regulated 1.20E-08 
CAL0006076 2.93 Uncharacterized ORF  7.76E-81 
CAL0005712 2.96 Uncharacterized ORF  1.76E-42 
CAL0001467 3.00 Glycerol permease involved in glycerol uptake  3.86E-41 
CAL0006301 3.05 Dubious ORF                                         1.01E-163 
CAF0007089 3.08 Ortholog(s) have electron carrier activity  1.56E-27 
CAL0001013 3.12 Uncharacterized ORF; Biofilm-induced gene                                       2.24E-174 
CAL0120807 3.14 Putative adhesin-like protein                                      8.61E-11 
CAL0005860 3.15 Predicted hydrolase activity                                   1.00E-209 
CAL0003136 3.35 Ortholog(s) have role in cytoplasmic translation                         4.70E-19 
CAL0003776 3.43 Cell wall protein  1.66E-113 
CAL0004550 3.87 Alternative oxidase  0.000190087 
CAL0000982 3.89 Formate dehydrogenase  2.04E-207 
CAL0004487 4.02 Putative cytosolic iron-sulfur (FeS) protein assembly machinery 
protein; induced by nitric oxide  
8.97E-156 
CAL0000550 5.15 Glycerophosphoinositol permease  1.03E-78 
CAL0003313 5.23 Putative TFIID and SAGA complex subunit 1.00E-300 
CAL0005695 5.88 Uncharacterized ORF  1.01E-129 
CAL0001883 7.40 Uncharacterized ORF  1.00E-300 
CAL0120803 7.86 Uncharacterized ORF                                         1.00E-300 
CAL0000501 8.37 Putative potassium transporter  3.25E-32 
CAL0005929 8.61 Putative oxidoreductase                             2.22E-62 
CAL0002987 9.03 Putative oxidoreductase, iron utilization  6.73E-43 
CAL0000931 20.80 Uncharacterized ORFe  4.50E-153 
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CAL0002907 17.62 Putative phosphomethylpyrimidine kinase 1.00E-300 
CAL0004215 14.21 Putative tRNA splicing endonuclease subunit; Hap43p-induced  3.01E-261 
CAL0004374 11.99 NADP-glutamate dehydrogenase  1.00E-300 
CAL0004601 9.51 Uncharacterized ORF; Ortholog(s) have cytosol localization                                     1.82E-32 
CAL0001974 9.22 Urea amidolyase        1.00E-300 
CAL0005400 9.14 Protein similar to S. cerevisiae Hcm1p; Hap43p-induced gene                              2.20E-88 
CAL0002939 8.90 UDP-glucose:ceramide glucosyltransferase                         4.54E-108 
CAL0000318 8.83 Uncharacterized ORF; Hap43p-induced gene                                       1.00E-300 
CAL0002632 8.53 Verified ORF; G1 cyclin  1.63E-259 
CAL0000377 8.33 Uncharacterized ORF; Planktonic growth-induced gene                                      2.44E-16 
CAL0004068 8.12 High affinity spermidine transporter 1.00E-300 
CAL0004528 7.71 Putative transporter  6.72E-143 
CAL0001357 7.54 Uncharacterized ORF  1.00E-300 
CAL0003064 7.45 Uncharacterized ORF                         4.01E-127 
CAL0003075 7.42 Dubious ORF  7.39E-12 
CAL0000215 7.18 Inositol-1-phosphate synthase; inositol biosynthesis  8.84E-59 
CAL0002798 7.00 Uncharacterized ORF                                         7.71E-30 
CAL0004602 6.93 Putative transporter 1.94E-98 
CAL0000494 6.79 Essential protein involved in cytokinesis  1.73E-55 
CAL0003463 6.78 Uncharacterized ORF; Cyclin homolog  3.41E-73 
CAL0003477 6.47 Uncharacterized ORF                                         1.23E-58 
CAL0005136 6.34 Putative transcription factor; oxidative stress-induced  1.00E-300 
CAL0004833 6.31 Uncharacterized ORF; mitochondrion localization                                     1.00E-300 
CAL0000998 6.30 Uncharacterized ORF  1.00E-300 
CAL0001407 6.25 Putative DNA-binding transcription factor  3.81E-42 
CAF0007042 6.09 Uncharacterized ORF                                         4.64E-14 
CAL0004275 6.08 Uncharacterized ORF; Hap43p-repressed gene                                       4.37E-12 
CAL0004519 6.06 Putative GPI-anchored cell wall adhesin-like protein 1.00E-300 
CAL0003555 5.77 Putative ATP-binding protein with a predicted role in DNA replication 2.47E-89 
CAL0000707 5.77 Uncharacterized ORF; Ortholog of <i>S. cerevisiae</i> : PRM5                                   1.91E-79 
CAL0000371 5.74 Predicted membrane transporter; member of the proton coupled 
folate transporter/heme carrier protein (PCFT/HCP) family  
1.90E-70 
CAL0002531 5.70  Putative adhesin-like protein                                      1.00E-300 
CAL0120975 5.66 Uncharacterized ORF  3.44E-155 
CAL0005322 5.65 Uncharacterized ORF  8.14E-07 
CAL0000344 5.54 Ortholog(s) have exoribonuclease II activity, role in RNA catabolic 
process and mitochondrial matrix localization                           
2.00E-218 
CAL0004436 5.50 Putative DEAD-box protein required for efficient splicing of 
mitochondrial Group I and II introns; Hap43p-induced gene          
1.00E-300 
127 
 
 
Gene ID 
 
Fold up-
regulated 
 
Function                     
 
P-value 
CAL0000259 5.40 GPI-anchored protein; hypoxia, Hap43p-induced            1.22E-62 
CAL0005923 5.36 Uncharacterized ORF  7.91E-48 
CAL0003499 5.30 Uncharacterized ORF; Hap43p-repressed gene                     1.09E-25 
CAL0001605 5.27 ALS family cell wall adhesin  3.09E-177 
CAL0001358 5.22 Putative mitochondrial leucyl-tRNA synthetase                                     1.00E-300 
CAL0004847 5.21 Protein affects filamentous growth  5.85E-09 
CAL0000413 5.10 General amino acid permease  2.53E-24 
CAL0002161 5.06 Ortholog(s) have metalloendopeptidase activity, cellular iron ion 
homeostasis and mitochondrion localization                    
1.00E-300 
CAL0005574 5.01 Ortholog(s) have structural constituent of ribosome activity and 
mitochondrial small ribosomal subunit localization                            
1.00E-300 
CAL0005771 5.01 Ortholog(s) have role in mitochondrial tRNA 
threonylcarbamoyladenosine modification and mitochondrion 
localization                              
4.33E-146 
CAL0006360 4.98 Uncharacterized ORF                                         1.24E-28 
CAL0001415 4.96 Uncharacterized ORF  1.67E-102 
CAL0005693 4.94 Uncharacterized ORF  2.68E-10 
CAL0000885 4.91 Uncharacterized ORF  1.02E-114 
CAL0004840 4.89 Dubious ORF                                         4.90E-05 
CAL0000601 4.88 Uncharacterized ORF                                 1.00E-300 
CAL0003267 4.86 Nucleoside permease  6.01E-167 
CAL0004522 4.86 Putative transcription factor with zinc cluster DNA-binding motif                                 7.30E-11 
CAL0001440 4.81 Adhesin  1.00E-300 
CAL0002354 4.81 Putative ribonucleotide reductase large subunit                           1.73E-82 
CAL0001629 4.80 Uncharacterized ORF  2.25E-82 
CAL0002549 4.75 Uncharacterized ORF  1.38E-05 
CAL0004976 4.75 Ortholog(s) have 1-acylglycerophosphocholine O-acyltransferase 
activity                                    
1.61E-168 
CAL0004789 4.69 Uncharacterized ORF                                         3.99E-78 
CAL0002550 4.67 Predicted zinc-finger protein  1.00E-300 
CAL0000151 4.66 Predicted zinc-finger protein  4.92E-20 
CAL0004952 4.66 Uncharacterized ORF  1.82E-77 
CAL0000028 4.65 Putative RNA-binding protein                        2.42E-126 
CAL0003637 4.62 Uncharacterized ORF                                         1.00E-300 
CAL0002630 4.61 Putative mitochondrial translation initiation factor     1.00E-300 
CAL0005203 4.60 Putative GPI-anchored protein                                      2.05E-13 
CAL0001515 4.60 Uncharacterized ORF  8.01E-39 
CAL0003797 4.55 Amino acid permease  1.70E-255 
CAL0005710 4.52 Putative transporter                        5.69E-29 
CAL0002049 4.51 Putative mitochondrial carrier protein        1.01E-258 
CAL0003166 4.40 Putative vacuolar protease  1.00E-300 
CAL0000858 4.38 Uncharacterized ORF  1.99E-22 
CAL0003697 4.37 Putative mitochondrial membrane protein 1.00E-300 
CAL0005633 4.37 Uncharacterized ORF; Putative transcription factor with zinc finger 
DNA-binding motif; Hap43p-induced                                
4.56E-59 
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CAL0000188 4.35 Plasma-membrane-localized protein; filament induced, hypoxia-
induced             
1.64E-200 
CAL0005320 4.35 Uncharacterized ORF                                         2.33E-50 
CAL0005583 4.35 Uncharacterized ORF                                         5.76E-64 
CAL0000430 4.35 Putative mitochondrial translation elongation factor                                  1.00E-300 
CAL0002964 4.34 Protein involved in nuclear membrane fusion during karyogamy 4.06E-06 
CAL0001309 4.34 Uncharacterized ORF 3.66E-62 
CAL0000374 4.33 Putative protein of GPI synthesis   1.09E-48 
CAL0000782 4.31 Uncharacterized ORF; Putative Pol protein of retrotransposon Tca2  1.00E-300 
CAL0000285 4.29 Uncharacterized ORF                                         1.27E-42 
CAL0002139 4.29 Uncharacterized ORF                                         3.58E-47 
CAL0002992 4.28 Uncharacterized ORF; Basic amino acid permease  1.37E-116 
CAL0003611 4.21 Uncharacterized ORF; Hap43p-repressed gene                                       6.26E-13 
CAL0001720 4.16 Ribosomal protein of the large subunit, mitochondrial  1.00E-300 
CAL0000808 4.16 Protein similar to isoleucyl-tRNA synthetase  1.00E-300 
CAL0000715 4.13 Plasma membrane protein of heme-iron utilization  2.42E-17 
CAL0001591 4.12 Protein has role in mitotic spindle positioning  6.88E-75 
CAL0005579 4.10 Uncharacterized ORF  1.03E-29 
CAL0120984 4.10 Uncharacterized ORF  2.08E-18 
CAL0000023 4.10 Uncharacterized ORF; transcription is induced upon yeast-hyphal 
transition                 
2.58E-84 
CAL0001478 4.09 Uncharacterized ORF                               1.05E-261 
CAL0000709 4.08 Basic amino acid permease  2.18E-49 
CAL0001283 4.08 ALS family protein 1.12E-65 
CAF0007422 4.05 Putstive role in mitochondrial genome maintenance and integral to 
mitochondrial inner membrane localization                           
2.99E-226 
CAF0006931 4.02 Uncharacterized ORF                                         1.10E-15 
CAL0006161 3.99 Protein induced upon induction of hyphal growth  2.75E-212 
CAL0001294 3.97 Uncharacterized ORF 5.57E-23 
CAL0004745 3.95 Purine-cytosine permease of pyrimidine salvage  2.08E-205 
CAL0001919 3.89 Uncharacterized ORF                                         3.38E-144 
CAL0003673 3.89 Uncharacterized ORF  1.90E-113 
CAL0002117 3.88 Transcriptional regulator of the CTR1 copper transporter 4.59E-94 
CAL0003035 3.86 NADPH oxidoreductase  3.22E-42 
CAL0004790 3.86 Uncharacterized ORF  6.21E-15 
CAL0000929 3.86 Uncharacterized ORF        6.30E-135 
CAL0000209 3.85 Putative transcription factor with zinc cluster DNA-binding motif  9.09E-211 
CAL0001735 3.84 Putative ribonucleoside diphosphate reductase 6.67E-120 
CAL0000390 3.82 Protein similar to mitochondrial tryptophanyl-tRNA synthetase  4.81E-161 
CAL0005937 3.81 Uncharacterized ORF                               3.22E-12 
CAL0005126 3.81 Uncharacterized ORF; Putative mitochondrial RNA polymerase                                1.00E-300 
CAL0003199 3.79 G1 cyclin; required for hyphal growth  4.01E-89 
CAL0000443 3.78 Cell wall acid trehalase  1.05E-85 
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CAL0005563 3.77 Uncharacterized ORF  1.07E-79 
CAL0004832 3.76 Ortholog(s) have ATP-dependent RNA helicase activity                    1.00E-300 
CAL0005442 3.75 Transcriptional regulator of iron-responsive genes  8.04E-149 
CAL0002996 3.74 Uncharacterized ORF                1.09E-07 
CAL0004594 3.74 Protein similar to S. cerevisiae Esc4p, which represses transposition                  4.46E-75 
CAL0002565 3.74 Putative biotin synthase, Hap43p-repressed               2.68E-38 
CAL0003435 3.73 Uncharacterized ORF  1.70E-10 
CAL0004394 3.73 Uncharacterized ORF                                         4.06E-256 
CAL0003968 3.72 Uncharacterized ORF; Hap43p-repressed gene                                       4.49E-19 
CAL0004100 3.71 Uncharacterized ORF       7.25E-73 
CAL0003188 3.69 Uncharacterized ORF                                   3.47E-37 
CAL0001087 3.68 Uncharacterized ORF  1.23E-24 
CAL0003714 3.66 Uncharacterized ORF; Hap43p-repressed gene                                       1.00E-300 
CAL0005306 3.66 Uncharacterized ORF                        1.41E-76 
CAL0001776 3.62 Uncharacterized ORF 1.80E-27 
CAL0004447 3.60 Uncharacterized ORF; Putative SH3-domain-containing protein                                      2.19E-12 
CAL0000618 3.59 GPI-anchored cell wall protein involved in hemoglobin utilization  7.08E-55 
CAL0003484 3.56 Uncharacterized ORF                                         1.16E-26 
CAL0002282 3.55 Putative ceramide hydroxylase  1.00E-300 
CAL0005948 3.54 Uncharacterized ORF                     1.02E-29 
CAL0002890 3.53 Uncharacterized ORF                                         7.30E-78 
CAL0006398 3.52 Hyphal-induced GPI-anchored cell wall protein  2.61E-30 
CAL0003880 3.50 Uncharacterized ORF                                         1.66E-31 
CAL0006303 3.50 Uncharacterized ORF                                  1.58E-56 
CAL0003338 3.49 Predicted zinc-finger protein  7.45E-52 
CAL0003133 3.49 Putative mitochondrial acidic matrix protein;  1.00E-300 
CAL0003532 3.48 Putative GPI-anchored protein; hyphal induced; Hog1p-
downregulated 
3.57E-149 
CAL0005195 3.48 Uncharacterized ORF; Predicted ORF in retrotransposon  4.82E-30 
CAL0002436 3.47 Putative prolyl-tRNA synthetase  2.12E-163 
CAL0003149 3.46 Uncharacterized ORF; Hap43p-induced gene 1.33E-26 
CAL0003984 3.45 Putative DNA damage checkpoint protein 6.29E-26 
CAL0005876 3.45 Putative peptide:N-glycanase  1.83E-160 
CAL0001213 3.44 Putative serine/threonine protein kinase                       5.97E-162 
CAL0002156 3.42 Uncharacterized ORF                                   5.50E-37 
CAL0000393 3.42 Uncharacterized ORF                               3.18E-59 
CAL0002229 3.40 Uncharacterized ORF                                         1.17E-24 
CAL0000351 3.40 Uncharacterized ORF                                     7.70E-32 
CAL0002383 3.38 Uncharacterized ORF                                         2.55E-15 
CAL0005700 3.38 Putative polysome-associated RNA binding protein                         1.08E-32 
CAL0002283 3.36 NAD(P)H oxidoreductase family protein; induced by nitric oxide 9.23E-62 
CAL0003705 3.36 Similar to CCAAT-binding transcription factor that regulates 
respiration  
4.38E-14 
Table A-5 continued 
130 
 
 
Gene ID 
 
Fold up-
regulated 
 
Function                     
 
P-value 
CAL0002467 3.36 Uncharacterized ORF                             7.50E-48 
CAL0006315 3.35 Uncharacterized ORF          8.70E-37 
CAL0000807 3.33 Putative adhesin-like protein                                      4.28E-49 
CAL0005323 3.31 Secreted lipase  2.06E-13 
CAL0002540 3.28 Putative zinc cluster protein  8.99E-95 
CAL0004624 3.28 Putative GPI-anchored protein  7.99E-51 
CAL0004933 3.27 Immunogenic stress-associated protein; regulated by filamentous 
growth  
4.09E-59 
CAL0005593 3.27 Putative mitochondrial protein with a predicted role in respiratory 
growth  
1.00E-300 
CAL0005544 3.26 Uncharacterized ORF                                         6.18E-57 
CAL0003073 3.26 Dubious ORF; Protein induced by nitric oxide                   2.14E-11 
CAL0001524 3.24 Ribonucleotide reductase large subunit; regulated by Sef1p, Sfu1p, 
and Hap43p          
1.00E-300 
CAL0002799 3.22 Putative vacuolar transporter of large neutral amino acids            1.10E-76 
CAL0004709 3.22 Protein with predicted role in beta-1,6-glucan synthesis  2.49E-123 
CAL0000422 3.22 Cytochrome oxidase assembly protein  1.00E-300 
CAL0003007 3.22 Mitochondrial methionyl-tRNA synthetase   2.67E-118 
CAL0000621 3.22 Putative processing peptidase  4.83E-224 
CAL0005145 3.21 Uncharacterized ORF  3.18E-122 
CAL0005785 3.21 Predicted Zn2-Cys6 zinc-finger protein       1.13E-197 
CAL0006202 3.21 Putative MFS transporter  4.08E-31 
CAL0006237 3.20 Uncharacterized ORF                                         2.57E-44 
CAL0003627 3.19 Lanosterol 14-alpha-demethylase; hypoxia regulated             1.00E-300 
CAL0001075 3.17 Uncharacterized ORF  1.75E-91 
CAL0000906 3.17 Transcriptional repressor; required for white-phase cell type; hyphal 
growth, metabolism, cell-wall gene regulator  
1.83E-289 
CAL0003631 3.17 Putative exodeoxyribonuclease 7.36E-191 
CAL0001968 3.16 Uncharacterized ORF  2.18E-197 
CAF0006940 3.16 Uncharacterized ORF                              6.42E-05 
CAL0001860 3.16 Uncharacterized ORF                   0.00063809 
CAL0003614 3.15 Uncharacterized ORF; Hap43p-induced gene                                       1.04E-32 
CAL0005303 3.15 Uncharacterized ORF      5.27E-35 
CAL0001656 3.15 Protein similar to Ste3p, the receptor for a-factor mating pheromone     1.06E-12 
CAL0004994 3.15 Uncharacterized ORF; Hap43p-induced gene                                       1.34E-48 
CAL0006312 3.14 Putative DNA mismatch repair factor  1.30E-39 
CAL0004031 3.14 Protein similar to S. cerevisiae Smc3p, which is an  6.03E-74 
CAL0001744 3.13 Heat shock protein 1.00E-300 
CAL0000721 3.13 Putative urea permease  7.34E-22 
CAL0003557 3.13 Uncharacterized ORF; Protein of major facilitator superfamily  2.26E-95 
CAL0003896 3.13 Putative cell wall integrity and stress response subunit 4 precursor  1.34E-73 
CAL0005933 3.12 Uncharacterized ORF  1.00E-300 
CAL0000997 3.12 Uncharacterized ORF                                         3.06E-28 
CAL0004675 3.11 component of RNA polymerase II holoenzyme 1.15E-53 
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CAL0004339 3.11 Uncharacterized ORF  5.06E-16 
CAL0001963 3.10 Uncharacterized ORF  1.78E-193 
CAL0001123 3.10 Putative integral inner mitochondrial membrane protein  2.10E-176 
CAL0003443 3.10 Uncharacterized ORF                                         2.35E-264 
CAL0001036 3.10 Protein involved in regulation of DNA-damage-induced filamentous 
growth 
4.42E-137 
CAL0003069 3.09 Uncharacterized ORF                                         5.21E-09 
CAL0003834 3.09 High-affinity iron permease  1.00E-300 
CAL0004027 3.08 Sphingolipid delta-8 desaturase 5.54E-82 
CAL0005069 3.08 Uncharacterized ORF  3.53E-98 
CAL0006272 3.08 Acyl CoA:sterol acyltransferase  1.05E-60 
CAL0005620 3.07 Uncharacterized ORF 2.46E-09 
CAL0004064 3.06 Uncharacterized ORF  7.85E-13 
CAL0002008 3.06 Uncharacterized ORF                                         0.000116314 
CAL0003082 3.06 Uncharacterized ORF                                         3.06E-13 
CAL0006390 3.06 Uncharacterized ORF; Hap43p-induced gene                                       4.15E-89 
CAL0002724 3.05 Protein member of a family encoded by FGR6-related genes  5.13E-11 
CAL0005805 3.05 Uncharacterized ORF; Hap43p-repressed gene                                       3.63E-16 
CAL0001145 3.05 Uncharacterized ORF  4.48E-05 
CAL0006305 3.05 Uncharacterized ORF; Protein involved in mismatch repair  5.44E-223 
CAL0001687 3.04 Uncharacterized ORF                                         4.88E-10 
CAL0004368 3.04 Member of a family encoded by FGR6-related genes  5.31E-19 
CAL0004107 3.04 Uncharacterized ORF; Ortholog(s) have ATPase activator activity  1.00E-300 
CAL0005580 3.04 Uncharacterized ORF; Ortholog(s) have metallochaperone activity 5.44E-100 
CAL0002835 3.04 Verified ORF; Putative ammonium transporter  9.19E-166 
CAL0004999 3.04 Uncharacterized ORF  2.75E-19 
CAL0001931 3.04 Uncharacterized ORF                                         1.91E-06 
CAL0000652 3.03 Uncharacterized ORF; Hap43p-induced gene                                       5.60E-146 
CAL0006262 3.03 Uncharacterized ORF                                         1.33E-125 
CAL0006204 3.03 Putative Ribonuclease H (RNAse H); hyphal-induced 9.71E-123 
CAL0005519 3.03 Ste20p family Ser/Thr kinase required for wild-type filamentous 
growth 
1.26E-128 
CAL0000884 3.03 Uncharacterized ORF  2.68E-11 
CAL0000324 3.02 Predicted zinc ion binding activity                                 1.15E-119 
CAL0005767 3.01 Dubious ORF                                         3.42E-07 
CAL0004443 3.00 Uncharacterized ORF 1.00E-300 
CAL0003193 3.00 Uncharacterized ORF                                         3.39E-28 
CAL0001534 3.00 Uncharacterized ORF;Hap43p-repressed gene                                  1.52E-29 
CAL0001655 3.00 Uncharacterized ORF                                         1.43E-81 
CAL0002184 2.99 Putative glucose-6-phosphate isomerase 1.00E-300 
CAL0003671 2.99 Uncharacterized ORF  1.83E-48 
CAL0005558 2.99 Uncharacterized ORF 2.26E-20 
CAL0005696 2.98 Uncharacterized ORF 2.70E-292 
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CAL0000561 2.98 Uncharacterized ORF                                         8.86E-102 
CAL0002790 2.98 Uncharacterized ORF; Has domain(s) with predicted structural 
molecule activity                                  
1.00E-300 
CAL0006337 2.97 Ammonium permease  7.51E-137 
CAL0003251 2.97 Uncharacterized ORF                                         1.31E-94 
CAL0003161 2.97 Protein required for virulence in reconstituted human epithelium 
(RHE) model of ex vivo infection             
5.59E-70 
CAL0005031 2.97 Uncharacterized ORF  6.81E-35 
CAL0004892 2.96 Uncharacterized ORF; Hap43p-repressed gene                                       1.66E-09 
CAL0002431 2.96 Putative DNA directed DNA polymerase alpha      4.78E-224 
CAL0002878 2.96 Member of a family encoded by FGR6-related genes 5.84E-27 
CAL0001746 2.95 Putative RNA polymerase I subunit  1.53E-39 
CAL0000369 2.95 Protein involved in telomere maintenance  7.87E-09 
CAL0004072 2.94 Uncharacterized ORF                                         3.88E-10 
CAL0005941 2.94 Putative Argonaute protein involved in RNA silencing  6.07E-164 
CAL0120845 2.94 Uncharacterized ORF                                         0.0526201 
CAL0001396 2.93 Predicted acyl-CoA oxidase 2.03E-59 
CAL0001936 2.93 Putative homeodomain-containing transcriptional repressor     7.49E-65 
CAL0006244 2.93 Uncharacterized ORF                                         1.67E-37 
CAL0000499 2.93 Uncharacterized ORF  1.26E-113 
CAL0003229 2.92 Putative multidrug resistance protein; upregulated by Efg1p                                  3.33E-34 
CAL0001481 2.92 Protein similar to S. cerevisiae Smc5p, which is involved in DNA 
repair             
6.44E-96 
CAL0004412 2.92 Putative GPI-anchored protein                                      3.40E-15 
CAL0001158 2.92 Aldo-keto reductase family member  3.95E-39 
CAL0006363 2.91 Uncharacterized ORF                                         6.27E-15 
CAL0004048 2.91 Component of the general transcription factor for RNA polymerase 
III                    
8.26E-78 
CAL0003781 2.91 Putative transcription factor 1.00E-300 
CAL0005187 2.91 Heme oxygenase 9.54E-218 
CAL0004987 2.91 Uncharacterized ORF; Hap43p-repressed gene                                       1.74E-108 
CAL0000244 2.91 Putative oligopeptide transporter  1.00E-300 
CAL0003239 2.91 Ortholog(s) have rRNA (guanine-N1-)-methyltransferase activity  1.37E-152 
CAL0001295 2.91 Uncharacterized ORF; Hap43p-repressed gene                                       1.46E-13 
CAL0003154 2.91 Verified ORF; Hap43p-repressed gene                           1.73E-43 
CAL0000464 2.91 Uncharacterized ORF 2.03E-145 
CAL0000614 2.91 Ferric reductase 1.38E-08 
CAL0003304 2.90 Uncharacterized ORF  5.35E-36 
CAL0004977 2.90 Uncharacterized ORF                                         2.56E-63 
CAL0003638 2.90 Uncharacterized ORF                                         2.96E-185 
CAL0003737 2.90 Uncharacterized ORF  1.00E-300 
CAL0001318 2.89 Uncharacterized ORF               0.00284226 
CAL0003641 2.89 Uncharacterized ORF 1.00E-300 
CAL0000780 2.89 Putative Gag protein of retrotransposon Tca2  8.01E-234 
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CAL0001380 2.88 Uncharacterized ORF                                         3.33E-24 
CAL0003370 2.87 Protein similar to beta-1,3-glucan synthase  3.64E-59 
CAL0000729 2.87 Uncharacterized ORF                                         2.41E-100 
CAL0001169 2.86 Uncharacterized ORF 1.84E-105 
CAL0005779 2.86 Putative mismatch repair protein  2.15E-21 
CAL0005652 2.86 Uncharacterized ORF  8.21E-31 
CAL0002712 2.86 Uncharacterized ORF; Major facilitator superfamily protein  6.86E-53 
CAL0002807 2.85 Uncharacterized ORF                                 2.52E-56 
CAL0000075 2.85 A subunit of the mitochondrial inner membrane m-AAA protease 1.00E-300 
CAL0006245 2.85 Uncharacterized ORF; Hap43p-repressed gene                                       1.38E-11 
CAL0005653 2.84 Protein mannosyltransferase with roles in hyphal growth 1.00E-300 
CAL0001828 2.84 Heat shock protein          1.00E-300 
CAL0000273 2.83 Uncharacterized ORF                                         4.35E-62 
CAL0005752 2.83 Putative nicotinic acid mononucleotide adenylyltransferase 9.50E-154 
CAL0006182 2.83 Uncharacterized ORF                                         1.95E-79 
CAL0003874 2.83  Putative GPI-anchored protein  7.66E-23 
CAL0000890 2.83 Uncharacterized ORF  5.05E-24 
CAL0005385 2.82 Uncharacterized ORF                                         2.93E-90 
CAL0005976 2.82 Uncharacterized ORF  2.14E-49 
CAL0003619 2.82 Putative fructose-bisphosphate aldolase, enzyme of glycolysis  1.00E-300 
CAL0002087 2.81 Uncharacterized ORF  6.44E-10 
CAL0001215 2.81 Zn2-Cys6 transcription factor; regulates iron uptake  1.52E-64 
CAL0004463 2.81 Uncharacterized ORF; Hap43p-induced gene           1.74E-42 
CAL0001117 2.81 Uncharacterized ORF                                         1.50E-11 
CAL0000116 2.81 Uncharacterized ORF  1.00E-300 
CAL0000955 2.80 Uncharacterized ORF  1.59E-44 
CAL0000429 2.80 Uncharacterized ORF                                         7.82E-42 
CAL0001753 2.80 Uncharacterized ORF  5.80E-46 
CAL0000811 2.80 Role in mitochondrial translation and mitochondrial inner membrane 
localization                              
9.26E-46 
CAL0005560 2.79 Protein mannosyltransferase required for normal cell wall 
composition  
1.00E-300 
CAL0002663 2.79 Protein required for chlamydospore formation 1.07E-133 
CAL0003196 2.79 Uncharacterized ORF                           1.00E-300 
CAL0005365 2.79 Putative RNA-binding protein 2.54E-126 
CAL0001139 2.78 Uncharacterized ORF                                         1.95E-42 
CAL0002874 2.78 Uncharacterized ORF                            5.03E-74 
CAL0001080 2.77 Uncharacterized ORF  2.80E-100 
CAL0002245 2.77 Ribonucleoside-diphosphate reductase  1.00E-300 
CAL0005977 2.77 Pyruvate kinase 1.00E-300 
CAL0000180 2.77 Uncharacterized ORF; Putative mRNA maturation factor  1.00E-300 
CAL0002758 2.77 Uncharacterized ORF  1.62E-56 
CAL0002127 2.76 Uncharacterized ORF  9.41E-173 
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CAL0003243 2.76 Uncharacterized ORF  1.10E-33 
CAL0000402 2.76 Putative dynamin-related GTPase  2.76E-251 
CAL0001564 2.76 Uncharacterized ORF; Hap43p-repressed gene                               2.13E-61 
CAL0001595 2.76 Class V myosin  1.00E-300 
CAL0004060 2.76 Uncharacterized ORF  1.01E-99 
CAL0006036 2.76 Putative dicarboxylic amino acid permease; upregulated by 
Rim101p  
1.00E-300 
CAL0006143 2.75 Predicted membrane transporter  2.47E-39 
CAL0001981 2.75 Ortholog(s) have role in vacuole organization, endocytosis,  1.73E-59 
CAL0005901 2.75 Glucosaminyl-phosphotidylinositol O-acyltransferase activity, role in 
GPI anchor biosynthetic process  
6.90E-99 
CAL0000530 2.75 Putative beta-mannosyltransferase 5.03E-117 
CAL0004042 2.74 Protein required for normal filamentous growth                               5.78E-69 
CAL0000873 2.74 Putative transcription factor with zinc finger DNA-binding motif  5.59E-24 
CAL0004669 2.74 Uncharacterized ORF; tubulin-dependent ATPase activity                           1.27E-58 
CAL0003055 2.74 Phosphofructokinase alpha subunit 1.00E-300 
CAL0004069 2.74 Putative thiamin-phosphate pyrophosphorylase  2.36E-40 
CAL0000385 2.73 Uncharacterized ORF; oxidoreductase activity  3.47E-116 
CAL0000486 2.73 Uncharacterized ORF                                         1.93E-64 
CAL0001160 2.73 Putative phospholipase B  3.58E-12 
CAL0001319 2.73 Putative fatty acid elongase with a predicted role in sphingolipid 
biosynthesis           
1.62E-116 
CAL0004557 2.73 Putative dihydroxyacetone kinase  1.00E-300 
CAL0003940 2.72 Uncharacterized ORF 1.69E-17 
CAL0001136 2.72 Putative mitochondrial carrier protein  1.00E-300 
CAL0000969 2.71 Uncharacterized ORF 1.51E-80 
CAL0001865 2.71 Putative mitochondrial large subunit ribosomal protein           2.79E-137 
CAL0002507 2.70 Uncharacterized ORF; Role in osmosensory signaling pathway  9.99E-47 
CAL0002602 2.70 Uncharacterized ORF                                         1.00E-300 
CAL0000712 2.70 Ammonium permease and regulator of nitrogen starvation-induced 
filamentation  
5.14E-23 
CAL0000720 2.70 Uncharacterized ORF  1.00E-300 
CAL0000861 2.69 Uncharacterized ORF; Putative GINS complex subunit  4.92E-12 
CAL0006048 2.69 Uncharacterized ORF 7.06E-92 
CAL0005024 2.69 Lysine histone methyltransferase 1.02E-64 
CAL0000842 2.69 Predicted membrane transporter  3.45E-40 
CAL0005453 2.68  Ortholog(s) have metalloendopeptidase activity  3.56E-183 
CAL0004828 2.68 Protein involved in regulation of filamentous growth and virulence  3.36E-163 
CAL0006276 2.68 Ortholog(s) have role in mitochondrial translation and localization                                1.00E-300 
CAL0002488 2.68 Uncharacterized ORF; Hap43p-repressed gene; gene induced by 
hypoxia                             
2.66E-17 
CAL0002211 2.68 Uncharacterized ORF; Hap43p-induced gene  1.49E-62 
CAL0005516 2.67 Possible regulatory protein; putative adhesin-like protein;  3.46E-87 
CAL0004799 2.67 Uncharacterized ORF; Hap43p-repressed gene  6.91E-07 
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CAL0003178 2.67 Uncharacterized ORF                                         1.78E-19 
CAL0003761 2.66 Uncharacterized ORF                                         9.98E-21 
CAL0004810 2.66 Uncharacterized ORF                              6.82E-274 
CAL0001202 2.66 Dubious ORF                                         0.00734558 
CAL0006399 2.66 Uncharacterized ORF  7.21E-40 
CAL0004281 2.66 Putative transcription factor with zinc finger DNA-binding motif  2.34E-34 
CAL0001498 2.66 Putative glucose transporter of the major facilitator superfamily  2.58E-22 
CAL0004071 2.66 Uncharacterized ORF; Stationary phase enriched protein  3.43E-51 
CAL0003878 2.65 Uncharacterized ORF  8.94E-73 
CAL0005112 2.65 Protein member of a family encoded by FGR6-related genes  1.79E-14 
CAF0006928 2.64 Uncharacterized ORF                      3.49E-18 
CAL0000249 2.64 Predicted zinc-finger protein                                      4.55E-08 
CAL0003703 2.64 Protein required for damage to oral epithelial cells and for normal 
hyphal growth and stress resistance  
0.000649097 
CAL0000703 2.64 Uncharacterized ORF; Hap43p-repressed gene;  2.47E-43 
CAL0004889 2.64 Uncharacterized ORF                                         1.37E-48 
CAL0002334 2.63 Putative RNA binding protein  3.14E-39 
CAL0003255 2.63 Putative structural maintenance of chromosomes protein; Hap43p-
induced gene  
5.18E-99 
CAL0006010 2.63 Uncharacterized ORF                                         2.51E-55 
CAL0001166 2.62 Uncharacterized ORF; Protein of RGS superfamily  6.31E-10 
CAL0005675 2.62 Role in DNA repair, replication fork arrest  3.32E-72 
CAL0004934 2.62 Dubious ORF                                         0.0259515 
CAL0002933 2.61 Transcriptional repressor; regulator of filamentation 1.63E-23 
CAL0005764 2.61 Uncharacterized ORF                    5.27E-56 
CAL0004575 2.61 Corticosteroid binding protein  3.75E-260 
CAL0005537 2.61 Cyclin homolog  4.73E-32 
CAL0004555 2.61 Uncharacterized ORF; Ortholog(s) have protein kinase activator 
activity                                   
1.00E-36 
CAL0005055 2.61 Putative flavodoxin  3.91E-83 
CAL0003249 2.60 Membrane insertase activity and role in protein insertion into 
mitochondrial membrane from inner side  
1.00E-300 
CAL0001985 2.60 Putative ceramide hydroxylas; regulated by iron  1.62E-278 
CAL0000894 2.60 Probable protein kinase involved in determination of morphology 
during the cell cycle of both yeast-form and hyphal cells  
4.19E-135 
CAL0005058 2.60 Uncharacterized ORF                                         9.22E-60 
CAL0000375 2.60 Thioredoxin reductase  1.00E-300 
CAL0004518 2.59 Putative mitochondrial biogenesis protein  4.95E-169 
CAL0004521 2.59 Predicted membrane transporter  2.20E-13 
CAL0000796 2.59 Rab guanyl-nucleotide exchange factor activity 2.13E-95 
CAL0003227 2.59 Similar to Rab GTPase activators; Hap43p-induced gene                                  1.14E-45 
CAL0000134 2.59 Putative high-affinity glutamine permease  1.32E-24 
CAL0000846 2.58 Uncharacterized ORF                      1.04E-25 
CAL0005338 2.58 Uncharacterized ORF; GTPase activity                       9.68E-103 
CAL0001987 2.58 Uncharacterized ORF                                 2.25E-144 
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CAL0000863 2.58 Uncharacterized ORF  1.21E-79 
CAL0000816 2.58 Uncharacterized ORF; Putative tRNA-Pro synthetase  4.84E-212 
CAL0005944 2.58 Dubious ORF                                         0.000959105 
CAL0004026 2.58 Chitin synthase  6.85E-74 
CAL0001441 2.58 ALS family cell-surface glycoprotein  7.25E-32 
CAL0003151 2.57 Dubious ORF                                         0.0032933 
CAL0001245 2.57 Plasma membrane protein; negatively regulated by Rim101p                 1.28E-81 
CAL0002662 2.57 Uncharacterized ORF; ubiquitin-protein ligase activity  1.94E-160 
CAL0004490 2.57 Cytochrome oxidase assembly protein  3.76E-187 
CAL0120672 2.56 Uncharacterized ORF                                         8.49E-08 
CAL0003502 2.56 Uncharacterized ORF                   2.07E-49 
CAL0003947 2.56 Uncharacterized ORF; Hap43p-induced gene                                       3.11E-23 
CAL0005202 2.56 Putative pyruvate decarboxylase  1.00E-300 
CAL0004148 2.55 Putative mannosyltransferase  6.07E-122 
CAL0002787 2.55 Uncharacterized ORF; L-glutamate transmembrane transporter 
activity  
1.39E-72 
CAL0001575 2.55 Putative termination and polyadenylation protein  1.06E-161 
CAL0003828 2.55 Secretory protein  1.25E-64 
CAL0004938 2.55 Uncharacterized ORF  7.05E-09 
CAL0005685 2.55 C-14 sterol reductase                     3.54E-166 
CAL0001578 2.55 Uncharacterized ORF; mitochondrion localization                                     4.04E-68 
CAL0005823 2.55 Uncharacterized ORF                                         2.06E-27 
CAL0006186 2.54 Mannosyltransferase  2.31E-09 
CAL0004577 2.54 Putative copper transporter; Hap43p-repressed gene                                    1.20E-252 
CAL0004586 2.54 Uncharacterized ORF                                         3.86E-152 
CAL0002917 2.54 Uncharacterized ORF  6.40E-171 
CAL0000278 2.54 Manganese transporter required for normal filamentous growth  2.01E-213 
CAL0004816 2.54 Uncharacterized ORF; DNA-directed DNA polymerase activity  9.16E-30 
CAL0000616 2.54 possible GPI-anchor; induced by Rim101p, cell wall regeneration-
induced  
6.51E-06 
CAL0005541 2.54 Squalene epoxidase  1.00E-300 
CAL0001313 2.53 Uncharacterized ORF  4.40E-233 
CAL0002789 2.53 ALS family protein  1.27E-77 
CAL0006287 2.53 mRNA-binding protein that localizes specific mRNAs to daughter 
yeast-form cells and to hyphal tips  
4.38E-171 
CAL0005009 2.53 Uncharacterized ORF                                         9.14E-26 
CAL0006342 2.53 Protein similar that affects filamentous growth; Hap43p-repressed 
gene                            
5.08E-62 
CAL0000015 2.53 Putative role in regulation of mitochondrion organization, signal 
peptide processing and mitochondrial inner membrane localization                      
6.15E-155 
CAL0006191 2.53 Putative protein with a predicted role in establishment and 
maintenance of sister chromatid condensation and cohesion 
1.62E-88 
CAL0001119 2.53 Predicted GPI-anchor, role in 1,6-beta-D-glucan biosynthesis  1.68E-06 
CAL0002448 2.52 Amino acid permease 2.14E-85 
CAL0003398 2.52 Glucose and galactose sensor  3.36E-18 
CAL0005819 2.52 Outwardly rectifying, noisily gated potassium channel  1.67E-33 
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CAL0004120 2.52 Uncharacterized ORF; Hap43p-repressed gene                                       6.54E-05 
CAL0003218 2.52 Uncharacterized ORF                        8.31E-10 
CAF0006965 2.52 flavin-linked sulfhydryl oxidase activity and role in cellular iron ion 
homeostasis  
2.11E-74 
CAL0005524 2.51 Uncharacterized ORF                                         3.71E-27 
CAL0005657 2.51 NAD-linked glyceraldehyde-3-phosphate dehydrogenase  1.00E-300 
CAL0006044 2.51 Uncharacterized ORF                                         4.04E-47 
CAL0004468 2.51 Enzyme regulator involved in phospholipid metabolism  3.92E-36 
CAL0004875 2.51 GABA/polyamine transporter  1.32E-07 
CAL0000727 2.51 Cysteine transporter                                1.10E-76 
CAL0000173 2.50 Uncharacterized ORF; Hap43p-induced gene                                       1.85E-20 
CAL0004672 2.50 Uncharacterized ORF                              1.70E-75 
CAL0001047 2.50 Uncharacterized ORF 1.10E-32 
CAL0005999 2.50 Subunit of beta-1,3-glucan synthase  1.00E-300 
CAL0000350 2.50 Transcription factor that positively regulates rRNA and ribosomal 
protein gene transcription                  
4.65E-73 
CAL0000093 2.50 Dubious ORF                                         7.39E-07 
CAL0001239 2.50 Transcriptional activator, required for hyphal growth                     5.25E-44 
CAF0006924 2.49 Uncharacterized ORF  2.99E-39 
CAL0003261 2.49 Putative endosomal transmembrane protein; Hap43p-induced  3.25E-65 
CAL0003907 2.49 Uncharacterized ORF                                         1.17E-49 
CAL0005775 2.49 Uncharacterized ORF  4.44E-24 
CAL0006074 2.49 Uncharacterized ORF                                         2.33E-13 
CAL0003275 2.49 Putative SH3-domain-containing protein  7.87E-126 
CAL0005141 2.49 Uncharacterized ORF  3.69E-32 
CAL0001241 2.49 Putative pre-replication complex helicase subunit  3.04E-61 
CAL0005040 2.48 Uncharacterized ORF  2.70E-44 
CAL0003148 2.48 Putative mitochondrial lysine-tRNA synthetase                                  1.06E-88 
CAL0003431 2.48 Putative glucose transporter of the major facilitator superfamily  2.73E-15 
CAL0000304 2.48 Putative GPI-anchored protein  7.07E-99 
CAL0002655 2.48 Uncharacterized ORF  0.00136654 
CAL0003029 2.48 Protein member of conserved Mcm1p regulon  3.46E-67 
CAL0004231 2.48 Uncharacterized ORF; Ortholog(s) have role in invasive growth in 
response to glucose limitation  
3.51E-155 
CAL0005986 2.47 Mitochondrial 60S ribosomal protein subunit; Hap43p-repressed 
gene                                  
1.00E-300 
CAL0005745 2.47 Putative PDR-subfamily ABC transporter  2.79E-87 
CAL0004733 2.47 Uncharacterized ORF   5.08E-45 
CAL0005199 2.47 DNA topoisomerase II 9.72E-177 
CAL0004882 2.47 Uncharacterized ORF                      0.00010797 
CAL0003260 2.47 Putative iron transporter                                 4.51E-52 
CAL0005204 2.47 Putative GPI-anchored protein  9.63E-23 
CAL0005038 2.47 Uncharacterized ORF  5.93E-21 
CAL0002525 2.47 Uncharacterized ORF  9.34E-24 
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CAL0002687 2.46 Protein kinase involved in growth control, normal cell size, prevents 
hypha formation under hypoxia at high CO2 levels         
1.78E-56 
CAL0004874 2.46 Putative transcription factor with zinc finger DNA-binding motif; 
Hap43p-repressed gene                               
6.59E-25 
CAL0001311 2.46 Putative serine transporter with possible role in assimilation of sulfur  4.74E-21 
CAL0001054 2.46 Autophosphorylated kinase  7.72E-151 
CAL0004706 2.46 Uncharacterized ORF                       3.55E-44 
CAL0005239 2.46 Uncharacterized ORF  8.80E-36 
CAL0002321 2.46 Uncharacterized ORF  1.74E-34 
CAL0000889 2.46 Amino acid permease  5.54E-185 
CAL0004778 2.46 Putative subunit of the Nucleotide Excision Repair Factor 4  2.23E-46 
CAL0001514 2.45 Dubious ORF  0.0572537 
CAL0002494 2.45 Putative DNA replication protein  8.61E-128 
CAL0002812 2.45 Uncharacterized ORF  1.00E-300 
CAL0006175 2.45 Uncharacterized ORF  8.12E-168 
CAL0004826 2.45 Uncharacterized ORF  2.97E-78 
CAL0000957 2.45 Uncharacterized ORF                                         3.31E-47 
CAF0006932 2.45 Putative copper metallochaperone  7.48E-37 
CAL0005042 2.45 Polo-like kinase  1.17E-195 
CAL0001758 2.45 Putative methionyl-tRNA transformylase  1.73E-38 
CAL0000546 2.44 Verified ORF; Putative calcium-transporting ATPase                                      1.00E-300 
CAL0003256 2.44 Putative sensor/transporter protein with a predicted role in cell wall 
biogenesis  
1.51E-216 
CAL0002841 2.44 CCAAT-binding factor regulates low-iron induction of FRP1  2.06E-21 
CAL0005540 2.44 Uncharacterized ORF  1.20E-10 
CAL0005874 2.43 Uncharacterized ORF  2.64E-71 
CAL0006391 2.43 Chitinase  4.70E-36 
CAL0000087 2.43 Uncharacterized ORF                                         3.27E-14 
CAL0003574 2.42 Phosphoglycerate mutase  1.00E-300 
CAF0006926 2.42 Uncharacterized ORF                                         0.000470138 
CAL0005084 2.42 Putative mitochondrial ATP-dependent RNA helicase  1.00E-300 
CAL0002487 2.42 Putative GPI-linked phospholipase B  6.87E-27 
CAL0001448 2.42 Uncharacterized ORF  2.07E-261 
CAL0004837 2.42 Golgi membrane GDPase, required for wild-type O-mannosylation  1.89E-207 
CAL0000639 2.42 Uncharacterized ORF                                         1.61E-10 
CAL0001553 2.42 Cell wall protein; putative GPI-anchor  4.52E-194 
CAL0004016 2.41 Monopolar spindle protein, a putative kinase  8.90E-33 
CAL0001905 2.41 C-5 sterol desaturase  3.35E-168 
CAL0001962 2.41 Aldo-keto reductase family member  2.59E-78 
CAL0005794 2.41 Uncharacterized ORF                                         1.00E-300 
CAL0005800 2.41 Uncharacterized ORF                                         0.000211114 
CAL0003752 2.41 Putative transcription factor; required for resistance to cell wall 
perturbation           
1.17E-38 
CAL0004243 2.41 Uncharacterized ORF                              2.45E-59 
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CAL0002370 2.41 Putative role in heme a biosynthetic process and mitochondrion 
localization                              
1.66E-195 
CAL0005713 2.40 Uncharacterized ORF  1.50E-192 
CAL0004509 2.40 Aldo-keto reductase family protein  3.40E-38 
CAL0000363 2.40 Putative role in protein N-linked glycosylation and endoplasmic 
reticulum membrane localization                          
2.24E-10 
CAL0001854 2.40 Uncharacterized ORF                                         0.000202792 
CAL0006365 2.40 Uncharacterized ORF                                         1.86E-08 
CAL0002909 2.40 Uncharacterized ORF  1.10E-74 
CAL0003716 2.40 Uncharacterized ORF  7.58E-50 
CAL0000820 2.40 Putative cytochrome c lysine methyltransferase  4.38E-206 
CAL0002088 2.39 Uncharacterized ORF; Has domain(s) with predicted catalytic 
activity                                   
2.15E-14 
CAL0000642 2.39 Uncharacterized ORF  4.90E-30 
CAL0000542 2.39 Uncharacterized ORF                                         1.20E-68 
CAL0004598 2.39 Uncharacterized ORF                                         1.38E-28 
CAL0000099 2.39 Protein similar to S. cerevisiae Yta6p ATPase  6.86E-53 
CAL0005683 2.39 Verified ORF; Protein that affects filamentous growth  7.45E-10 
CAL0000378 2.39 Uncharacterized ORF                                         1.86E-36 
CAL0000432 2.39 Uncharacterized ORF                                         1.56E-27 
CAL0005781 2.38 Uncharacterized ORF; Has domain(s) with predicted binding activity                                   1.47E-89 
CAL0000141 2.38 Predicted zinc-finger protein  6.01E-65 
CAL0004953 2.38 Enolase, enzyme of glycolysis and gluconeogenesis  1.00E-300 
CAL0003854 2.38 Uncharacterized ORF                                         1.76E-08 
CAL0005542 2.38 Uncharacterized ORF                                         3.54E-17 
CAL0001426 2.38 ALS family adhesin  1.48E-30 
CAL0003341 2.38 Uncharacterized ORF                    8.65E-22 
CAL0001614 2.38 Uncharacterized ORF; Hap43p-induced gene                                       2.22E-22 
CAL0004511 2.38 Alpha-tubulin  1.00E-300 
CAL0000685 2.38 Putative ketol-acid reductoisomerase  1.00E-300 
CAL0003282 2.37 Uncharacterized ORF  2.07E-18 
CAL0001940 2.37 Putative mitochondrial ribosomal protein  1.26E-174 
CAL0002946 2.37 Putative mitochondrial ribosomal protein of the small subunit  4.96E-213 
CAL0005223 2.37 Putative DNA primase  3.92E-34 
CAL0003220 2.36 Uncharacterized ORF  3.69E-19 
CAL0003572 2.36 Uncharacterized ORF                                         4.52E-15 
CAL0004802 2.36 Protein with a potential role in beta-1,6 glucan biosynthesis  3.98E-10 
CAL0001279 2.36 Uncharacterized ORF  1.00E-47 
CAL0004944 2.36 Zn2-Cys6 transcriptional regulator of ergosterol biosynthetic genes 
and sterol uptake  
3.43E-145 
CAL0004434 2.36 Uncharacterized ORF  1.11E-37 
CAL0001977 2.36 Uncharacterized ORF                                         9.64E-27 
CAL0003593 2.36 Putative pyruvate decarboxylase  9.64E-09 
CAL0003799 2.36 Carboxypeptidase Y  5.21E-210 
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CAL0002735 2.36 Neutral arginine-, alanine-, leucine-specific metallo-aminopeptidase  1.00E-300 
CAL0000620 2.36 Component of actomyosin ring                                2.12E-88 
CAL0000963 2.35 Putative plasma membrane transporter of the ATP-binding cassette 
family           
2.95E-93 
CAL0006226 2.35 Uncharacterized ORF 1.82E-33 
CAL0003571 2.35 Uncharacterized ORF  1.29E-13 
CAL0000936 2.35 Cell surface mannoprotein; cell-wall glucan metabolism 1.00E-300 
CAL0004102 2.34 Predicted UDP-glucose:glycoprotein glucosyltransferase  4.40E-90 
CAL0002343 2.34 Uncharacterized ORF  1.01E-16 
CAL0002619 2.34 Uncharacterized ORF  1.19E-137 
CAL0002122 2.34 Uncharacterized ORF 3.58E-19 
CAL0004864 2.34 Na+/H+ antiporter 4.35E-109 
CAL0003540 2.34 Uncharacterized ORF  7.40E-63 
CAL0004759 2.33 Uncharacterized ORF; role in DNA replication  5.89E-68 
CAL0002588 2.33 Uncharacterized ORF                                         1.51E-35 
CAL0001055 2.33 protein channel activity and role in protein import into mitochondrial 
inner membrane, protein import into mitochondrial matrix                  
1.00E-300 
CAL0004340 2.33 Uncharacterized ORF  8.57E-248 
CAL0000130 2.33 Probable subunit of DNA polymerase II   1.69E-39 
CAL0003132 2.33 B-type mitotic cyclin  7.47E-65 
CAL0005885 2.32 Uncharacterized ORF; Ortholog(s) have 
acetylglucosaminyltransferase activity  
5.52E-43 
CAL0000041 2.32 Uncharacterized ORF; Hap43p-repressed gene                                       4.57E-14 
CAL0005930 2.32 Uncharacterized ORF  5.36E-97 
CAL0002406 2.32 Uncharacterized ORF  1.00E-300 
CAL0001496 2.32 Uncharacterized ORF; Has domain(s) with predicted binding activity                                   4.75E-43 
CAL0003323 2.32 Uncharacterized ORF  1.56E-88 
CAL0004155 2.32 Protein similar to a mitochondrial complex I intermediate-associated 
protein                              
5.58E-33 
CAL0001260 2.31 Putative mannosyltransferase; transcriptionally regulated by iron                              2.46E-11 
CAL0002772 2.31 Uncharacterized ORF  8.44E-12 
CAL0004474 2.31 Uncharacterized ORF                                         1.42E-27 
CAL0005080 2.31 Transcriptional regulator of filamentous growth and hyphal genes        4.86E-37 
CAL0002685 2.31 Uncharacterized ORF  1.71E-227 
CAL0004446 2.31 Uncharacterized ORF  0.0516619 
CAL0003287 2.31 Putative NADPH dehydrogenase 8.97E-07 
CAL0002266 2.31 Uncharacterized ORF                   3.22E-12 
CAL0005826 2.30 Uncharacterized ORF                                         9.33E-18 
CAL0002857 2.30 GATA transcription factor involved in regulation of filamentous 
growth induced by nitrogen starvation  
3.44E-59 
CAL0000800 2.30 Putative GPI-anchored protein                                      0.0184641 
CAL0005604 2.30 Uncharacterized ORF  1.46E-21 
CAL0005434 2.30 Uncharacterized ORF; Ortholog(s) have phosphatidylinositol-4-
phosphate phosphatase activity 
4.24E-85 
CAL0002875 2.30 GDP-mannose transporter  2.27E-184 
CAL0002053 2.30 Putative pre-tRNA processing protein  2.70E-63 
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CAL0004678 2.29 Uncharacterized ORF  1.64E-67 
CAL0001551 2.29  Mannosyltransferase of glycosylphosphatidylinositol (GPI) 
biosynthesis 
5.52E-24 
CAL0005455 2.29 Role in regulation of cell budding, protein monoubiquitination                               5.57E-46 
CAL0001538 2.29 Putative peroxisomal copper amine oxidase                                    4.08E-12 
CAL0005436 2.29 VH1 family MAPK phosphatase  9.47E-30 
CAL0005945 2.29 Uncharacterized ORF; Putative kinase  2.67E-41 
CAL0004988 2.29 Uncharacterized ORF                1.43E-17 
CAL0003326 2.29 Uncharacterized ORF  1.34E-32 
CAL0002941 2.29 Uncharacterized ORF                                         1.19E-19 
CAL0002636 2.29 Uncharacterized ORF  9.09E-98 
CAL0004564 2.29 Uncharacterized ORF; Putative DNA replication factor A          1.54E-197 
CAL0002777 2.29 Putative secreted aspartyl protease  0.00289642 
CAL0001352 2.29 Uncharacterized ORF  3.55E-17 
CAL0003053 2.28 Uncharacterized ORF                                         3.13E-14 
CAF0006892 2.28 Uncharacterized ORF 2.60E-28 
CAL0000595 2.28 Uncharacterized ORF  4.61E-105 
CAL0005015 2.28 Uncharacterized ORF  3.70E-60 
CAL0000101 2.28 Uncharacterized ORF; Putative heat shock protein  7.58E-42 
CAL0005740 2.28 Uncharacterized ORF  3.29E-28 
CAF0006989 2.28  Cytoplasmic protein expressed specifically in white phase yeast 
cells  
2.09E-10 
CAL0004499 2.28 Uncharacterized ORF  4.51E-15 
CAL0003800 2.28 NAD-dependent histone deacetylase  6.78E-102 
CAL0003915 2.27 1,3-beta-glucan-linked structural cell wall protein  1.82E-188 
CAL0004861 2.27 Triose-phosphate isomerase  1.00E-300 
CAL0001039 2.27 Uncharacterized ORF                       8.49E-62 
CAL0006092 2.26 Role in mitochondrial respiratory chain complex III assembly       4.79E-143 
CAL0001476 2.26 Uncharacterized ORF; Putative protein  4.20E-85 
CAL0000235 2.26 Monooxygenase of the cytochrome P450 family  6.70E-07 
CAL0000237 2.26 Uncharacterized ORF; Ortholog of <i>C. glabrata CBS138</i> : 
CAGL0C02871g                                  
2.26E-59 
CAL0003812 2.26 Uncharacterized ORF                                         2.12E-54 
CAL0004007 2.26 Uncharacterized ORF; Predicted ORF in Assemblies 19, 20 and 21; 
Hog1p-downregulated                                
3.51E-37 
CAL0004981 2.26 Putative beta-mannosyltransferase  7.94E-82 
CAL0000072 2.26 Uncharacterized ORF  7.39E-55 
CAL0001812 2.26 Uncharacterized ORF  2.04E-49 
CAL0004476 2.26 Zinc finger transcription factor  2.16E-44 
CAL0005210 2.26 Uncharacterized ORF; mitochondrion localization                         1.07E-116 
CAL0001359 2.25 Protein involved in cell polarity 7.27E-194 
CAL0000328 2.25 Uncharacterized ORF; Putative RNA-binding protein                    4.05E-148 
CAL0002621 2.25 Protein with a role in MAP kinase kinase kinase of cell integrity 
pathway 
1.42E-30 
CAL0003545 2.25 Uncharacterized ORF; role in mitochondrial fusion, mitochondrial 
genome maintenance                                
5.17E-78 
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CAL0000044 2.25 Putative glucosyltransferase involved in cell wall mannan 
biosynthesis 
2.39E-31 
CAL0006009 2.25 Uncharacterized ORF  1.62E-262 
CAL0006397 2.25 Delta(24)-sterol C-methyltransferase, converts zymosterol to 
fecosterol in ergosterol biosynthesis  
1.00E-300 
CAL0003343 2.25 Protein involved in telomere maintenance  0.00042065 
CAL0001625 2.25 Zinc cluster DNA-binding transcription factor required for wild-type 
hyphal extension  
1.34E-05 
CAL0005082 2.25 Uncharacterized ORF 1.46E-196 
CAL0005961 2.25 Putative glucokinase  1.90E-72 
CAL0004777 2.25 Putative component of the U1 snRNP, involved in splicing                         7.21E-21 
CAL0000789 2.25 Uncharacterized ORF  6.74E-05 
CAL0004347 2.24 Uncharacterized ORF; Ortholog(s) have tRNA adenylyltransferase 
activity 
1.43E-85 
CAL0001681 2.24 Uncharacterized ORF; Putative mitochondrial protein                            1.32E-32 
CAL0003512 2.24 Uncharacterized ORF                                         1.15E-19 
CAL0002825 2.24 Uncharacterized ORF; Hap43p-induced gene  9.81E-45 
CAL0000801 2.24 Uncharacterized ORF                          1.32E-18 
CAL0003486 2.24 Uncharacterized ORF  1.06E-18 
CAL0000111 2.24 Uncharacterized ORF  1.55E-20 
CAL0004238 2.24 Uncharacterized ORF; role in protein import into mitochondrial inner 
membrane  
6.37E-53 
CAL0001732 2.24 Uncharacterized ORF  3.61E-139 
CAL0004553 2.24 Uncharacterized ORF; Hap43p-repressed gene  6.44E-48 
CAL0003779 2.23 Putative transcription factor with C3HC4 zinc finger DNA-binding 
motif  
4.68E-179 
CAL0006340 2.23 Putative transcription factor with a role in colony morphology and 
virulence            
3.48E-25 
CAL0003180 2.23 Phosphofructokinase beta subunit  1.00E-300 
CAL0002570 2.23 Putative magnesium ion transporter, mitochondrial                         7.73E-34 
CAL0003790 2.23 Putative membrane transporter; Hap43p-induced gene                 7.33E-25 
CAL0005423 2.23 Uncharacterized ORF                                 3.11E-94 
CAL0002649 2.23 Uncharacterized ORF                                         9.82E-15 
CAL0006027 2.23 Protein with similarity to ferric reductases  1.82E-05 
CAL0002629 2.23 Putative Cdc7p-Dbf4p kinase complex regulatory subunit  4.38E-52 
CAL0005441 2.23 Uncharacterized ORF  1.37E-42 
CAL0004808 2.23 Protein similar Cullin-Associated Nedd8-Dissociated protein 
involved in regulation of SCF complexes       
4.93E-83 
CAL0005947 2.23 Putative GPI-anchored adhesin-like protein  0.0103604 
CAL0001554 2.23 Uncharacterized ORF; Transcriptionally regulated by iron  1.81E-77 
CAL0000270 2.23 Kinesin-like microtubule motor protein  4.35E-18 
CAL0003306 2.23 3-Keto sterol reductase of ergosterol biosynthesis  1.13E-70 
CAL0004640 2.23 Uncharacterized ORF  4.70E-38 
CAL0000537 2.23 Uncharacterized ORF                                         3.73E-116 
CAL0000549 2.22 Uncharacterized ORF  3.99E-180 
CAL0004070 2.22 Uncharacterized ORF  3.60E-14 
CAL0000444 2.22 Uncharacterized ORF  1.00E-300 
Table A-5 continued 
143 
 
 
Gene ID 
 
Fold up-
regulated 
 
Function                     
 
P-value 
CAL0000462 2.22 Catalase; resistance to oxidative stress  3.73E-246 
CAL0004647 2.22 Activator of Chs3p chitin synthase  5.33E-155 
CAL0001930 2.22 Uncharacterized ORF  1.07E-113 
CAL0000768 2.22 DNA polymerase epsilon  4.90E-70 
CAL0003016 2.22 Protein with role in resistance to host antimicrobial peptides  5.24E-257 
CAL0005175 2.22 Uncharacterized ORF  5.86E-45 
CAL0002392 2.22 Uncharacterized ORF  4.99E-17 
CAL0000668 2.22 Protein similar to ferric reductase Fre10p  8.74E-10 
CAL0004525 2.22 Uncharacterized ORF                                         2.46E-86 
CAL0004177 2.22 Uncharacterized ORF  3.74E-213 
CAL0004663 2.21 Putative allantoin permease  2.20E-08 
CAL0004305 2.21 Uncharacterized ORF  2.38E-42 
CAL0000090 2.21 Uncharacterized ORF; Putative transporter  8.32E-21 
CAL0003062 2.21  Plasma membrane-localized protein of unknown function; Hap43p-
repressed gene                                 
2.15E-37 
CAL0002010 2.21 Putative mitochondrial respiratory protein        1.33E-22 
CAL0001212 2.21 DNA binding protein with Cys2-His2 zinc-finger  2.60E-58 
CAL0005569 2.21 Putative U3 snoRNP protein 8.07E-202 
CAL0000217 2.21 Protein kinase of Ste20p/p65PAK family, required for wild-type 
mating efficiency  
7.51E-64 
CAL0005422 2.21 Protein required for chlamydospore formation 7.91E-44 
CAL0005518 2.20 Ubiquitin-activating enzyme  1.00E-300 
CAL0000415 2.20 Phosphoglycerate kinase  1.00E-300 
CAL0000516 2.20 Putative glutamate synthase  1.06E-267 
CAL0005212 2.20 Putative patatin-like phospholipase  9.64E-10 
CAL0004496 2.20 Dubious ORF                                         0.0828716 
CAL0001593 2.20  Phosphoacetylglucosamine mutase                                1.15E-83 
CAL0000849 2.20 Putative GPI-anchored protein  1.76E-19 
CAL0005623 2.20 Putative bud formation and morphogenesis protein 3.27E-34 
CAL0005443 2.20 Uncharacterized ORF  7.29E-102 
CAL0005185 2.20 Essential protein with similarity to S. cerevisiae Cdc13p, involved in 
telomere maintenance                             
1.43E-21 
CAL0001227 2.20 Uncharacterized ORF                                         1.99E-05 
CAL0004414 2.20 Putative diacylglycerol kinase activity  3.90E-57 
CAL0001388 2.19 Member of RNase L inhibitor (RLI) subfamily of ABC family             3.79E-233 
CAL0002640 2.19 Putative mannoprotein of cell wall with role in response to stress  6.51E-32 
CAL0005578 2.19 Uncharacterized ORF                                         0.000351824 
CAL0005862 2.19 Endoplasmic reticulum (ER) protein-translocation complex subunit                                   7.82E-219 
CAL0005255 2.19 Uncharacterized ORF  6.29E-14 
CAF0007077 2.19 Putative nuclear protein                 1.28E-15 
CAL0002673 2.19 Uncharacterized ORF; Similar to thioredoxins 0.00722364 
CAL0003775 2.19 Cell wall protein, regulated by Sef1p, Sfu1p, Hap43p              3.44E-64 
CAL0003698 2.19 Uncharacterized ORF                                         4.04E-21 
CAL0004726 2.19 Uncharacterized ORF  1.40E-170 
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CAL0000338 2.19 Ortholog(s) have structural constituent of ribosome activity and 
mitochondrial large ribosomal subunit localization                            
1.55E-256 
CAL0003091 2.18 Uncharacterized ORF  1.01E-13 
CAL0006264 2.18 Uncharacterized ORF, role in phosphatidylinositol 
dephosphorylation  
1.69E-18 
CAL0004677 2.18 Uncharacterized ORF                                         0.0164763 
CAL0000438 2.18 Uncharacterized ORF  4.79E-13 
CAL0000406 2.18 Copper transporter  1.13E-122 
CAL0003535 2.18  Mitochondrial ribosomal protein S9 3.92E-239 
CAL0004983 2.18 Uncharacterized ORF  0.0120357 
CAL0002198 2.18 Uncharacterized ORF  9.00E-26 
CAL0003835 2.18 Uncharacterized ORF  6.17E-55 
CAL0004788 2.18 Uncharacterized ORF  5.32E-18 
CAL0003142 2.17 Putstive role in protein import into mitochondrial matrix and 
mitochondrial inner membrane presequence translocase complex 
localization                     
7.31E-94 
CAL0006105 2.17 Uncharacterized ORF                                         8.47E-68 
CAL0006372 2.17 Uncharacterized ORF  2.68E-05 
CAL0003001 2.17 Delta-12 fatty acid desaturase 4.27E-247 
CAL0003916 2.17 Uncharacterized ORF  2.36E-27 
CAL0005285 2.17 Activator of CDR1 induction by antifungal drugs  5.11E-146 
CAL0005804 2.17 Putative role in mitochondrial translation and mitochondrion 
localization                                
1.10E-47 
CAF0007117 2.17 Role in protein refolding and mitochondrial matrix localization                         5.14E-263 
CAL0002012 2.17 Uncharacterized ORF                                         1.17E-12 
CAL0005490 2.16 Uncharacterized ORF  2.77E-48 
CAL0001022 2.16 Uncharacterized ORF  1.33E-42 
CAL0005830 2.16 Putative mitochondrial ribosomal protein                                     8.03E-262 
CAL0005224 2.16 ERK-family protein kinase 1.50E-40 
CAL0002858 2.16 Verified ORF; Protein required for respiratory growth                                    4.27E-65 
CAL0004372 2.16 Ortholog(s) have tubulin binding activity, role in microtubule 
cytoskeleton organization, mitochondrion inheritance 
1.48E-112 
CAL0004422 2.16  Protein with a possible role in ER to Golgi transport  1.00E-300 
CAL0000739 2.16  Putative heat shock protein 6.77E-08 
CAL0001772 2.16 Uncharacterized ORF  2.20E-19 
CAL0005975 2.16 Uncharacterized ORF  4.06E-14 
CAL0006341 2.16 Biofilm- and planktonic growth-induced gene 1.55E-23 
CAL0005820 2.15 Uncharacterized ORF                            8.99E-254 
CAL0003344 2.15 Histidine kinase involved in a two-component signaling pathway that 
regulates cell wall biosynthesis  
1.54E-46 
CAL0001255 2.15 Uncharacterized ORF                                         1.19E-16 
CAL0001626 2.15 Uncharacterized ORF  4.31E-21 
CAL0005406 2.15 Putative transporter  1.21E-177 
CAL0005404 2.15 Phosphatidylinositol 3-phosphate 5-kinase  1.46E-43 
CAL0003518 2.15 Putative RNA exonuclease                1.52E-11 
CAL0002210 2.15 Uncharacterized ORF  9.16E-07 
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CAL0004475 2.15 Uncharacterized ORF  1.30E-145 
CAL0005260 2.15 Putative kynurenine 3-monooxygenase  3.30E-150 
CAL0000261 2.15 Integrin-like protein 1.60E-85 
CAL0006159 2.14 Uncharacterized ORF                                         5.80E-38 
CAL0003115 2.14 Similar to Snu114p, which is an RNA helicase involved in pre-
mRNA splicing  
9.83E-27 
CAL0002681 2.14 Uncharacterized ORF  3.55E-60 
CAL0002861 2.14 Uncharacterized ORF  5.85E-122 
CAL0000869 2.14 Uncharacterized ORF  2.30E-128 
CAL0002071 2.14 Uncharacterized ORF  2.94E-25 
CAL0006185 2.14 Uncharacterized ORF                                         1.42E-08 
CAL0000959 2.14 Copper-transporting P-type ATPase of Golgi 2.32E-24 
CAL0000615 2.14 Uncharacterized ORF  8.83E-61 
CAL0001739 2.14 kinesin from the bipolar family; involved in formation of mitotic 
spindle                           
8.18E-15 
CAL0000463 2.14 Septin 1.56E-83 
CAL0005619 2.14 Uncharacterized ORF                                         6.61E-38 
CAL0005953 2.14 Putative class III aminotransferase  0.00281208 
CAL0005231 2.14 Putative role in cellular zinc ion homeostasis and mitochondrial 
matrix localization                             
2.10E-56 
CAL0001612 2.14 Uncharacterized ORF                                         3.92E-08 
CAL0000192 2.13 Uncharacterized ORF  1.02E-38 
CAL0002960 2.13 Uncharacterized ORF  1.13E-69 
CAL0003350 2.13 Putative component of the microtubule-nucleating gamma-tubulin 
complex 
2.92E-19 
CAL0002441 2.13 Verified ORF; Protein with similarity to S. cerevisiae Pin4p        7.83E-64 
CAL0004671 2.13 Uncharacterized ORF  1.03E-55 
CAL0004773 2.13 Putative acyl CoA synthetase  2.98E-08 
CAL0004150 2.13 Component of mitochondrial ribosome  2.88E-209 
CAL0003753 2.13 Hyphal cell wall protein  4.38E-05 
CAL0002204 2.13 GPI-linked chitinase required for normal filamentous growth 1.00E-300 
CAL0001958 2.13 Mannosyltransferase 4.92E-39 
CAL0003546 2.13 Uncharacterized ORF                                 0.000580363 
CAL0006152 2.13 Putative RNA helicase                                      1.20E-24 
CAL0000977 2.13 Role in ER-associated protein catabolic process  1.90E-50 
CAL0006130 2.13 Role in mitochondrial threonyl-tRNA aminoacylation and 
mitochondrion localization                               
1.44E-75 
CAL0005698 2.13 Uncharacterized ORF  1.40E-14 
CAL0002725 2.13 Uncharacterized ORF  1.23E-09 
CAL0005346 2.12 Putative hexameric MCM complex subunit with a predicted role in 
control of cell division  
3.98E-68 
CAL0005954 2.12 Putative transcriptional repressor                                      4.04E-36 
CAL0002606 2.12 Essential transcriptional activator that regulates ribosomal protein 
genes and the rDNA locus  
1.95E-52 
CAL0000070 2.12 Uncharacterized ORF 
  
5.86E-34 
CAL0002529 2.12 Cell wall adhesin-like protein  8.21E-15 
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CAL0000527 2.12 Uncharacterized ORF                                 4.19E-08 
CAL0004337 2.12 Ortholog(s) have protein binding, bridging activity  9.23E-58 
CAL0004782 2.12 Putative transcription factor with zinc cluster DNA-binding motif                                 0.000378361 
CAL0000437 2.12 Uncharacterized ORF                                2.84E-16 
CAL0005448 2.12 Putative mitochondrial RNA polymerase specificity factord                         8.09E-68 
CAL0001479 2.12 Member of PDR subfamily of ABC family  9.21E-64 
CAL0004753 2.12 Zinc-finger protein; regulator of MDR1 transcription 1.87E-24 
CAL0004400 2.12 Putative component of the MBF and SBF transcription complexes 
involved in G1/S cell-cycle progression  
9.71E-50 
CAL0003395 2.11 Putative GPI-anchored adhesin-like protein  1.27E-16 
CAL0002781 2.11 Predicted membrane transporter  1.48E-19 
CAL0006077 2.11 Putative transcription factor with zinc finger DNA-binding motif                                 7.02E-24 
CAL0006238 2.11 Uncharacterized ORF  3.59E-15 
CAL0003451 2.11 Putative protein of unknown function  8.38E-19 
CAL0000288 2.11 Uncharacterized ORF  5.85E-26 
CAL0004686 2.11 Uncharacterized ORF 2.77E-217 
CAL0004712 2.11 Protein of beta-1,6-glucan synthesis  2.69E-72 
CAL0002610 2.11 Uncharacterized ORF; Hap43p-repressed gene  8.97E-76 
CAL0001819 2.11 Putative oxysterol-binding protein  5.47E-103 
CAL0003329 2.11 DNA topoisomerase type I activity  4.39E-18 
CAL0004461 2.11 Uncharacterized ORF                                8.66E-11 
CAL0002014 2.10 Uncharacterized ORF                                         5.70E-76 
CAL0002015 2.10 Putative heteropentameric replication factor C subunit                           6.47E-39 
CAL0003708 2.10 Putative transcription factor with zinc cluster DNA-binding motif                                 1.12E-34 
CAL0000074 2.10 Uncharacterized ORF                     3.07E-17 
CAL0000186 2.10 Uncharacterized ORF 4.21E-07 
CAL0000531 2.10 Uncharacterized ORF                                    2.25E-68 
CAL0003492 2.10 Uncharacterized ORF                                         1.36E-29 
CAL0002327 2.10 Uncharacterized ORF  3.46E-158 
CAL0001082 2.10 Uncharacterized ORF                              8.89E-14 
CAL0001228 2.10 Member of MDR subfamily of ABC family           3.29E-41 
CAL0005369 2.10 Transcriptional activator; regulates filamentous growth 3.99E-05 
CAL0005596 2.10 CNT family H(+)/nucleoside symporter  4.23E-183 
CAL0004656 2.10 Putative 3'-5' RNA exonuclease  6.17E-48 
CAL0006201 2.10 Involved in acidification of the vacuole 1.92E-57 
CAL0002234 2.10 Uncharacterized ORF                                         4.13E-12 
CAL0004910 2.09 Protein involved in sphingolipid biosynthesis 3.26E-44 
CAL0002186 2.09 Uncharacterized ORF                                         2.09E-08 
CAL0005742 2.09 Role in chaperone-mediated protein complex assembly  2.00E-108 
CAL0005679 2.09 Uncharacterized ORF  2.33E-23 
CAL0003791 2.09 Protein with homology to mitochondrial intermembrane space 
proteins; regulated by Sef1p-, Sfu1p-, and Hap43p                           
3.09E-47 
CAL0000346 2.09 Uncharacterized ORF                    2.07E-38 
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CAL0003516 2.09 Putative GPI transamidase  2.29E-48 
CAL0005087 2.09 Uncharacterized ORF                                         3.43E-15 
CAL0003695 2.09 Uncharacterized ORF                                         3.53E-70 
CAL0005435 2.08 Uncharacterized ORF                                         4.98E-39 
CAL0004523 2.08 Putative nuclear pore membrane glycoprotein                                    1.21E-72 
CAL0005915 2.08 Putative thymidylate synthase 5.61E-42 
CAL0003522 2.08 Predicted role in sphingolipid-mediated signaling pathway  4.00E-35 
CAL0005039 2.08 Ortholog(s) have ubiquitin binding activity  4.00E-231 
CAL0004451 2.08 Putative phosphatidylinositol 3-phosphate (PI3P) phosphatase  5.50E-28 
CAL0003511 2.08 NADPH-cytochrome P450 reductase 5.19E-243 
CAL0005246 2.08 Uncharacterized ORF                                         1.59E-27 
CAL0005461 2.08 Uncharacterized ORF 2.66E-166 
CAL0002620 2.08 Putative NAD-dependent (R,R)-butanediol dehydrogenase  0.0546733 
CAL0005144 2.08 Putative role in regulation of biogenesis of the cell wall                        3.00E-24 
CAL0003872 2.08 Putative adhesin-like protein                                      3.75E-25 
CAL0000767 2.08 Uncharacterized ORF                                         9.89E-16 
CAL0002954 2.07 Putative GTPase-activating protein  1.34E-283 
CAL0004925 2.07 Acts in regulation of glycolytic genes 2.01E-144 
CAL0003049 2.07 Uncharacterized ORF; Putative DNA polymerase III subunit  3.87E-50 
CAL0001944 2.07 Uncharacterized ORF                                         2.45E-11 
CAL0001642 2.07 Putative adhesin-like protein involved in cell wall maintenance                 1.00E-300 
CAL0004886 2.07 Uncharacterized ORF; Ortholog(s) have structural constituent of 
ribosome activity and mitochondrial small ribosomal subunit 
localization                            
2.00E-99 
CAL0006136 2.07 Putative nuclear polyadenylated RNA-binding protein 1.04E-70 
CAL0004962 2.07 Ortholog(s) have phospholipid-translocating ATPase activity and 
role in intracellular protein transport  
1.25E-54 
CAL0003054 2.07 Putative cell wall protein  8.06E-20 
CAL0006042 2.07 Uncharacterized ORF  1.22E-33 
CAL0005725 2.07 Putative pre-mRNA processing RNA-helicase  2.15E-36 
CAL0006099 2.07 ER protein-translocation complex subunit  1.00E-300 
CAL0003713 2.07 Uncharacterized ORF  9.99E-14 
CAL0000105 2.07 Role in ER to Golgi vesicle-mediated transport  7.56E-254 
CAL0004157 2.07 Role in mitochondrial asparaginyl-tRNA aminoacylation and 
mitochondrion localization                            
1.22E-40 
CAL0003413 2.06 Beta-mannosyltransferase 1.94E-11 
CAL0006031 2.06 Uncharacterized ORF; Putative cyclin-like protein                       3.68E-191 
CAL0000084 2.06 Uncharacterized ORF  1.16E-22 
CAL0005879 2.06 Role in protein import into mitochondrial matrix                      4.04E-83 
CAL0004527 2.06 Inositol phosphoryl transferase 1.43E-25 
CAL0004063 2.06 Predicted membrane transporter  1.73E-20 
CAL0002306 2.06 Role in mitotic cell cycle spindle orientation checkpoint       3.54E-09 
CAL0002583 2.06 Uncharacterized ORF; Putative multidrug resistance factor  6.41E-21 
CAL0004535 2.06 Uncharacterized ORF  3.51E-12 
Table A-5 continued 
148 
 
 
Gene ID 
 
Fold up-
regulated 
 
Function                     
 
P-value 
CAL0004924 2.06 Putative translation initiation factor 1.56E-297 
CAL0000073 2.06 Uncharacterized ORF; Hap43p-repressed gene                                       3.63E-15 
CAL0005807 2.06 Ortholog(s) have role in protein targeting to vacuole  2.82E-12 
CAL0003539 2.06 Rhomboid-like protein  7.58E-37 
CAL0000177 2.06 Putative aminopeptidase  2.34E-12 
CAL0004387 2.06 Uncharacterized ORF                                         0.0397405 
CAL0004319 2.06 Putative regulatory subunit of trehalose-phosphate synthase  4.47E-103 
CAL0002873 2.06 Uncharacterized ORF; Ortholog(s) have mitochondrion localization                                     1.12E-25 
CAL0002555 2.06 Uncharacterized ORF                                   1.09E-12 
CAL0006314 2.05 Protein similar to quinone oxidoreductases  9.60E-11 
CAL0005655 2.05 Uncharacterized ORF; Hap43p-induced gene                                       1.46E-06 
CAL0004985 2.05 Putative ammonia transport protein  1.97E-72 
CAL0001871 2.05 Uncharacterized ORF  1.92E-236 
CAL0004219 2.05 Predicted phosphotransferase activity          2.16E-55 
CAL0002638 2.05 Uncharacterized ORF  8.55E-120 
CAL0003727 2.05 Uncharacterized ORF                                         6.89E-09 
CAL0001431 2.05 Putative phospholipase  3.09E-97 
CAL0004037 2.05 Uncharacterized ORF;                      8.39E-07 
CAL0000342 2.05 Putative vesicular transport protein                         3.66E-116 
CAL0005647 2.05 Putative DNA-binding transcription factor                                     2.94E-12 
CAL0001274 2.05 Ortholog(s) have structural constituent of ribosome activity and 
mitochondrial large ribosomal subunit localization                            
3.64E-38 
CAL0004781 2.05 Putative transcription factor with zinc finger DNA-binding motif                 2.42E-12 
CAL0004606 2.05 Uncharacterized ORF                                         1.21E-13 
CAL0003093 2.05 Uncharacterized ORF                                     0.00152667 
CAL0003032 2.05 Uncharacterized ORF 3.99E-71 
CAL0002576 2.05 Role in protein import into mitochondrial inner membrane and 
mitochondrial inner membrane protein insertion complex localization                    
4.33E-195 
CAL0003873 2.05 Putative vacuolar membrane protein with a predicted role in 
sphingolipid metabolism 
1.76E-44 
CAL0006212 2.05 Putative casein kinase                                 3.60E-23 
CAL0005955 2.05 Uncharacterized ORF  7.70E-28 
CAL0005556 2.05 Uncharacterized ORF  9.43E-25 
CAL0001252 2.05 Protein part of the CCR4-NOT transcription regulatory complex                  9.66E-129 
CAF0006960 2.04 Ortholog(s) have structural constituent of ribosome activity  9.86E-60 
CAL0003480 2.04 Serine/threonine protein phosphatase catalytic subunit  1.00E-40 
CAL0005343 2.04 Involved in ubiquitin-mediated protein degradation 2.91E-93 
CAL0001018 2.04  Putative serine/threonine protein kinase; Hog1p-induced                                    1.19E-35 
CAL0004213 2.04 Uncharacterized ORF                               0.0135147 
CAL0002501 2.04 Dubious ORF; Late-stage biofilm-induced gene                                      0.144972 
CAL0003745 2.04 Ortholog(s) have chromatin binding activity  2.60E-61 
CAL0000365 2.03 Putative cell wall assembly regulatory protein;  2.15E-20 
CAL0001016 2.03 Uncharacterized ORF; Ortholog(s) have protein anchor activity  2.26E-83 
CAL0001175 2.03 Putative mitochondrial exonuclease 6.43E-14 
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CAL0004029 2.03 Uncharacterized ORF                                         3.13E-39 
CAL0001427 2.03 Putative Arf3p GTPase activating protein; Hap43p-repressed gene                        1.89E-31 
CAL0001302 2.03  Putative GPI-anchored adhesin-like protein                                    4.17E-24 
CAL0002855 2.03 Putative S-adenosyl-L-homocysteine hydrolase  1.00E-300 
CAL0004269 2.03 Putative GTPase-activating protein; involved in cell signaling 
pathways that control cell polarity               
5.78E-31 
CAL0004406 2.03 Uncharacterized ORF                                         2.08E-65 
CAL0002762 2.03 Putative component of the SBF transcription complex involved in 
G1/S cell-cycle progression 
1.45E-57 
CAL0002547 2.03 Putative protein disulfide-isomerase 1.00E-300 
CAL0001722 2.02 Uncharacterized ORF  2.03E-11 
CAL0000127 2.02 Uncharacterized ORF                                  2.15E-25 
CAL0006318 2.02 Protein with similarity to fatty acid desaturase (stearoyl-CoA 
desaturase)                
2.26E-33 
CAL0005717 2.02 Ortholog(s) have Rho GTPase activator activity  7.35E-81 
CAL0002765 2.02 Protein with a predicted role in docking and fusion of post-Golgi 
vesicles with the plasma membrane   
6.67E-62 
CAL0003877 2.02 Ortholog(s) have role in pseudohyphal growth  6.58E-13 
CAL0005023 2.02 Uncharacterized ORF  1.92E-24 
CAL0004481 2.02 Subtilisin-like protease (proprotein convertase)  1.68E-69 
CAL0001621 2.02 Putative serine palmitoyltransferase component  7.37E-86 
CAL0003712 2.02 Uncharacterized ORF; Hap43p-repressed gene  8.14E-101 
CAL0005225 2.02 Uncharacterized ORF  6.84E-30 
CAL0006108 2.02 Uncharacterized ORF; Hap43p-repressed gene                                       5.78E-231 
CAL0001280 2.02 Transcription factor; regulates hyphal gene expression  1.23E-52 
CAL0000071 2.01 Alpha-1,2-mannosyl transferase  1.00E-300 
CAL0005672 2.01 Ortholog(s) have trans-hexaprenyltranstransferase activity 6.47E-113 
CAL0120555 2.01 Uncharacterized ORF  7.04E-13 
CAL0003666 2.01 Putative role in nonsense-mediated mRNA decay  2.93E-98 
CAL0006369 2.01 Putative cytochrome c oxidase assembly protein                               2.38E-30 
CAL0003146 2.01 Ortholog(s) have FAD transmembrane transporter activity  1.68E-07 
CAL0001700 2.01 Ortholog(s) have DNA helicase activity                          5.70E-56 
CAL0001915 2.01 Putative transcription factor, regulator of purine biosynthetic genes 2.74E-39 
CAL0000132 2.01 Phosphorylated protein                        2.23E-34 
CAL0004392 2.01 Putative phenylalanine-tRNA ligase                            1.91E-92 
CAL0002780 2.01 Putative thiol-specific monooxygenase  3.24E-15 
CAL0004359 2.01 Putative DNA-dependent ATPase  2.87E-19 
CAL0006187 2.01 Ortholog(s) have structural constituent of ribosome activity                            1.01E-156 
CAL0001654 2.01 Uncharacterized ORF; Has domain(s) with predicted binding activity                                   3.35E-16 
CAL0004881 2.01 Uncharacterized ORF                             2.13E-31 
CAL0003506 2.01 Uncharacterized ORF; Putative acyl-CoA thioesterase                                      5.45E-09 
CAL0005220 2.01 Putative high-affinity, high-capacity xanthine-uric acid/H+ symporter 2.45E-08 
CAL0000068 2.01 Ortholog(s) have structural constituent of ribosome activity         2.27E-156 
CAL0004274 2.01 Uncharacterized ORF  1.93E-07 
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CAL0000743 2.01 Alpha-1,2-mannosyltransferase  5.09E-75 
CAL0000027 2.01 Transcriptional activator that likely regulates genes involved in 
phosphatidylcholine and phosphatidylinositol biosynthesis  
8.50E-06 
CAL0002272 2.01 Uncharacterized ORF; Ortholog(s) have role in translational 
termination and nucleus localization                                
5.45E-138 
CAL0002739 2.00 Required asymmetric inheritance of oxidatively damaged proteins  1.18E-07 
CAL0003059 2.00 Probable transcription factor required for filamentous growth 7.61E-21 
CAL0004311 2.00 Uncharacterized ORF 6.27E-16 
CAL0002493 2.00 Predicted methyltransferase activity and role in RNA capping 3.28E-23 
CAL0001948 2.00 Uncharacterized ORF                                         4.62E-17 
CAL0006370 2.00  Putative transcription factor with zinc cluster DNA-binding motif                                 1.42E-09 
 
CAL0001272 2.00 MAP kinase kinase kinase (MAPKKK) that regulates Hog1p 
activation and signaling 
4.85E-74 
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CAL0004548 132.07 Alternative oxidase 1.00E-300 
CAL0000931 115.14 Uncharacterized ORF  1.00E-300 
CAL0000982 73.36 Formate dehydrogenase 1.00E-300 
CAL0001883 50.68 Uncharacterized ORF  1.00E-300 
CAF0006908 36.29 Uncharacterized ORF; Hap43p-repressed gene; hypoxia 
downregulated                                
1.00E-300 
CAL0001258 19.28 Uncharacterized ORF; Hap43p-induced gene                                       1.00E-300 
CAL0005695 18.42 Uncharacterized ORF  3.21E-58 
CAL0120803 17.58 Uncharacterized ORF                                         1.69E-195 
CAL0000550 14.28 Glycerophosphoinositol permease 1.00E-300 
CAL0002678 13.70 Similar to heat-shock protease protein  1.08E-143 
CAL0002987 10.18 Putative oxidoreductase, iron utilization; regulated by Sfu1p, 
Sef1p, Hap43p  
1.64E-55 
CAL0004080 9.95 Uncharacterized ORF; Hap43p-repressed gene                         1.00E-300 
CAL0000590 9.51 Uncharacterized ORF  1.00E-300 
CAL0002189 8.56 Uncharacterized ORF   1.00E-300 
CAL0005929 7.97 Putative oxidoreductase  1.00E-300 
CAL0000501 7.75 Putative potassium transporter  3.63E-224 
CAL0004550 7.70 Alternative oxidase  1.80E-66 
CAL0003857 7.53 Uncharacterized ORF; Hap43p-repressed gene  3.23E-140 
CAL0001071 7.21 Nitric oxide dioxygenase  1.26E-200 
CAL0003313 7.07 Late-stage biofilm-induced gene; induced by nitric oxide; 
Hap43p-repressed             
1.00E-300 
CAL0000448 6.66 UDP-glucose 4-epimerase  1.00E-300 
CAL0004676 6.29 Protein similar to Pcl5p and other cyclins for Pho85p kinase; 
Gcn4p-induced  
3.85E-247 
CAL0006389 6.21 Phosphoenolpyruvate carboxykinase             1.00E-300 
CAL0002175 6.15 Uncharacterized ORF 2.32E-135 
CAL0000451 5.98 Putative galactose-1-phoshphate uridyl transferase; 
downregulated by hypoxia                     
1.00E-300 
CAL0003136 5.70 Putative high-affinity maltose transporter 1.00E-300 
CAL0005139 5.66 Uncharacterized ORF; Hap43p-repressed gene 1.00E-300 
CAL0001847 5.66 Protein of unknown function; Plc1p-regulated 3.94E-55 
CAL0000195 5.57 Uncharacterized ORF; Hap43p-induced gene                                  3.36E-86 
CAL0003582 5.54 Putative transcription factor with zinc finger DNA-binding 
motif 
1.00E-300 
CAL0003856 5.32 Dubious ORF                       5.08E-96 
CAL0002350 5.29 Response regulator of a two-component system involved in 
stress, morphogenesis, virulence  
1.00E-300 
CAL0004997 5.26 Uncharacterized ORF             2.49E-168 
CAL0001097 5.24 Uncharacterized ORF; Similar to cell wall proteins  8.61E-155 
CAL0005709 4.92 Putative phosphatidyl synthase 1.00E-300 
CAL0003246 4.90 TEA/ATTS transcription factor involved in pheromone 
response in white cells  
1.00E-300 
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CAL0004456 4.90 Copper- and zinc-containing superoxide dismutase  1.00E-300 
CAL0003028 4.88 Uncharacterized ORF                                         1.00E-300 
CAL0002696 4.77 High-affinity glucose transporter  1.00E-300 
CAL0005548 4.61 Plasma membrane-localized protein  4.29E-20 
CAL0004872 4.39 Uncharacterized ORF                          1.00E-300 
CAL0000706 4.39 Uncharacterized ORF                                         1.00E-300 
CAL0003529 4.35 Uncharacterized ORF                          4.59E-284 
CAL0001013 4.13 Uncharacterized ORF                                  8.02E-133 
CAL0002216 4.08 ADP-ribosylation factor, probable GTPase involved in 
intracellular transport                     
4.88E-19 
CAL0003860 4.07 Predicted type 2C protein phosphatase                    1.00E-300 
CAL0004432 3.94 Possible role in polyamine transport; MFS-MDR family  3.72E-291 
CAL0003510 3.88 Uncharacterized ORF  1.00E-300 
CAL0120801 3.87 Uncharacterized ORF                                         1.00E-300 
CAF0006934 3.80 Protein involved in ATP biosynthesis  1.00E-300 
CAL0000843 3.70 Uncharacterized ORF; Hap43p-repressed gene  8.16E-146 
CAL0004487 3.70 Major cell-surface ferric reductase under low-iron conditions  1.00E-300 
CAL0003807 3.59 Putative protein phosphatase inhibitor; Hap43p-repressed 1.00E-300 
CAL0120807 3.57 Putative adhesin-like protein                                      1.41E-293 
CAL0005504 3.52 Protein similar to S. cerevisiae Ecm21p ; alkaline upregulated 
by Rim101p  
8.71E-36 
CAL0006378 3.46 Uncharacterized ORF; Hap43p-repressed gene; biofilm-
induced                                      
0.00013006
8 
CAL0005271 3.35 Copper- and zinc-containing superoxide dismutase  8.01E-254 
CAL0003653 3.34 Putative alcohol dehydrogenase  1.58E-207 
CAL0004170 3.32 Predicted flavin adenine dinucleotide binding, oxidoreductase 
activity and role in oxidation-reduction process                          
3.24E-128 
CAL0120629 3.26 Uncharacterized ORF                                         1.00E-300 
CAL0004199 3.25 Uncharacterized ORF; Hap43p-repressed gene                                    1.26E-41 
CAL0003785 3.16 Uncharacterized ORF; Beta-mannosyltransferase            0.00445478 
CAL0003833 3.14 Uncharacterized ORF                                         4.87E-147 
CAL0001177 3.09 Uncharacterized ORF                         5.25E-29 
CAL0120835 2.98 Uncharacterized ORF 4.26E-06 
CAL0001581 2.95 Uncharacterized ORF; Protein similar to pirin 1.10E-26 
CAL0004585 2.92 Uncharacterized ORF                                         1.00E-300 
CAL0005860 2.92 Uncharacterized ORF                                  3.46E-79 
CAL0120981 2.92 Uncharacterized ORF  1.24E-25 
CAL0120705 2.92 Uncharacterized ORF                                         5.01E-25 
CAL0000450 2.91 Putative UDP-glucose-4-epimerase                       1.00E-300 
CAL0002961 2.89 Uncharacterized ORF; Hap43p-repressed gene                                   6.97E-14 
CAL0003891 2.85 Uncharacterized ORF 9.13E-102 
CAL0001598 2.85 Uncharacterized ORF                                         1.47E-42 
CAL0004943 2.85 Uncharacterized ORF                             8.23E-49 
CAL0004792 2.85 Putative fumarate hydratase  1.00E-300 
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CAL0000972 2.84 Putative methyltransferase  1.42E-181 
CAL0004974 2.83 Uncharacterized ORF                1.00E-300 
CAL0002816 2.82 Uncharacterized ORF 2.16E-229 
CAL0120493 2.80 Pseudogene                               7.08E-30 
CAL0001619 2.78 Uncharacterized ORF; ATP sulfurlyase of sulfate assimilation  3.17E-08 
CAL0004502 2.77 Protein that affects filamentous growth; late-stage biofilm-
induced gene                                 
1.20E-25 
CAL0004289 2.74 Putative subunit of the F1F0-ATPase complex     1.96E-15 
CAL0000682 2.72 Uncharacterized ORF; Similar to glutathione peroxidase  9.16E-96 
CAL0006076 2.71 Putative transmembrane protein 1.00E-300 
CAL0005475 2.70 Putative NAD-specific glutamate dehydrogenase  1.00E-300 
CAL0005645 2.70 Putative glucose transporter of the major facilitator 
superfamily 
1.06E-08 
CAL0002676 2.69 Putative glycerophosphoinositol permease                  1.00E-300 
CAL0004471 2.67 Putative protein with a predicted role in mitochondrial iron 
metabolism; Hap43p-repressed gene 
3.00E-137 
CAL0000649 2.66 Ortholog(s) have oxidoreductase activity    3.09E-257 
CAL0002133 2.65 Uncharacterized ORF 7.41E-284 
CAL0005376 2.64 Ortholog(s) have oxidoreductase activity        7.60E-121 
CAL0002044 2.63 Putative glutamate decarboxylase  1.00E-300 
CAL0004247 2.60 GPI-anchored cell wall protein 6.82E-106 
CAF0007037 2.59 Protein localized to the mitochondrial membrane                                   1.00E-300 
CAL0001649 2.57 Uncharacterized ORF; Hap43p-induced gene                                       1.00E-300 
CAL0003690 2.56 Putative adenylylsulfate kinase; predicted role in sulfur 
metabolism  
1.00E-300 
CAL0004054 2.56 Uncharacterized ORF                                         1.51E-10 
CAL0003826 2.55 Uncharacterized ORF  6.54E-61 
CAF0006952 2.54 Uncharacterized ORF  5.91E-18 
CAF0007053 2.54 Uncharacterized ORF  1.34E-11 
CAL0004298 2.51 Transcription factor with zinc cluster DNA-binding motif 
involved in glycolysis           
1.00E-300 
CAL0006005 2.51 Uncharacterized ORF                                         1.00E-300 
CAL0005909 2.50 Protein with Gal4p-like DNA-binding domain         1.00E-300 
CAL0006377 2.50 Putative 3-dehydroquinate dehydratase                             8.38E-253 
CAL0005485 2.49 Putative endoplasmic reticulum protein; possibly adherence-
induced                                   
8.86E-53 
CAL0001146 2.49 Putative constitutive acid phosphatase; negatively regulated 
by Rim101p  
1.00E-300 
CAL0002956 2.46 Putative phosphate permease 1.77E-273 
CAL0002899 2.46 Putative GPI-anchored protein; Hap43p-repressed gene                                    8.00E-33 
CAL0120690 2.45 Uncharacterized ORF                                         1.48E-62 
CAL0120739 2.45 Uncharacterized ORF                                         8.64E-06 
CAL0000788 2.44 Putative glucoamylase                                1.23E-221 
CAL0120789 2.44 Uncharacterized ORF                    4.63E-06 
CAL0004657 2.43 Cytochrome c oxidase                             1.36E-72 
CAL0000439 2.42 Putative glucose transporter of the major facilitator 
superfamily  
2.50E-104 
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CAL0001572 2.41 Uncharacterized ORF 1.00E-300 
CAL0005980 2.39 Putative F0-ATP synthase subunit 4  6.46E-30 
CAF0007126 2.38 Mitochondrial ATPase complex subunit           3.60E-46 
CAL0120954 2.35 Uncharacterized ORF                                         1.00E-300 
CAL0001467 2.35 Glycerol permease involved in glycerol uptake          1.00E-300 
CAF0007051 2.34 Putative mitochondrial F1F0 ATP synthase subunit                             1.03E-64 
CAL0002512 2.33 Protein similar to S. cerevisiae Sds24p; transcription 
regulated by Mig1p and Tup1p                       
2.30E-89 
CAL0000917 2.33 Nucleoside diphosphate kinase   1.00E-300 
CAL0120750 2.32 Uncharacterized ORF                                         1.00E-300 
CAL0003972 2.29 Uncharacterized ORF  1.00E-300 
CAL0002995 2.29 Transcriptional repressor; regulates chlamydospore 
development  
9.44E-250 
CAL0005201 2.28 Transcription factor that binds upstream of ribosomal protein 
genes 
1.87E-51 
CAL0000320 2.27 Putative proline oxidase; alkaline upregulated by Rim101p                              1.00E-300 
CAL0000857 2.27 Uncharacterized ORF; Hap43p-repressed gene                                       1.00E-300 
CAL0003212 2.26 Uncharacterized ORF; Hap43p-repressed gene                         1.10E-223 
CAL0001980 2.26 Uncharacterized ORF                   1.83E-17 
CAL0000358 2.26 Uncharacterized ORF                1.53E-92 
CAL0004380 2.25 Uncharacterized ORF                                         1.03E-44 
CAL0003363 2.24 Putative alcohol dehydrogenase  2.39E-58 
CAL0003390 2.23 Putative constitutive acid phosphatase  3.73E-48 
CAL0001669 2.23 Uncharacterized ORF  1.00E-300 
CAL0003361 2.23 Uncharacterized ORF                                         3.96E-96 
CAL0000446 2.23 Galactokinase  7.24E-43 
CAL0000301 2.22 Uncharacterized ORF; Hap43p-repressed gene; repressed 
by nitric oxide                                   
2.33E-68 
CAL0006052 2.22 Uncharacterized ORF; Hap43p-repressed gene; repressed 
by nitric oxide                                   
1.00E-300 
CAF0007033 2.21 Putative cytochrome c oxidase                            1.00E-300 
CAL0003939 2.20 Uncharacterized ORF                       1.00E-300 
CAL0003242 2.20 Imidazoleglycerol-phosphate dehydratase, enzyme of 
histidine biosynthesis 
1.00E-300 
CAL0120612 2.19 Uncharacterized ORF 1.00E-300 
CAL0004762 2.19 Putative NADH dehydrogenase that could act alternatively to 
complex I in respiration            
3.92E-136 
CAL0000684 2.19 Uncharacterized ORF; Putative thiol peroxidase                                      0.0109287 
CAL0004848 2.17 Putative DNA-binding transcription factor 1.00E-300 
CAL0005196 2.17 Uncharacterized ORF                                         1.03E-14 
CAL0003019 2.16 Uncharacterized ORF                 2.82E-67 
CAL0001782 2.15 Putative inducible acid phosphatase 0.00392063 
CAL0003397 2.14 Uncharacterized ORF                         6.48E-14 
CAL0005651 2.13 Uncharacterized ORF; Ortholog(s) have role in iron-sulfur 
cluster assembly     
1.61E-08 
CAF0007449 2.13 Uncharacterized ORF                               2.92E-131 
CAL0004062 2.12 Uncharacterized ORF; Hap43p-repressed gene                                       2.93E-102 
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CAL0005907 2.12 Uncharacterized ORF 2.22E-131 
CAL0003434 2.11 Plasma membrane-localized protein; repressed by nitric 
oxide                 
6.59E-11 
CAL0002597 2.11 Ortholog(s) have omega peptidase activity, role in glutathione 
catabolic process                          
1.00E-300 
CAL0001093 2.11 Protein related to flavohemoglobins            1.00E-300 
CAL0000792 2.08 Glutathione-dependent formaldehyde dehydrogenase 
involved in glycine catabolism              
6.32E-88 
CAL0004747 2.07 Uncharacterized ORF; regulated by Sef1p-, Sfu1p-, and 
Hap43p                                
1.44E-87 
CAL0003892 2.06 Protein involved in proteolytic activation of Rim101p, which 
regulates pH response        
1.00E-300 
CAL0002622 2.06 Putative homocitrate synthase; repressed by nitric oxide and 
by hypoxia              
3.19E-47 
CAL0003655 2.06 Mitochondrial ADP/ATP carrier protein involved in ATP 
biosynthesis  
1.44E-64 
CAL0120862 2.05 Uncharacterized ORF  7.09E-209 
CAL0005662 2.05 Zinc cluster transcription factor 1.00E-300 
CAL0001727 2.04 Uncharacterized ORF                                         1.00E-300 
CAL0120825 2.04 Uncharacterized ORF                                         6.11E-141 
CAL0001540 2.04 Uncharacterized ORF  6.20E-09 
CAL0004908 2.02 Uncharacterized ORF 1.00E-300 
CAL0005780 2.02 Putative NADH-cytochrome-b5 reductase; soluble protein in 
hyphae;  
2.61E-09 
CAL0120936 2.02 Uncharacterized ORF                                         1.00E-300 
CAL0004024 2.01 Putative cation conductance protein 1.00E-300 
CAF0007034 2.01 Putative subunit VIIa of cytochrome c oxidase                                2.46E-49 
CAL0000596 2.01 Putative ubiquinol-cytochrome-c reductase, subunit 7; 
Hap43p-repressed gene                                  
2.42E-107 
CAL0001616 2.01 Ortholog(s) have inorganic cation transmembrane transporter 
activity                  
1.70E-273 
CAL0003729 2.01 Ortholog(s) have phosphoprotein phosphatase activity  1.00E-300 
CAL0003252 2.00 F1-ATP synthase complex subunit 5.08E-171 
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